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Abstract  
Cardiovascular disease (CVD) is the leading cause of global mortality, with the incidence of 
cardiovascular related pathologies remaining a public health burden. CVD encompasses pathologies 
of the vascular tree and heart, including, for example, peripheral artery disease, coronary heart 
disease and ischaemic stroke. Atherosclerosis is the primary pathological process leading to CVD and 
is characterised by a multifactorial pathophysiology that first manifests in the vascular endothelium. 
Termed endothelial dysfunction, this early marker of atherosclerosis has become a focus of interest 
for identifying individuals at risk of a profound cardiovascular insult, particularly arising from lifestyle 
choices such as physical inactivity and calorie-rich diets. Dietary interventions have received increasing 
attention in recent years as inexpensive strategies to potentially combat the ever-increasing global 
burden of CVD. A high dietary flavonoid intake is associated with a reduction in CVD risk and several 
studies have revealed a strong, inverse relation between the regular intake of tea, a major source of 
dietary flavonoids, and CVD risk. Tea has demonstrated improved conduit artery endothelial function 
and glucose handling in both healthy individuals and in those with overt CVD. However, the effects of 
tea on the microvasculature and cerebrovasculature are not yet understood, particularly in relation 
to lifestyle factors. The primary aim of this thesis was to explore the impact of tea ingestion on 
peripheral and cerebral micro- and macrovascular function in humans. 
 
In an initial methodological study, the day-to-day reproducibility of thermally stimulated cutaneous 
microvascular function was assessed. Fifteen, healthy males (28 ± 5 yrs, BMI 25 ± 2 kg/m2) attended 
two experimental trials 2-7 days apart. During each trial, baseline and maximal thermally stimulated 
forearm skin responses were examined simultaneously at four sites on the dominant forearm using 
laser Doppler flowmetry (LDF). The following heating protocols were adopted: 1. Rapid 39°C (0.5°C/5-
s), 2. Rapid 42°C (0.5°C/5-s) 3. Gradual 42°C (0.5°C/2-min 30-s) and 4. Slow 42°C (0.5°C/5-min). The 
coefficient of variation (CV) was calculated for absolute flux, cutaneous vascular conductance (CVC; 
flux/mean arterial pressure, MAP) and CVC expressed as a percentage of maximal CVC at 44°C 
(%CVCmax) at three different time points; baseline (33°C), plateau (39/42°C) and maximal (44°C). 
Reproducibility of baseline flux, CVC and %CVCmax was 17-29% across all protocols. During the plateau, 
Rapid, Gradual and Slow 42°C demonstrated a reproducibility of 13-18% for flux and CVC and 5-11% 
for %CVCmax. However, Rapid 39°C demonstrated a lower reproducibility for flux, CVC and %CVCmax 
(21%). Reproducibility at 44°C was 12-15% for flux and CVC across all protocols. The good-to-moderate 
reproducibility of the Rapid, Gradual and Slow 42°C protocols supported their (simultaneous) use to 
assess peripheral microvascular function.  
 
The aim of Chapter 5 was to examine the acute (2-hour) cutaneous vascular responses to local skin 
heating following ingestion of black tea in a healthy adult population. Twenty healthy participants (58 
± 5 yrs, BMI 26 ± 4 kg/m2, 9 men) attended two experimental trials (tea, placebo), 7-days apart in a 
randomised, controlled, double-blind, cross-over design. Participants ingested a single dose of 200 ml 
black tea or placebo, followed by assessment of forearm cutaneous microvascular function using LDF 
and three distinct local skin heating protocols to distinguish between axon- and endothelium-
dependent vasodilation: 1. Rapid 42°C, 2. Rapid 39°C and 3. Gradual 42°C. On the contralateral arm, 
full-field laser perfusion imaging (FLPI) was used to assess forearm cutaneous microvascular function 
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during Gradual 42°C. Data were analysed as CVC and %CVCmax. Rapid local heating to 39°C or 42°C 
demonstrated no effect of tea for flux, CVC or %CVCmax (all P>0.05). Gradual local heating to 42°C, 
however, produced a higher skin blood flow following black tea ingestion for absolute CVC (P=0.04) 
when measured by LDF, and higher absolute flux (P<0.001) and CVC (P<0.001) measured with FLPI. No 
effect of tea was found for %CVCmax when assessed by either LDF or FLPI.  
 
The aim of the study outlined in Chapter 6 was to examine the effect of daily green tea consumption 
(equivalent to 6 cups/day) on changes in peripheral vascular function and glucose handling after a 7-
day ‘unhealthy’ lifestyle in healthy males. Twelve healthy males (29 ± 6 yrs, BMI 25 ± 2 kg/m2) 
underwent two periods of 7-days ‘unhealthy’ lifestyle (UL) comprising of combined physical activity 
reduction (-50% steps per day) and high fat, high carbohydrate overfeeding (+50% kcal per day, 
comprising 65% fat) in a randomised, controlled, double-blind, cross-over design. Each intervention 
period was separated by a 2-week washout. During each 7-day UL-period, participants ingested three 
doses of an active green tea drink (UL-Tea) or a placebo drink (UL-Placebo) per day at regular intervals. 
Participants attended the laboratory before and after each 7-day intervention (a total of 4 visits). 
During each visit the following were examined: mean arterial blood pressure (MAP), dominant 
forearm cutaneous microvascular function using LDF and local heating protocols 1. Rapid 42°C, 2. 
Rapid 39°C and 3. Gradual 42°C, macrovascular function using brachial artery and femoral artery 
endothelium-dependent function via flow-mediated dilation (FMD), carotid artery vasoreactivity to 
the cold pressor test (CAR%), cerebrovascular function via CO2 reactivity and dynamic cerebral 
autoregulation, and insulin sensitivity and glucose handling through a mixed-meal (1200kcal, 
comprising 60% carbohydrates, 33% fat and 7% protein) tolerance test. Linear mixed models (main 
effects of intervention and time) were used to examine the impact of the lifestyle intervention (pre vs 
post) and green tea ingestion (UL-Tea vs UL-Placebo). Body mass demonstrated a slight increase 
following both UL-Tea and UL-Placebo (P>0.05). MAP was increased after UL-Placebo, whereas it was 
reduced after UL-Tea (P=0.06). LDF responses to rapid local heating demonstrated non-significant 
reductions in CVC following UL-Placebo but no difference following UL-Tea (P>0.05), with a significant 
interaction of time*condition*temperature observed following Gradual 42°C (P=0.02). Brachial artery 
FMD was not different pre vs post or between UL-Placebo and UL-Tea (P>0.05), whereas femoral 
artery FMD decreased after UL-Placebo, which was prevented during UL-Tea (P<0.001). CAR% 
decreased following UL-Placebo, which was prevented during UL-Tea (P=0.04). CO2 reactivity and 
dynamic cerebral autoregulation demonstrated no differences between UL-Placebo and UL-Tea or 
over time. Postprandial glucose was increased after UL-Placebo, whereas a reduction in postprandial 
glucose occurred after UL-Tea (P=0.03). Postprandial insulin levels were higher after UL-Placebo, 
consistent with insulin resistance, whereas following UL-Tea the insulin response was reduced and 
demonstrated an interaction of time*condition (P<0.001).  
 
The aim of Chapter 7 was to examine the effect of acute oral (-)-epicatechin ingestion on 
cerebrovascular function in healthy adults. Seven healthy males (32 ± 13 yrs, BMI 25 ± 1 kg/m2) 
attended two experimental trials ((-)-epicatechin and placebo) 7-days apart in a randomised, 
controlled, double-blind, cross-over design. Participants underwent baseline assessment of 
cerebrovascular function using transcranial Doppler ultrasound (TCD), comprising CO2 reactivity to 
hypercapnia and dynamic cerebral autoregulation via squat-stand manoeuvres at 0.10 Hz and 0.05 Hz. 
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Following completion of the baseline measures, participants immediately consumed an oral dose of 
the test product (2 x 50 mg capsules of (-)-epicatechin or 2 capsules of colour-matched placebo) 
together with a glass of water, following which participants relaxed in the laboratory. 2-hours post-
ingestion repeat measures of cerebrovascular function were performed. Linear mixed models (main 
effects of condition and time) examined the differences between (-)-epicatechin and placebo 
interventions (pre vs post) on cerebrovascular function. No differences were observed at pre vs post 
baseline for middle cerebral artery velocity (MCAv) or MAP (all P>0.05). There were no differences in 
the cerebrovascular responses to CO2 or dynamic autoregulation between (-)-epicatechin and 
placebo.  
 
The findings from this thesis suggest that, firstly, use of simultaneous skin local heating protocols 
provides a valuable means of interrogating the cutaneous microvessels for mechanistic insight in 
intervention studies. Secondly, current findings evidence improved cutaneous microvascular function 
following acute black tea consumption. Furthermore, the research work undertaken in this thesis 
provides important insight into the effects of tea consumption on peripheral (micro- and macro-) 
vascular function and insulin sensitivity, particularly its abrogative effects on lifestyle-induced vascular 
impairments. However, the effects of tea consumption on the cerebrovasculature remain uncertain. 
Overall, based on the current findings, tea consumption presents a simple, inexpensive, non-
pharmacological cardioprotective strategy to help combat the ever-increasing global burden of CVD.  
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Chapter 1. Introduction 
Cardiovascular disease (CVD) remains the leading cause of global mortality, representing ~30% of all 
deaths annually (WHO, 2016). Despite a decline in CVD mortality in the United Kingdom during the 
last 25 years, the incidence of cardiovascular related pathologies remains a public health burden, as 
CVD morbidity has shown little change (Bhatnagar et al., 2016). CVD encompasses pathologies of the 
vascular tree and heart, including, for example, peripheral artery disease, coronary heart disease 
(CHD) and ischaemic stroke. Atherosclerosis is the primary pathological process leading to CVD and is 
characterised by a multifactorial pathophysiology that first manifests in the vascular endothelium, 
prior to any detectable structural changes to the vessel wall being apparent on angiography or 
ultrasound imaging (Davignon & Ganz, 2004). Termed endothelial dysfunction, this early marker of 
atherosclerosis has become a focus of interest for identifying individuals at risk of a profound 
cardiovascular insult, as well as investigating therapeutic strategies targeting a reversal of this 
pathological process.  
 
Ongoing epidemiological evidence implicates lifestyle as being a key component in endothelial 
dysfunction and, therefore, CVD risk and progression. In contrast to the non-modifiable risk factors 
for CVD, which include genetics, gender, age and ethnicity, lifestyle modification through changes to 
behavioural patterns can reduce the risk of CVD and somewhat reverse the pathological processes 
associated with endothelial dysfunction. Physical inactivity, and obesity arising from poor dietary 
habits, are continuing to increase across the United Kingdom (Baker, 2017; BHF, 2017) and are 
considered two of the most important modifiable risk factors for the development of cardiometabolic 
disorders, in addition to smoking, hypertension and hypercholesterolaemia. Diets rich in sodium and 
saturated fat are associated with CVD, whereas other dietary components are suggested to be 
cardioprotective and exert a positive influence upon cardiovascular health, such as fruits and 
vegetables, spices, omega-3-fatty acids and low-fat dairy products (Feyh et al., 2016; Mangels & 
Mohler, 2017). As the deleterious effects of sedentary lifestyles have become more apparent and the 
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beneficial effects of certain dietary components receive wider scientific recognition, dietary 
interventions have received greater attention as inexpensive tools to combat the ever-increasing 
global burden of CVD.  
 
The Mediterranean diet is widely reputed to exert a protective effect upon cardiometabolic health, 
largely achieved via mechanisms related to its richness in plant-derived products, such as olive oil, 
fruits and vegetables, which contain bioactive compounds known as polyphenols (Ros et al., 2014). 
These naturally occurring compounds are the most abundant antioxidant in the human diet; to date, 
in excess of 8,000 polyphenolic compounds have been identified (Pandey & Rizvi, 2009). Polyphenols 
can be broadly categorised into four subclasses according to their phenolic ring structure and ring-
binding elements: flavonoids, phenolic acids, lignans and stilbenes (Pandey & Rizvi, 2009; Amiot et al., 
2016). Flavonoids account for the greatest proportion of polyphenols (60%) and were discovered in 
the 1930s by the Hungarian scientists Rusznyak and Szent-Györgyi, who observed that a substance 
derived from lemon peel reduced the permeability and fragility of the human capillary (Rusznyak & 
Szent-Györgyi, 1936; Geleijnse & Hollman, 2008). The substance was subsequently known as “vitamin 
P” and was later considered a mixture of flavonoids, rather than a pure substance (Bruckner & Szent-
Györgyi, 1936; Geleijnse & Hollman, 2008). Interest in flavonoids waned in the 1950s after they lost 
their vitamin status and were subsequently thought to be detrimental to health in the 1970s (Geleijnse 
& Hollman, 2008). Scientific focus towards flavonoids was renewed in the early 1990s when red wine 
was observed to inhibit the oxidation of low density lipoprotein (LDL) in vitro and was implicated in 
explaining why the French diet is high in saturated fat, yet epidemiological observations suggest that 
the population have a low incidence of coronary heart disease, known as the “French paradox” 
(Ferrières, 2004). A subsequent Dutch study reported a substantial protective effect of up to a 70% 
reduction in coronary artery disease-related mortality, following regular consumption of several 
flavonoids in elderly men (Hertog et al., 1993). The major source of flavonoids in the cohort was tea 
(61%), followed by onions (13%) and apples (10%).  
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Following the seminal studies in the early 1990s, a new era of polyphenol research began and the role 
of dietary factors on CVD risk has been explored in recent years. Epidemiological studies have reported 
conflicting results, but the consensus of scientific opinion is that a high dietary flavonoid intake is 
associated with a reduction in CVD risk (Arts et al., 2001; Geleijnse et al., 2002; Mink et al., 2007; 
McCullough et al., 2012; Cassidy et al., 2013; Ponzo et al., 2015; Kim et al., 2016). Such reductions 
have been reported in middle-aged (Cassidy et al., 2013; Ponzo et al., 2015) and elderly (Arts et al., 
2001; McCullough et al., 2012) populations, with reductions in ischaemic heart disease risk being 
observed related to flavonoids derived from both tea (Geleijnse et al., 2002) and berries (Cassidy et 
al., 2013) over 5- and 18-year follow-ups, respectively. Nevertheless, many mechanistic studies have 
been undertaken in vitro and in animal models, with observational human studies often lacking longer-
term interventions (Williamson & Manach, 2005) and reporting inconsistent findings due to 
heterogeneity in the study design, a lack of control group, background lifestyle and dietary factors, in 
addition to a lack of clarity regarding the polyphenol dosage (Chong et al., 2010). This is particularly 
true for studies investigating the chronic effects of tea (Deka & Vita, 2011), which is the major source 
of dietary flavonoids in many countries globally (Yahya et al., 2016).  
 
Several studies have revealed a strong, inverse relation between regular intake of tea and CVD risk 
(Grassi et al., 2009b; Greyling et al., 2014), with regular consumption of black tea suggested to dose-
dependently improve endothelial function in conduit vessels in healthy males (Duffy et al., 2001; 
Hodgson et al., 2002; Hodgson et al., 2005; Grassi et al., 2009b; Schreuder et al., 2014). Similar benefits 
of tea ingestion on endothelial function have also been observed in conduit vessels in both healthy 
individuals with mildly elevated serum cholesterol and triglycerides (Hodgson et al., 2002) and in those 
with CVD (Duffy et al., 2001). However, to date, no previous study has robustly explored whether 
beneficial effects of tea are also apparent in smaller vessels, e.g., the skin microcirculation.  
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The microcirculation represents an important vascular bed in the pathogenesis of many 
cardiometabolic diseases and acts as a surrogate for generalised vascular function (Holowatz et al., 
2008). Furthermore, valuable insight into the mechanisms associated with vascular function can be 
gained by assessment of microvascular function. The cutaneous microcirculation, therefore, presents 
an easily accessible site to detect changes in function following dietary interventions, e.g., tea 
ingestion, that may be representative of other vascular beds. Microvascular integrity can be assessed 
through non-invasive methods, with local skin heating increasingly used in conjunction with laser 
imaging techniques, such as laser Doppler flowmetry (LDF), to evaluate skin blood flow (SkBF) 
responses. Currently, several local heating protocols are used to assess cutaneous microvascular 
function (Minson et al., 2001; Black et al., 2008b; Choi et al., 2014), with variations in the rate of skin 
heating and plateau temperature presenting differences in the contribution of the vasodilator 
pathways in the local heating response. Such protocols are, therefore, useful in achieving an insight 
into the distinct dilator pathways involved in intervention studies, such as tea. However, the 
comparable reproducibility of the various local heating protocols is unknown. Therefore, aim 1 of this 
thesis was to simultaneously determine the inter-day reproducibility of four commonly used local 
heating protocols for assessing cutaneous microvascular function. Upon establishing the 
reproducibility of these protocols, appropriate protocols were selected to fulfil aim 2 of this thesis, 
which was to examine the acute (2-hour) cutaneous vascular responses to local skin heating following 
ingestion of black tea in a healthy adult population.  
 
The negative consequences of poor lifestyle behaviours are well documented, with modern lifestyles 
typically characterised by low levels of daily energy expenditure and high fat, high calorie diets that 
are strongly associated with long-term cardiometabolic disease risk (Hennig et al., 2001). In addition 
to the vascular effects of tea, regular intake of tea is also associated with a lower risk for developing 
diabetes (Iso et al., 2006; Stote & Baer, 2008; Jing et al., 2009; Park et al., 2014). The mechanisms for 
a potential positive relationship between tea ingestion and diabetes are unclear and have not been 
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thoroughly examined in humans. Acute studies have observed a reduction in postprandial insulin 
following a single dose of black tea in both insulin-resistant (Fuchs et al., 2016) and healthy individuals 
(Bryans et al., 2007). Findings from in vitro and animal models are suggestive of tea influencing glucose 
metabolism through mechanisms such as enhanced insulin sensitivity although, to date, limited 
human trials have been performed, particularly with green tea. Furthermore, no previous work has 
investigated the simultaneous effects of tea on glucose handling, insulin sensitivity and vascular 
function using a Western lifestyle model, characterised by inadequate physical activity and excessive 
caloric intake. Therefore, aim 3 of this thesis was to examine the effect of daily green tea consumption 
(equivalent to 6 cups/day) on changes in peripheral vascular function and glucose handling after a 7-
day ‘unhealthy’ lifestyle combining physical activity reduction and overfeeding in healthy males.  
 
Flavonoids are also suggested to help maintain and even improve cognitive function, possibly via 
improved vascular function and glucose metabolism (Mastroiacovo et al., 2015). To date, limited 
research has been undertaken exploring the acute and chronic effects of flavonoids on 
cerebrovascular function. Cocoa-derived flavanols have demonstrated increased cerebral blood flow 
(CBF) both acutely (Francis et al., 2006; Lamport et al., 2015) and following regular (1-12 weeks) 
ingestion (Fisher et al., 2006; Sorond et al., 2008a; Brickman et al., 2014). Despite tea being the major 
source of dietary flavonoids for much of the global population, only one study has examined the effect 
(acute) of tea on CBF which concluded that caffeine was responsible for tea-induced decreases in 
steady-state CBF and potentially masked any flavonoid related changes in CBF (Vidyasagar et al., 
2013). A study of the isolated flavonoid epigallocatechin gallate (EGCG) that is abundant in tea was 
equivocal (Wightman et al., 2012). Epicatechin is also a natural compound that is present in both tea 
and cocoa, and has exhibited improved peripheral vascular function (Dower et al., 2016b). 
Furthermore, (-)-epicatechin has also demonstrated a protective effect on transient ischaemia-
induced brain injury in mice (Shah et al., 2010), suggesting that it may have a beneficial impact on the 
cerebrovasculature. Given the encouraging findings of cocoa-derived flavanols on CBF and the role 
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that (-)-epicatechin is suspected to play in tea/flavanol-induced acute improvements in vascular 
function (Dower et al., 2016b), aim 4 of this thesis was, therefore, to examine the effect of acute oral 
(-)-epicatechin ingestion on cerebrovascular function in healthy adults.  
 
In summary, evidence suggests that acute and chronic tea ingestion may be beneficial for 
cardiovascular health in humans. However, the effects of tea on microvascular function and 
cerebrovascular function are not yet understood. Furthermore, given that the limited previous 
research suggests that tea has a positive influence on vascular function and glucose handling and that 
poor lifestyle behaviours are shown to have a detrimental impact upon cardiovascular health, further 
investigation is warranted to determine whether tea ingestion may contribute to the 
amelioration/prevention of vascular and metabolic impairments induced by an unhealthy lifestyle. 
Therefore, the overarching aim of this thesis was to explore the impact of tea ingestion on peripheral 
and cerebral micro- and macrovascular function in humans.  
Aims  
The aims of this thesis were to:  
1. Simultaneously determine the inter-day reproducibility of four commonly used local heating 
protocols for assessing cutaneous microvascular function.  
2. Examine the acute (2-hour) cutaneous vascular responses to local skin heating following 
ingestion of black tea in a healthy adult population.  
3. Explore the changes in peripheral (conduit artery and skin microvessels) and cerebrovascular 
function and insulin sensitivity after a 7-day metabolic challenge or ‘unhealthy’ lifestyle, 
combining physical activity reduction (-50% steps per day) and overfeeding (+50% kcal per 
day, comprising 65% fat) in healthy male participants.  
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4. Examine the effect of acute oral (-)-epicatechin ingestion on cerebrovascular function in 
healthy adults. 
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CHAPTER 2: LITERATURE REVIEW
10 
 
2.1 Microvascular Function  
The cardiovascular system is a complex, interrelated organ system that forms an efficient delivery 
network for cellular nutrition and removal of metabolic waste products, gaseous exchange and 
hormonal transport, in addition to being a key regulator of homeostasis for body temperature, pH 
balance, hydration and blood pressure (Smith & Fernhall, 2011). In order to achieve these vital 
functions, however, the cardiovascular system must closely interact with other major systems, 
particularly the respiratory, neural, endocrine, digestive, skeletal, urinary and integumentary systems. 
In this regard, the vascular tree, particularly the microvasculature, is integral in providing an extensive 
transport network of vessels to serve each of these systems as a site to facilitate exchange of 
macromolecules and fluids, in addition to responding to various mechanical forces and chemical 
signals concerned with homeostasis via thermoregulatory mechanisms (Johnson, 2011).  
 
The microvasculature encompasses the smallest resistance vessels (<15 µm in diameter) embedded 
within all human tissues and organs, consisting of terminal arterioles, capillaries and venules (Levy et 
al., 2001; Roustit & Cracowski, 2013). Given the large surface area of these vessels, the 
microcirculation, therefore, consists of a large proportion (>95%) of the body’s vascular endothelium, 
a squamous epithelial layer that lines the inner surface of all blood vessels and is critical in maintaining 
vascular homeostasis (Deanfield et al., 2007; Hewett, 2009). Optimal microvascular function is 
essential for organ systems to function effectively, from the brain, eyes, kidneys, heart, muscle and 
adipose tissue to the skin. The cerebral microcirculation, for example, serves a pivotal role in 
homeostatic control to enable adequate central nervous system function. Precise regulation is 
required due to the brain’s high metabolic rate and its limited capacity for energy storage, which is 
achieved through a combination of complex endothelial, myogenic, metabolic and neural regulatory 
mechanisms (Willie et al., 2014; Phillips et al., 2016).  
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The microcirculation continues to receive widespread attention for its contribution towards overt 
cardiovascular disease and type 2 diabetes (Jaap et al., 1994; Wiernsperger, 2000; Nguyen et al., 2007; 
Sprague & Ellsworth, 2010). Considered a transitional stage between diet-induced obesity and insulin 
resistance (de Boer et al., 2012; Houben et al., 2012), microvascular dysfunction is characterised by 
structural and functional changes to the microvasculature that largely arise from impaired endothelial 
function. A healthy endothelium is essential for maintaining overall vascular health and as a major 
regulator of vascular homeostasis, the endothelial monolayer is crucial in maintaining the balance 
between vasodilation and vasoconstriction (Sena et al., 2013). Endothelium-derived chemical 
mediators are central to this regulated equilibrium, with any disturbance leading to endothelial 
dysfunction and the associated pathological processes of cardiovascular and metabolic diseases 
(Bonetti et al., 2003; Avogaro et al., 2011; Sena et al., 2013). Microvascular dysfunction often precedes 
microvascular complications and (macro)vascular dysfunction in larger vessels that subsequently leads 
to pathological interactions and the development of both small and large vessel disease (Krentz et al., 
2007), such as atherosclerosis and other plaque-related problems including stenosis and ischaemic 
vascular disease. Furthermore, microvascular degeneration with advancing age is associated with 
cerebrovascular disease, such as stroke arising from microbleeds (Nishimura & Schaffer, 2013) and 
Alzheimer’s disease (Farkas & Luiten, 2001). Cerebral hypoperfusion leads to increased systemic blood 
pressure as a compensatory mechanism to ensure that the brain tissue receives enough oxygen and 
nutrients in order to function adequately (Qin et al., 2008). This compensation can lead to the 
development of systemic cardiovascular disease, such as essential hypertension, and demonstrates 
how local changes can impact systemic cardiovascular health.  
   
Microvascular beds are thought to exhibit detectable changes in endothelial (dys)function earlier than 
macrovessels (Levy et al., 2001; Bonetti et al., 2003; Minson, 2010; Sena et al., 2013) and can provide 
an insight into the mechanisms underlying these disease states. The cutaneous microcirculation is 
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primarily concerned with thermoregulation and to a lesser extent, fulfilling nutritive demands, and 
represents an easily accessible vascular bed that may be used as a surrogate for generalised vascular 
function (Holowatz et al., 2008).  
2.1.1 The Skin  
The skin represents a crucial component of human thermoregulation and is a highly specialised 
vascular network that is organised into two plexuses within the dermis, in the superficial and deep 
layers which run parallel to the surface of the skin (Johnson et al., 2014). The majority of vessels, 
consisting of papillary loops (true capillaries), high-resistance terminal arterioles and post-capillary 
venules, are located in the superficial papillary dermis, 1-2 mm beneath the epidermal surface (Figure 
2.1). The papillary loops are a major determinant for heat exchange, being located in close proximity 
to the dermal-epidermal junction where there is a high thermal gradient due to a large surface area 
and high blood flow from the vessels (Charkoudian & Stachenfeld, 2014; Johnson et al., 2014). Highly 
innervated arterioles control blood flow through the papillary loops, consisting of a lining of 
endothelial cells encircled by a dual layer of vascular smooth muscle cells. A second vascular plexus is 
located at the dermal-subdermal junction, where the vessels are typically greater in diameter than 
those of the upper plexus, with 4-5 layers of vascular smooth muscle (Johnson et al., 2014). At this 
lower plexus, ascending arterioles connect to the upper plexus, hair follicles and sweat glands.  
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Figure 2.1 Cross-section of the cutaneous membrane and subcutaneous components, comprising of a 
superficial layer, a relatively thin epidermis and a thicker, deeper dermis. The subcutaneous layer, 
deep to the skin, attaches the dermis to underlying tissues and organs. The dermis contains the nerves, 
smooth muscle and sweat glands.  
 
Despite the plexus and papillary loop arrangement being consistent, anatomical differences exist 
between regions. In the glabrous (non-hairy) skin of the palms, lips and plantar aspect of the feet, 
arteriovenous anastomoses (AVAs) bypass the resistance vessels, directly connecting the arterioles 
and venules (Johnson et al., 2014). The AVAs are richly innervated by sympathetic adrenergic fibres 
and possibly also by cholinergic fibres. As AVAs have a smaller surface area and lie deeper in the dermis 
than papillary loops, they are less efficient for thermoregulation (Johnson et al., 2014). Non-glabrous 
(hairy) skin of the limbs, head and trunk is largely governed by dual sympathetic neural control through 
noradrenergic vasoconstrictor and cholinergic or sympathetic vasodilator mechanisms (Charkoudian, 
2003; Cable, 2006; Kellogg, 2006; Johnson et al., 2014), in addition to local effectors, such as 
endothelial release of nitric oxide (NO). During normothermic conditions, sympathetic vasoconstrictor 
nerves are tonically active and emit little neural stimulation to the cutaneous arterioles (Kellogg, 
2006). Under cold stress or subtle changes in ambient temperature, however, increased noradrenergic 
vasoconstrictor tone mediates a thermoregulatory reflex to conserve body heat via arteriolar 
vasoconstriction and a subsequent reduction in skin blood flow (SkBF) (Kellogg, 2006; Johnson et al., 
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2014).  Conversely, during mild heat stress, small variations in both vasoconstrictor and vasodilator 
activity are responsible for controlling SkBF via a passive vasodilation that provides large changes in 
heat dissipation from relatively small changes in SkBF (Charkoudian & Stachenfeld, 2014). Any 
remaining sympathetic vasoconstrictor tone is released, following which the vasodilator system 
prevails, largely via cholinergic nerves and co-transmitters (Kellogg, 2006; Johnson et al., 2014). 
However, the vasodilatory pathways underpinning cutaneous hyperaemic responses to local skin 
heating differ and involve locally controlled mechanisms.  
2.1.2 Local Control of Skin Blood Flow – Neural Mechanisms  
The cutaneous response to local heating involves complex interactions involving neural and 
chemically-mediated mechanisms (Figure 2.2) that are dependent upon local skin temperature and 
are independent of one another (Minson et al., 2001). Vasoconstrictor responses are mediated by an 
axon reflex mechanism and feature prominent roles for noradrenaline and neuropeptide-Y, which 
have been extensively reviewed (Johnson et al., 2014). The hyperaemic vasodilatory response to non-
painful local heating of non-glabrous skin typically induces a biphasic response that is characterised 
by an early, transient peak predominantly mediated by neural factors (Minson et al., 2001; Johnson 
et al., 2014). The peak is succeeded by a brief nadir and a more prolonged secondary increase in SkBF 
to a plateau that is predominantly mediated by locally produced chemical factors (Minson et al., 2001; 
Johnson et al., 2014). Sustained heating at the plateau eventually returns SkBF towards baseline, 
resting levels, despite the continuation of local heating, thereby suggesting limited bioavailability of 
the local chemical messengers that are involved in cutaneous vasodilation. The rate of local skin 
heating influences the vascular mechanisms underlying the vasodilatory response, with more 
prolonged heating (e.g. 0.1°C per min) producing a plateau without the early, transient peak (Johnson 
et al., 2014). Locally heating the skin to 42-44°C is considered to achieve maximal cutaneous 
vasodilation and allow SkBF to be normalised for comparison between measurement sites or subject 
groups (Kellogg et al., 1999; McCord & Minson, 2005; Minson, 2010; Johnson et al., 2014).  
15 
 
The neurogenic changes in SkBF of non-glabrous skin are mediated by local activation of afferent 
sensory nerves and sympathetic adrenergic nerves, with a greater portion arising from sympathetic 
influences (Carter & Hodges, 2011). Minson and colleagues (2001)  observed a 50% reduction in the 
initial peak SkBF response to local heating following topical nerve blockade. However, no effect on 
SkBF was observed following a nerve block proximal to the local heating site that sufficiently blocked 
all sensory afferent and sympathetic efferent activity, suggesting that no perception of heat was 
required from the central nervous system, rather activation of local sensory nerves via an axon reflex 
was required for vasodilation. NO contributes towards the sensory nerve component of local skin 
heating and studies have demonstrated an absent (Hodges et al., 2008) or delayed (Houghton et al., 
2006) axon reflex following blockade of nitric oxide synthase (NOS) with NG-nitro-L-arginine methyl 
ester (L-NAME). Further studies suggest a role for transient receptor potential vanilloid type 1 (TRPV-
1) channels substantially contributing to the initial peak and nadir, and more modestly the plateau 
phase, of the hyperaemic response through activation of the NO component of the axon reflex (Wong 
& Fieger, 2010). Release of the neuropeptide substance P and calcitonin gene-related peptide, which 
are co-localised in the nerve terminals in the skin (Wallengren, 1997), are also considered to play a 
role in sensory nerve-mediated cutaneous vasodilation, with substance P believed to be partially 
dependent on NO (Wong et al., 2005; Wong & Minson, 2006). However, there remains limited 
research regarding these agents and current theories are reviewed elsewhere (Johnson et al., 2014) 
so will not be duplicated in this literature review.  
 
Sympathetic adrenergic nerves also play a role in the local control of SkBF in response to local skin 
heating. Antagonism of vasoconstrictor nerve function demonstrated that the axon reflex is abolished 
(Houghton et al., 2006; Hodges et al., 2008, 2009) or reduced (Carter & Hodges, 2011; Tew et al., 
2011b; Hodges & Sparks, 2014; Del Pozzi & Hodges, 2015), suggesting that cutaneous vasodilation is 
affected by vasoconstrictor nerve function. Furthermore, in addition to abolition of the axon reflex, 
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the overall hyperaemic response was attenuated following blockade with bretylium tosylate, an 
adrenergic neuronal blocking agent (Houghton et al., 2006). Further studies support the role of 
sympathetic nerves in the hyperaemic response (Carter & Hodges, 2011; Tew et al., 2011b), with the 
neurotransmitters noradrenaline and neuropeptide Y being implicated in the initiation of the axon 
reflex and overall hyperaemic response (Hodges et al., 2008). However, in a three-part study, Hodges 
and Sparks (2014) examined whether the sustained vasodilatation following local skin warming 
involved noradrenaline, neuropeptide Y and/or NOS, concluding that NOS contributes markedly to the 
sustained vasodilatation, but that noradrenaline and neuropeptide Y have little, or no, contribution. 
Nevertheless, the adrenergic system is required for increased SkBF following local thermal 
hyperaemia, in addition to the sensory nerves and chemically-mediated component.  
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Figure 2.2 Summary of the mechanisms that contribute to local thermal hyperaemia. The top figure 
represents a typical skin blood flow response to rapid local heating to 42°C, featuring the initial (axon) 
peak, nadir and sustained vasodilation (plateau). The middle figure depicts the current theory of local 
heating during the initial peak, with the bottom schematic outlining the theory of vasodilation during 
the plateau phase, both presenting the pathways in the endothelium and smooth muscle. Taken from 
(Johnson et al., 2014).  
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2.1.3 Local Control of Skin Blood Flow – Chemical Mediators  
The temperature-dependent sustained plateau phase of the hyperaemic response is largely mediated 
by NO and endothelial derived hyperpolarisation factors (EDHFs) via hyperpolarisation of the vascular 
smooth muscle (Johnson et al., 2014). Generated from the amino-acid L-arginine by endothelial nitric 
oxide synthase (eNOS), NO is the endothelium’s most potent vasodilator, and is essential for optimal 
endothelial function (Maiorana et al., 2001; Di Francescomarino et al., 2009). As an endocrine 
vasoregulator, NO modulates blood flow within the microcirculation (Datta et al., 2004; Sena et al., 
2013) and the role of NO as a major contributor to local thermal cutaneous vasodilation has been 
reviewed extensively (Johnson et al., 2014). Kellogg and colleagues (1999) observed a ~50% reduction 
in SkBF following infusion of locally heated skin with the eNOS inhibitor L-NAME, findings which were 
similarly replicated in later studies (Minson et al., 2001; Gooding et al., 2006). ~60% of the sustained 
SkBF plateau phase following local heating is thought to be attributable to NO, with the remaining 
~40% being linked to EDHFs, although the precise pathways involved remain inconclusive (Brunt & 
Minson, 2011). Calcium-activated potassium (KCa) channels are important in cutaneous vasodilation 
for NO and EDHFs such as cyclooxygenase (Garland & Dora, 2017), in addition to prostacyclin which 
has been shown to modulate SkBF in healthy males (Fujii et al., 2016) and females (Fujii et al., 2017). 
Scientific knowledge and understanding of the complex chemically-mediated pathways involved in 
local cutaneous vasodilation remains largely inconclusive, although it is widely accepted that NO is a 
key mediator of cutaneous vasodilation and in maintaining optimal endothelial function.  
 
2.2 Macrovascular (Conduit Artery) Function 
Conduit arteries, or macrovessels, are typically >200 µm in diameter and are characterised by a thick 
tunica media that contains a large number of collagen and elastin filaments, in addition to a greater 
number of smooth muscle cells compared to other branches of the arterial tree, such as resistance 
vessels/arterioles and the cutaneous vessels (Figure 2.3). The contractile structure of the vessel wall 
19 
 
allows active vasodilation via sympathetic neural control or vasoactive chemical mediators, such as 
NO, released from the endothelium. Once regarded as a passive interface, the vascular endothelium 
is an important endocrine organ and a healthy endothelium is essential for maintaining overall 
vascular health, via anti-atherogenic properties that protect against inflammatory responses, smooth 
muscle cell proliferation and vasoconstriction (Davignon & Ganz, 2004). Numerous paracrine 
substances are released from the endothelium including NO, which is a lipid soluble gas that is 
synthesised in the endothelial cells from the amino acid L-arginine through the action of eNOS (Palmer 
et al., 1988). NO rapidly diffuses into the vascular smooth muscle of the tunica media, binding to and 
activating the enzyme guanylate cyclase (Ignarro et al., 1986), the resultant increase in cyclic 
guanosine monophosphate induces smooth muscle relaxation and subsequent vasodilation 
(Furchgott & Jothianandan, 1991; Green et al., 2004).  
   
Figure 2.3 The arterial tree, depicting the conduit artery through to the capillaries.  
 
NO is tonically secreted by the endothelium, contributing ~50% to basal vascular tone (Vallance et al., 
1989). Upregulation of NO can be physiologically stimulated by increased laminar blood flow and the 
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resulting shear stress, termed flow-dependent NO formation, or alternatively, NO is produced in 
response to various endothelial stimulators, such as acetylcholine. Whilst the shear stress induced 
endothelial mechanotransduction and signalling cascade leading to the secretion of NO is not entirely 
understood, it is thought that several mechanisms are involved. Increased arterial blood flow and 
shear stress reportedly induce endothelial potassium channel activation (Oleson & Johnson, 1988), 
calcium influx in endothelial cells (Dull & Davies, 1991), the release of bradykinin and/or 
phosphorylation of serine residue (Groves et al., 1995; Kuga et al., 1997), all of which are believed to 
enhance NO bioavailability. Other vasoactive substances are released by the endothelium and 
contribute to vasodilation, such as prostacyclin and EDHFs (Grabowski et al., 1985; Spilk et al., 2013), 
although these are suggested to have a more important role in the smaller arteries (Shimokawa et al., 
1996). NO bioavailability is commonly considered the hallmark of endothelial (dys)function (Davignon 
& Ganz, 2004; Sena et al., 2013) that is regarded as the starting point of progression towards overt 
CVD and is characterised by a reduced vasodilatory capacity, a proinflammatory and prothrombic 
state, resulting in an altered endothelial cell phenotype and intracellular signalling pathways (Suganya 
et al., 2016). NO-mediated vasodilator function is commonly assessed in vivo through the non-invasive 
technique of flow-mediated dilation (FMD), whereby an artery’s dilator response is measured in 
response to a reactive hyperaemia following a brief (5-min) period of artificial limb ischaemia. 
Impaired FMD responses are associated with future cardiovascular events in healthy (asymptomatic) 
individuals (Shechter et al., 2009; Inaba et al., 2010; Shechter et al., 2014), and FMD is therefore 
regarded as a surrogate marker of cardiovascular disease (Vita & Keaney, 2002; Gokce et al., 2003; 
Green et al., 2011; Mutlu et al., 2011).  
 
2.3 Cerebrovascular Function 
The regulation of cerebral blood flow (CBF) is critical for maintaining an adequate supply of oxygen 
and nutrients to the brain, particularly given the high metabolic rate of brain tissue and its limited 
capacity for substrate storage (Brown & Ransom, 2007; Willie et al., 2014). The brain occupies only 2-
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3% of total human body mass, yet the metabolic demand of the cerebral tissue is ~20% of the body’s 
total oxygen consumption (Bain et al., 2014). Substantial reductions in CBF, therefore, rapidly lead to 
unconsciousness (van Lieshout et al., 2003) and, if sustained, brain damage and death ensues (Smith 
et al., 2011). Furthermore, decreases in steady-state CBF (Parkes et al., 2004; Bertsch et al., 2009), 
blunted task-specific CBF increases (Sorond et al., 2008b) and accentuated reductions in CBF 
contribute towards impaired cognitive function and cerebrovascular disease, such as in dementia and 
aging (Farkas & Luiten, 2001; Farkas et al., 2002; Ruitenberg et al., 2005a; Schuff et al., 2009; Spencer, 
2009). The control of CBF involves multiple integrated regulatory mechanisms, with the principle 
regulators involving arterial blood gases, such as the partial pressure of arterial carbon dioxide (PaCO2), 
mean arterial pressure (MAP), cerebral metabolism and the autonomic nervous system (Figure 2.4) 
(Willie et al., 2014).  
 
 
Figure 2.4 A schematic of the primary mechanisms responsible for control of cerebral blood flow (CBF). 
ABP, arterial blood pressure; CBV, cerebral blood volume; CPP, cerebral perfusion pressure; CSF, 
cerebrospinal fluid; ICP, intracranial pressure; PaCO2, partial pressure of arterial carbon dioxide. Taken 
from (Ainslie & Duffin, 2009).  
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2.3.1 Partial Pressure of Arterial Carbon Dioxide (PaCO2)  
Brain perfusion is highly sensitive to changes in PaCO2, with a ~3-6% increase and/or a ~1-3% decrease 
in flow per mmHg change in CO2 above and below eupnoeic PaCO2 (Willie et al., 2012; Skow et al., 
2013; Willie et al., 2014). The entire cerebrovasculature is sensitive to changes in blood gases, with 
the pial arterioles considered to modulate resistance. In response to increased PaCO2, CBF increases 
following smooth muscle relaxation and dilatation of the vessels, whereas a reduction in PaCO2, or 
hypocapnia, results in a decrease in CBF through increased cerebrovascular resistance (Kety & 
Schmidt, 1948; Wasserman & Patterson, 1961). The entire cerebrovascular arterial tree is vasoactive, 
with the arteries of the head and neck also being sensitive to changes in blood gases and perfusion 
pressure (Willie et al., 2012). The precise mechanism underlying CO2 regulation is uncertain, but 
appears to be independent of arterial pH as CBF was unchanged following metabolic acidosis and 
alkalosis (Lambertsen et al., 1961; Harper & Bell, 1963), whereas changes in arteriolar diameter were 
induced by manipulation of extracellular pH (Wahl et al., 1970; Kontos et al., 1977). The likely 
mechanism, therefore, relates to CBF regulation via a change in extracellular pH, such as the 
cerebrospinal fluid, induced by diffusion of CO2 molecules across the cerebrovascular blood-brain 
barrier. The subsequent lowering or elevation of extracellular pH thus alters the vascular smooth 
muscle tone to induce relaxation or contraction, respectively (Lambertsen et al., 1961; Harper & Bell, 
1963; Lassen, 1968). Metabolic regulation of CBF also involves local mechanisms, with local cerebral 
perfusion being tightly coupled to local neural metabolism due to the anatomical and metabolic 
relationship between elements of the neurovascular unit, such as the neurons, glial cells and 
microvasculature (Willie et al., 2014). The mechanisms related to neurovascular coupling and arterial 
blood gases have been thoroughly reviewed by Willie and colleagues (2014) .  
2.3.2 Cerebral Autoregulation  
Steady-state CBF reportedly remains relatively stable across a range of blood pressures, requiring 
reflex adjustments in cerebrovascular resistance concomitantly with fluctuations in blood pressure to 
maintain adequate blood flow (Lassen, 1959; Paulson et al., 1990). This physiological mechanism is 
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termed cerebral autoregulation (van Beek et al., 2008; Willie et al., 2014). Current within-subject in 
vivo data suggests that the CBF-MAP relationship is not stable through a broad range of pressures and, 
furthermore, is dependent upon the severity and direction of change in perfusion pressure (Willie et 
al., 2014). Experimentally, ‘static’, or steady-state, cerebral autoregulation has been examined to 
observe the relationship between CBF and MAP, with ‘dynamic’ cerebral autoregulation introduced 
to explore the pressure-flow relationship during transient changes in MAP, such as those induced by 
changes in posture or when coughing (Willie et al., 2014). Pial arterioles, larger intracranial arteries 
and the large conduit vessels in the neck are considered to contribute to cerebrovascular resistance 
and regulation of CBF, with studies demonstrating a change in carotid artery diameter in response to 
changes in PaCO2 and PaO2 (Wilson et al., 2011; Willie et al., 2012). Blood pressure is critical for cerebral 
autoregulation and CBF, with elevated PaCO2 and hypoxia impairing the capability of the brain, 
rendering it unable to defend against changes in blood pressure (Tzeng et al., 2012).  
2.3.3 Autonomic Control 
Although the precise mechanisms remain poorly understood, neurogenic control is important in 
autoregulation of the cerebrovasculature, which is richly innervated by adrenergic and cholinergic 
fibres. A higher proportion of longitudinal nerve bundles are found in the extracranial arteries, 
whereas the intracranial vessels possess a greater total density of perivascular nerve fibres and neuron 
terminals (Borodulya & Pletchkova, 1973, 1976; Bleys et al., 1996). In a series of studies, summarised 
by Willie and colleagues (2014), CBF was observed to increase following ganglionectomy in humans, 
suggesting sympathetic nerve involvement in CBF regulation, with animal models observing that this 
is most important in buffering changes in blood pressure and predominantly involves the larger 
arteries. Impaired cerebral autoregulation in healthy humans has been demonstrated following 
sympathetic nervous system blockade (Zhang et al., 2004), although the systemic effects of the 
blockade on the peripheral vasculature are difficult to dissociate from any direct effects on cerebral 
autoregulation (Willie et al., 2014). This is also true of the relationship between the sympathetic 
nervous system and the response of the cerebrovasculature to changes in arterial blood gases, with 
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human studies reporting inconsistent data. Unchanged CO2 reactivity was demonstrated following 
augmented sympathetic nerve activity to lower-body negative pressure (LeMarbre et al., 2003) and 
hand grip exercise (Ainslie et al., 2005), yet other studies have reported attenuation to lower-body 
negative pressure (Zhang et al., 2011) and ganglionic blockade (Jordan et al., 2000). The contribution 
of cholinergic nerves to CBF control also remains equivocal, with very few studies performed to date 
in humans or in animal models, as reviewed elsewhere (Willie et al., 2014).  
 
In summary, current literature supports integrated regulation of CBF control through multiple 
mechanisms that remain incompletely understood, as previously discussed. However, the lack of 
understanding of some of the mechanisms involved, such as autonomic control, is partly due to the 
assessment techniques used to quantify changes in CBF. Use of a vasoactive stimulus to challenge the 
cerebrovascular system is one such method. Termed cerebrovascular reactivity (CVR), this technique 
measures the change in CBF per change in vasoactive stimulus (Fierstra et al., 2013). CVR studies 
currently use various stimuli, such as CO2, and methods of measuring CBF, including transcranial 
Doppler ultrasound (TCD) and blood oxygen-dependent magnetic resonance imaging (BOLD-MRI). 
However, since the variety of stimuli and measurement techniques used do not allow accurate 
comparison of CVR between individuals, meaningful interpretation of data can be difficult. The 
cerebrovasculature is, therefore, critical for CBF regulation but provides many challenges with 
accurate assessment of its function.  
 
2.4 Metabolic Function: Insulin/Glucose 
Metabolic homeostasis is closely interrelated with cerebrovascular and peripheral vascular function, 
with disrupted signalling pathways leading to insulin resistance and endothelial dysfunction. Glucose 
homeostasis is mediated by several hormones including insulin, glucagon, cortisol, catecholamines, 
growth hormone and incretins (Xiang et al., 2011). Insulin is secreted from the pancreatic β cells and 
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regulates glucose homeostasis via disposal of glucose in skeletal muscle and adipose tissue 
(Muniyappa et al., 2008). Furthermore, insulin is also a key vasoactive hormone in the regulation of 
cerebral and peripheral blood flow (Hughes & Craft, 2016), and is pivotal in coordinating metabolic 
and vascular homeostasis (Muniyappa et al., 2007). Under normal conditions, insulin stimulates NO 
production from the vascular endothelium via activation of eNOS and the phosphatidylinositol-3-
kinase (PI-3K) pathway, which further facilitates glucose uptake via increased tissue perfusion 
(Muniyappa et al., 2008; Olver et al., 2013). However, impaired insulin sensitivity or insulin resistance, 
typically defined as reduced sensitivity or responsiveness to insulin and its metabolic actions, such as 
insulin-mediated glucose disposal, causes an accumulation of glucose in the bloodstream 
(hyperglycaemia) (Wheatcroft et al., 2003; Kim et al., 2006; Muniyappa et al., 2008; Sena et al., 2013). 
Consequently, a greater amount of insulin is required to allow glucose to enter the cells. However, the 
pancreatic β cells are unable to fulfil the increased demand for insulin indefinitely and cannot produce 
adequate quantities to overcome resistance, leading to diabetes. Whereas the etiopathogenesis of 
type I diabetes involves autoimmune destruction of the pancreatic β cells, resulting in inadequate 
insulin production and an accumulation of glucose in the bloodstream, type 2 diabetes is characterised 
by insulin resistance and endothelial dysfunction that is widely linked to environmental factors, such 
as physical inactivity and obesity (Kim et al., 2006).  
 
Increased CVD risk is associated with disrupted metabolic function, with hyperinsulinaemia, as seen 
when increased quantities of insulin are secreted in response to glucose accumulation, associated with 
down-regulation of eNOS and an imbalance in both the mitogen-activated protein kinase (MAPK) and 
PI-3K pathways (Muniyappa et al., 2008). Excessive levels of circulating insulin subsequently 
contribute towards morphological maladaptation of the vessel wall due to cellular hypertrophy and 
an altered extracellular matrix (Maria Assunta et al., 2009). Furthermore, hyperglycaemia-induced 
vascular damage exhibits reduced NO bioavailability, increased reactive oxygen species and harmful 
26 
 
metabolites, impaired endothelial-dependent vasodilation, increased proliferation and matrix 
degradation (Sena et al., 2013). Such damaging effects are largely caused by endothelial dysfunction 
arising as a consequence of an accumulation of glycolytic intermediates through inhibition of 
glyceraldehyde-3-phosphate dehydrogenase activity, a glycolytic enzyme (Sena et al., 2013; Suganya 
et al., 2016). Harmful mechanisms are subsequently activated, including protein kinase C (PKC) 
isoforms, advanced glycation end products (AGEs) and the sorbitol and hexosamine pathways (de 
Vriese et al., 2000; Sena et al., 2013). Given the reciprocal relationship between metabolic function 
and cardiovascular health, greater emphasis is increasingly being placed upon establishing corrective 
strategies for postprandial hyperglycaemia in the treatment and prevention of CVD, with use of 
overfeeding experiments, or metabolic challenges, providing an insightful tool in unravelling the 
physiological adaptations to caloric excess.  
 
2.5 Effects of a Metabolic Challenge/Overfeeding on CVD Risk  
Human studies are increasingly exploring the effects of Western sedentary lifestyles upon metabolic 
health, which are typically observed using overfeeding and/or inactivity models that mimic short- to 
medium-term periods of energy surplus, lasting from a single meal to several days or weeks. Such 
models are representative of holiday or celebratory periods, when otherwise healthy individuals 
adopt different dietary and activity patterns compared to their habitual lifestyle (Cornier et al., 2006). 
Previous models for inducing changes in insulin resistance level have involved complete bed rest and 
extreme step reduction (>10,000 to <1,500 steps/day), although such models are difficult to 
implement and are not representative of modern sedentary lifestyles that also typically involve high 
calorie dietary intake.  
 
Short-term (<7-days) overfeeding interventions have induced transient insulin resistance, without 
modifying activity levels. Whole-body insulin resistance was observed in lean ‘obese-resistant’ females 
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following 3-days of 50% overfeeding (50% carbohydrate, 30% fat, 20% protein), with no difference 
observed in lean males (Cornier et al., 2006). However, Adochio and colleagues (2009) observed no 
change in whole-body insulin sensitivity following 5-days of 40% caloric excess in healthy, lean adults. 
Nevertheless, this study observed distinct differences in insulin sensitivity according to the 
macronutrient composition of the overfeed. High carbohydrate (20% fat, 60% carbohydrate, 20% 
protein) overfeeding was associated with changes in ex-vivo skeletal muscle signalling compatible with 
increased insulin sensitivity, suggestive of enhanced glucose disposal that maintained whole-body 
insulin sensitivity. In contrast, the same study also found ex-vivo molecular changes in keeping with 
reduced insulin sensitivity following high fat (50% fat, 30% carbohydrate, 20% protein) overfeeding 
(Adochio et al., 2009). Further studies have also observed deleterious effects of high fat overfeeding. 
In a randomised, crossover trial in young, healthy males, 5-days of high fat (60% fat, 32.5% 
carbohydrate, 7.5% protein) overfeeding with 50% extra calories, a 26% increase in fasting hepatic 
glucose production was observed, with a borderline increase in fasting insulin (Brons et al., 2009). 
Following 7-days of high fat (65%) overfeeding (+50% calories), a significant increase in postprandial 
glucose and insulin was observed following a mixed meal tolerance test in healthy adults (Parry et al., 
2017). Increased fasting insulin and glucose was induced following 8-weeks of overfeeding (+40% 
calories) in young, healthy adults who followed either a low protein (59% fat, 36% carbohydrate, 5% 
protein), normal protein (49% fat, 36% carbohydrate, 15% protein) or high protein (39% fat, 36% 
carbohydrate, 25% protein) diet in a randomised, parallel-arm study (Bray et al., 2016). No significant 
between-group differences were observed, although the group who consumed the low protein diet, 
that comprised a greater proportion of fat (59%), exhibited a greater increase in body fat (%) at 8-
weeks. It is apparent from these findings that macronutrient composition in overfeeding studies may 
affect metabolic pathways and energy storage, with higher fat content in particular seeming to exhibit 
greater changes in insulin resistance.  
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Medium-term overfeeding has also demonstrated impaired metabolic function. Tam and colleagues 
(2010) observed an 11% reduction in insulin sensitivity in healthy adults following 28-days of 
overfeeding (+1250 kcal/day; 45% fat, 15% protein, 40% carbohydrate). Compared to baseline, 
peripheral insulin sensitivity decreased following 28-days of overfeeding in healthy, non-obese, 
sedentary adults, with a concomitant increase in oxidative stress that may have contributed towards 
the insulin resistance (Samocha-Bonet et al., 2012). A further 28-day overfeeding (+1250 kcal/day; 
45% fat, 15% protein, 40% carbohydrate) study in healthy adults demonstrated reduced insulin 
sensitivity, together with serum lipid changes and increased circulating ceramides that may promote 
systemic insulin resistance (Heilbronn et al., 2013).  
 
Diets high in fat and/or carbohydrate are strongly associated with long-term cardiometabolic risk 
(Hennig et al., 2001; Liu & Manson, 2001), although few studies have examined the effect of 
overfeeding on vascular function. Gupta and colleagues (2013) demonstrated a significant increase in 
CVD risk following 8-weeks of overfeeding (1.4 times habitual calorie consumption, comprising 44% 
fat, 41% carbohydrate, 15% protein) in healthy adults, that resulted in increased body fat, visceral 
adipose tissue mass, insulin resistance, systemic inflammation, BP disturbance and endothelial 
dysfunction (measured by EndoPAT). Consumption of a habitually high fat versus low fat (≥35% and 
<35% of total calories, respectively) diet was associated with impaired NO-mediated endothelium-
dependent vasodilation in sedentary adults (aged 43-67 years), assessed via 4-day dietary records and 
forearm blood flow responses to acetylcholine via strain-gauge venous occlusion plethysmography, 
respectively (Dow et al., 2015). Impairment in endothelial function has also been observed in healthy 
adults 2-4 hours following a single high fat meal (Vogel et al., 1997; Bae et al., 2001; Tsai et al., 2004). 
Such changes in endothelial function are largely attributed to reductions in NO bioavailability (Bae et 
al., 2001; Tsai et al., 2004).  
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Despite a lack of studies examining the effects of overfeeding on changes in vascular function per se, 
the effects of habitual overfeeding following long-term caloric excess and subsequent obesity have 
been established. Obesity represents a state of energy imbalance, whereby increased energy intake, 
or nutrient excess, is coupled with disproportionally low levels of physical activity (Cuthbertson et al., 
2017). Excess carbohydrate, above the 300-500g typically stored as glycogen, is oxidised or converted 
to triglyceride that is predominantly stored within adipose tissue, a largely infinite storage facility 
(Cuthbertson et al., 2017). Endothelial dysfunction arising from obesity is suggested to precede the 
development of insulin resistance (Suganya et al., 2016), with attenuated NO production and 
increased vasoconstrictor tone contributing towards blunted endothelium-dependent vasodilation 
(Okon et al., 2005). Human studies have observed impaired insulin action in dilating resistance vessels 
(Laakso et al., 1990) and in increasing the elasticity of conduit arteries (Westerbacka et al., 1999) in 
obese versus lean males. Furthermore, Clerk and colleagues (2006) demonstrated that forearm 
microvascular responses to insulin were severely blunted in otherwise healthy obese versus lean 
individuals, suggesting that obesity is associated with generalised endothelial dysfunction throughout 
the vascular tree. Such obesity-related impairments in endothelial function are likely caused by 
mechanisms related to inflammatory processes in combination with hyperglycaemia and insulin 
resistance, whereby NO bioavailability is reduced secondary to increased oxidative stress production 
(Lantorno et al., 2014; Virdis, 2016). Furthermore, obesity-induced impairments in microvascular 
function are linked to increased peripheral resistance and elevated BP (de Jongh et al., 2004; Jonk et 
al., 2007). Disrupted intracellular and endocrine signalling pathways are the likely cause of obesity-
related microvascular dysfunction, of which the renin-angiotensin system is thought to play a 
prominent role (Jonk et al., 2007). Several comprehensive reviews (Jonk et al., 2007; de Boer et al., 
2012; Houben et al., 2012) have been published focusing on microvascular dysfunction and its 
association with obesity, insulin resistance and the potential causal mechanisms.  
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2.6 Effects of Underactivity on CVD Risk  
Physical inactivity represents a major independent risk factor for CVD, with approximately one-third 
of the global population failing to meet the minimum physical activity required for the maintenance 
of health (Hallal et al.). Largely due to technological advances and a greater increase in more sedentary 
occupations, physical inactivity is an increasing characteristic of modern Western lifestyles that 
contributes towards a positive energy balance when combined with excess caloric intake. Methods 
used to examine the impact of inactivity on cardiovascular health include complete bed rest, space 
travel or simulated microgravity, lower limb immobilisation, assessment of individuals with spinal cord 
injury and step-reduction models. However, bed rest is an extreme model of physical inactivity that is 
limited in its approach as it causes a reduction in plasma volume (Gaffney et al., 1985; Convertino et 
al., 1986; Fortney et al., 1991), in addition to failing to restrict upper limb movement (Bleeker et al., 
2005c). Short-term physical inactivity models (4-8 weeks) demonstrate no differences in BP, BMI or 
cholesterol (Bleeker et al., 2005a; Bleeker et al., 2005b; Bleeker et al., 2005c; Demiot et al., 2007; 
Thijssen et al., 2007), with direct effects of inactivity on the vasculature likely having a greater 
contribution towards increased CVD risk, although the evidence remains mixed. The different models 
used to explore the effects of physical inactivity upon CVD risk factors may, however, explain some of 
the conflicting outcomes reported in studies exploring both the acute and chronic vascular 
adaptations of inactivity.  
 
Bed rest deconditioning demonstrated enhanced brachial artery FMD after 7-days (Bonnin et al., 
2001), yet no change was observed following 5-days of bed rest in a study that also found a significant 
impairment in microvascular function, measured via forearm and calf reactive hyperaemia, in addition 
to elevated systolic BP and increased cholesterol, triglycerides, fasting insulin and glucose, consistent 
with the development of insulin resistance (Hamburg et al., 2007). The differences in conduit artery 
responses may be explained by methodological variation and lack of adherence to consensus 
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guidelines (Thijssen et al., 2011), or alternatively, may be due to upper limb movement being 
unrestricted and, therefore, the vessel remaining under the influence of shear stress. In line with this, 
following 60-days of bed rest, van Duijnhoven and colleagues (2010) observed a 24% decrease in 
superficial femoral artery diameter and a significant increase in wall thickness and the wall-to-lumen 
ratio, which were also observed in the carotid artery. These findings suggest that complete physical 
inactivity induces changes in vessel wall diameter, with conduit artery wall thickening considered a 
vascular marker for atherosclerotic development (Bots et al., 1994; Lorenz et al., 2007). Exercise 
countermeasures performed thrice weekly completely abolished the increase in wall thickness in the 
carotid artery, with partial abolition in the femoral artery (van Duijnhoven et al., 2010), thus 
demonstrating the impact of physical inactivity versus activity. Further studies examining endothelial 
function of the femoral artery, however, reported improved endothelial function following 25- and 
52-days bed rest (Bleeker et al., 2005c), unilateral lower limb immobilisation (Bleeker et al., 2005a), 
and in individuals with acute (de Groot et al., 2006) and chronic (de Groot et al., 2004; de Groot et al., 
2005) spinal cord injury. However, normalising the femoral artery FMD response for prevailing shear 
preserves (de Groot et al., 2004) or only slightly increases (de Groot et al., 2005) function compared 
to able-bodied controls. Upregulation of smooth muscle cell sensitivity to NO may also be responsible 
for the preservation of endothelial function in deconditioned conduit arteries, possibly arising in 
response to the chronic reduction in endothelial shear stress and subsequent down-regulation of 
eNOS, a possible explanation that is discussed in greater detail elsewhere (Thijssen et al., 2010).  
 
Step counting, via pedometers or accelerometers, provides a useful tool for monitoring physical 
activity levels and habitual patterns amongst the general public. Schmidt and colleagues (2009) 
reported a substantially higher prevalence of cardiometabolic risk factors, including metabolic 
syndrome, systolic BP, fasting glucose and triglycerides, in individuals taking <5,000 steps per day. 
Further studies reported similar findings, with an increased risk of metabolic syndrome associated 
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with lower step counts (Sisson et al., 2010) and a higher BMI, waist circumference and arterial stiffness 
in individuals with type 2 diabetes (Jennersjo et al., 2012). Compared to extreme inactivity models 
such as bed rest, step-reduction models offer a more suitable approach to investigate the effect of 
inactivity and more accurately reflect Western lifestyles. Significant reductions in peripheral insulin 
sensitivity, cardiovascular fitness and lean leg mass were observed following a 2-week self-monitored 
reduction in ambulatory activity to 1,500 steps per day in healthy, non-exercising males (Krogh-
Madsen et al., 2010). Mikus and colleagues (2012) observed significant postprandial increases in 
glucose following reduced physical activity (<5,000 steps per day) for 3-days in habitually active 
individuals. 5-days of step reduction (<5,000 steps per day) also demonstrated impaired glycaemic 
control and insulin sensitivity in healthy, young males, although there were no changes in vascular 
function, assessed as peak blood flow (mL/min) and conductance (calculated as peak blood flow/MAP) 
of the brachial and femoral arteries, measured via ultrasound (Reynolds et al., 2015).  
 
Combined overfeeding and step-reduction models more closely mimic lifestyle behaviours than 
models focusing on one component contributing towards an energy surplus, such as physical inactivity 
models of complete bed rest failing to account for dietary factors. To date, only a handful of studies 
have explored the combined impact of overfeeding and inactivity, that more closely represents a 
Western lifestyle, on metabolic and/or vascular function. Insulin resistance was observed following 3-
days of overfeeding (+25% calories) combined with abstinence from structured exercise in healthy, 
habitually active adults (Hagobian & Braun, 2006). A subsequent single bout of exercise, combined 
with overfeeding, restored insulin sensitivity to baseline levels, demonstrating the deleterious impact 
of inactivity. Following 14-days of overfeeding (+50% calorie intake) combined with step-reduction 
(≤1,500 steps per day), Knudsen and colleagues (2012) demonstrated impaired insulin sensitivity after 
just 3-days in young, healthy males who habitually undertook ~10,000 steps per day and consumed 
~2,000 calories per day. A more pronounced reduction in insulin sensitivity was observed after 7- and 
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14-days of the intervention, with impairment in insulin sensitivity preceding changes in body 
composition. More recently, hyperinsulinaemia, reduced insulin sensitivity and altered adipose tissue 
gene expression were observed following 7-days overfeeding (+50% calories) combined with 
restricted physical activity (≤4,000 steps per day) in heathy, habitually active males, in a randomised 
parallel group design (Walhin et al., 2013). The addition of a daily exercise bout to a matched model 
of overfeeding and reduced physical activity largely prevented these changes, again demonstrating 
the profound effect of exercise compared to inactivity. To date, however, no studies have specifically 
examined the combined effects of overfeeding and physical activity reduction on both metabolic and 
vascular function, despite the close interrelationship between the two.   
 
Whilst combined overfeeding and inactivity models offer a more realistic approach to represent 
habitual lifestyle behaviour, step-reduction targets may not necessarily have been universal for all 
study participants, potentially influencing individual responses. For example, a targeted step-
reduction to ≤1,500 steps per day represents a 70% reduction for an individual who is habitually 
completing 5,000 steps per day, whereas the same target for an individual completing 10,000 steps 
per day is a reduction of 85%. Such targets represent dramatic reductions to an individual’s activity 
level and, therefore, their lifestyle. Nevertheless, the combined experimental model offers a more 
realistic approach to examine the impact of lifestyle behaviours and interventions on cardiometabolic 
health.   
 
2.7 Dietary Flavonoids    
Flavonoids are characterised by two or more aromatic rings bound together by a 3-carbon bridge 
forming an oxygenated heterocycle, with the degree of oxidation generating further subclasses, in 
ascending order of oxidation: flavanols (often called catechins), flavanones, flavones, isoflavones, 
flavonols and anthocyanins (Figure 2.5) (Bravo, 1998; Beecher, 2003). Hydroxylation and conjugation 
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patterns of the aromatic rings further characterise the individual flavonoids and isoflavones within 
these subclasses (Beecher, 2003). Phenolic acids are the second most abundant polyphenol subclass, 
accounting for 30% of dietary polyphenols (Bravo, 1998). These can be categorised as hydroxybenzoic 
acids, as found in tea, and hydroxycinnamic acids which are found in coffee, cinnamon and fruits such 
as blueberries, apples and plums (Manach et al., 2004; Pandey & Rizvi, 2009). Lignans are diphenolic 
compounds formed of 2 phenylpropane units and are found in fruits, legumes, cereals and grains 
(Manach et al., 2004). Several lignans are regarded as phytoestrogens, such as secoisolariciresinol 
(Pandey & Rizvi, 2009) which is found in linseed (flax), the richest sources of lignans. Stilbenes are the 
final of the four polyphenol subclasses and are characterised by two phenyl moieties connected by a 
two-carbon ethylene bridge. Low quantities of stilbenes occur in the human diet, with resveratrol and 
pterostilbene considered the main ones. Resveratrol is the most widely known of the two and is found 
in grapes and its derivative red wine, as well as blueberries, cranberries and peanuts. Pterostilbene is 
also found in grapes and blueberries, and is suggested to have superior bioavailability compared to 
resveratrol, in addition to neuroprotective properties in age-related diseases (Chang et al., 2012). 
Epidemiological research has explored the effects of a variety of polyphenol-rich foods upon 
cardiovascular health, with a negative correlation identified between the consumption of polyphenol-
rich dietary products and CVD incidence (Arts & Hollman, 2005; Vita, 2005; Habauzit & Morand, 2012). 
Flavonoids are increasingly of scientific interest as they are present in a vast array of dietary sources, 
such as fruits and vegetables, cocoa and tea, with several studies revealing a strong, inverse relation 
between regular intake of tea and cardiovascular risk (Grassi et al., 2009b; Greyling et al., 2014).  
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Figure 2.5 Dietary polyphenol subclasses, their basic chemical structure and typical dietary sources. 
Taken from (Woodward et al., 2017).  
 
2.7.1 Tea  
Tea, produced from the plant Camillia sinesis, is the major source of dietary flavonoids in many 
countries globally (Yahya et al., 2016) and has long been associated with medicinal benefits. Tea is 
classified according to the fermentation process (Figure 2.6), where flavonoids present in the tea leaf 
are oxidised following the release of intracellular polyphenol oxidase. The four major types of tea are 
white tea which is produced from very young leaves and buds (not oxidised), green tea (non-
fermented), oolong tea (semi-fermented) and black tea (fully fermented) (Cabrera et al., 2006; Dwyer 
& Peterson, 2013). The associated health benefits of tea are attributed to its richness in polyphenolic 
compounds called flavonoids, which are found as flavan-3-ols (catechins) in green tea and theaflavins, 
thearubigins and flavonols in black tea (Hodgson & Croft, 2010; Yarmolinsky et al., 2015). Both green 
and black teas contain similar quantities of flavonoids, but differ in their chemical structure. The main 
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catechins present in green tea are epicatechin (EC), epigallocatechin (EGC), epicatechin-3-gallate 
(ECG) and epigallocatechin-3-gallate (EGCG), the most abundant of which is EGCG (~59%) followed by 
EGC (~19%), ECG (~14%) and EC (~6%) (Cabrera et al., 2006). During fermentation of green to black 
tea, these catechins form dimers known as theaflavins, proanthocyandins and large oligomers and 
polymers called thearubigins (Dwyer & Peterson, 2013). However, the exact constituents within tea 
that are responsible for the reported improvements in cardiovascular health, along with their 
mechanisms of action, are unclear. Several biological actions of foods rich in flavonoids support the 
idea of a cardioprotective effect (Grassi et al., 2008a; Grassi et al., 2009a), with a direct impact of tea 
on the vasculature suggested as a cardioprotective mechanism, particularly its effects on the vascular 
endothelium (Grassi et al., 2008a; Grassi et al., 2009a; Ras et al., 2011), such as potentially improving 
the bioactivity of NO (Grassi et al., 2013a).  
 
Figure 2.6 Overview of the major tea classifications and summary of the manufacturing processes.  
 
2.7.2 Tea and Microvascular Function 
Few studies have examined the impact of tea ingestion on the cutaneous vasculature. Fuchs and 
colleagues (2016)  recently observed the ability of tea to prevent the increase in postprandial vascular 
resistance of forearm microvessels, assessed using near infra-red spectroscopy (NIRS), within 3-hours 
following 100 ml black tea in a single-blind, randomised, cross-over study in obese, insulin-resistant 
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males. Heinrich and colleagues (2011) performed an acute, double blind trial in 15 healthy, overweight 
females who were randomised into 3 groups, each of whom received a single dose of capsular green 
tea extract (0.5, 1.0 or 2.0 g). Skin blood flow after all three doses increased at 15-30-min with no 
difference between doses. A further acute pilot study by Miller and colleagues (2011)  investigated 
the effect of capsular green tea extract (836mg green tea catechins) on laser Doppler responses to 
ACh and SNP iontophoresis in healthy, non-smoking, overweight individuals, but found no impact of 
tea. Overall, these studies on the acute effects of tea suggest that flavonoid-rich tea has the capacity 
to acutely increase microvascular function, although only one study used a tea drink per se and both 
the subject populations and study designs make it difficult to compare the overall findings.  
 
In line with the acute observations, a 12-week double-blind, placebo-controlled study in 60 middle-
aged, healthy females observed increased forearm cutaneous blood flow at both the midpoint and 
end of the 12-week intervention for green tea consumption (Heinrich et al., 2011). Oxygen saturation 
of haemoglobin was also increased at 6- and 12-weeks following daily consumption of the green tea 
beverage. However, regular consumption of capsular green tea for 3-weeks was not associated with 
any difference in endothelium-dependent or endothelium-independent microvascular reactivity in a 
double-blind, placebo-controlled parallel study in healthy males (Frank et al., 2009). Recently, 
Wasilewski and colleagues (2016) observed improved microvascular function to rapid local heating in 
both young (18-35 years) and older (55-75 years) individuals following 14-days consumption of a green 
tea beverage. However, no placebo control was used and there was poor adherence to fundamental 
guidelines for vascular assessment (Cracowski et al., 2006; Thijssen et al., 2011).  
 
The microvascular effects of green tea have also been examined in individuals with increased CVD risk. 
Smoking is associated with impaired endothelial function, even when individuals are otherwise 
healthy (Heitzer et al., 1996; Papamichael et al., 2004). With this in mind, Oyama and colleagues (2010) 
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investigated whether daily consumption of green tea catechins for 2-weeks demonstrated any effect 
on forearm blood flow (FBF) responses to ACh and SNP in healthy, male smokers. Individuals were 
divided into three groups receiving daily green tea catechins: control (0mg), medium-dose (80mg) or 
high-dose (580mg). FBF was assessed acutely (2-hours), at the mid-stage (day-7) and at the end of the 
trial period (day-14). The acute response to ACh was increased for the high-dose group, but no 
difference was observed for the medium-dose or control groups. No significant acute response to SNP 
was observed for any group.  Similar to the acute responses, chronic consumption of green tea 
catechins was associated with significantly increased FBF responses to ACh for the high-dose group, 
but not for the medium-dose or control groups and no difference was observed for any group in 
response to SNP. These findings suggest an endothelium-dependent vasodilatory response for high-
dose green tea catechins, both acutely and following regular consumption. This improvement in 
endothelial function in at-risk populations is encouraging, however, additional studies are required to 
explore these effects further.  
 
Despite encouraging data supporting a beneficial effect of tea ingestion on microvascular function, it 
is difficult to draw any meaningful conclusions from existing data owing to differences in test products, 
subject populations and a lack of methodological standardisation. The nature of the intervention 
product may be responsible for some of the observed differences in microvascular function. Studies 
that used a beverage seem to show improved microvascular function, whilst such effects were not 
found when using a capsular form of tea. This may be due to the capsular shell material hampering 
bioavailability, as cellulose based shells and fillers are known to have a negative interaction with 
polyphenols, and gelatin capsules without a cellulose filler demonstrate more positive outcomes 
(Draijer & Duchateau, 2015). However, precise details are scarce regarding the shell and filler 
materials of capsules used in the studies discussed, so it is difficult to establish whether this may be a 
causal factor for the apparent differences between studies and their intervention products. Studies 
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that have used a tea beverage are also unclear regarding the tea constituents and, therefore, the 
flavonoid content of the test product. For example, Wasilewski and colleagues (2016) asked 
participants to steep a tea bag for 3-4 minutes, which gives no precise indication of the strength or 
flavonoid content of the tea that has been tested. Furthermore, in the same study, participants were 
asked to continue with their habitual dietary habits and, therefore, no attempt was made to eliminate 
confounding influences from other flavonoid dietary sources, such as cocoa, fruits and vegetables.  
 
In summary, the current evidence concerning the effect of tea consumption on microvascular function 
is promising but remains deficient due to a lack of robust methodology and study design. Further study 
of tea and its effects on the cutaneous microcirculation are warranted and should account for dietary 
sources confounding data, ensuring there is an adequate placebo control and that the test product 
itself can be quantified in terms of its constituents. Furthermore, studies should be adequately blinded 
and randomised, with adequate washout periods between interventions. Current methodologies do 
not allow for any interpretation of the potential mechanisms responsible for any effects of tea on the 
microvasculature. Along with the points outlined above, this should be borne in mind when designing 
future studies, to provide a more rigorous approach for detecting potential changes in cutaneous 
blood flow following tea ingestion and how any such changes might have been induced.  
2.7.3 Tea and Macrovascular Function 
A suggested mechanism for the CVD risk reduction associated with tea consumption relates to a direct 
effect of tea on the vasculature, particularly the vascular endothelium (Vita, 2003). In healthy males, 
Grassi and colleagues (2009) observed a dose-dependent increase in endothelium-dependent FMD 
following twice daily consumption of black tea for 1-week compared to placebo control, in a 
randomised, double-blind, crossover study. Both systolic and diastolic blood pressure were also 
reduced with the consumption of tea versus control. Furthermore, endothelial-dependent dilation 
acutely (90-min) increased following 300 ml black tea in healthy males and females, although no effect 
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was observed following regular black tea consumption (3-cups daily) for 7-days, versus abstinence 
from tea (Schreuder et al., 2014). Black tea and green tea demonstrated comparable acute increases 
in FMD versus water 2-hours after ingestion in healthy females, although no significant difference was 
observed for endothelial-independent vasodilation (Jochmann et al., 2008).  
 
Tea has also demonstrated positive findings in individuals with increased CVD risk. Green tea was 
associated with a significant increase in FMD ~90-min following ingestion, compared to water placebo, 
in heathy males and females, 50% of whom were smokers (Alexopoulos et al., 2008). Similarly, 2-
weeks green tea consumption significantly improved FMD in young, otherwise healthy, chronic 
smokers (Kim et al., 2006). Duffy and colleagues (2001) observed increased endothelium-dependent 
vasodilation in individuals with coronary artery disease, following both acute (2-hours) and chronic (4-
weeks) black tea ingestion versus water, although no difference was detected for endothelium-
independent dilation following nitroglycerin. Similarly, a parallel, single-blind study in individuals with 
elevated cholesterol demonstrated endothelial-dependent dilation following 5-cups of black tea daily 
for 4-weeks compared to hot water control (Hodgson et al., 2002). However, in contrast to Duffy and 
colleagues (2001), endothelial-independent dilation was also improved in this cohort. Green tea 
consumption for 4-weeks was associated with a significant improvement in FMD in a cohort with 
chronic kidney disease, compared to water control (Park et al., 2010). Overall, these studies are 
suggestive of a beneficial impact of tea ingestion on macrovascular function in at-risk populations.  
 
Several studies have examined the effect of tea on endothelial-dependent vasodilation in response to 
an acute oral fat load. In a randomised, double blind, placebo-controlled crossover study of healthy 
males and females (20-55 years), Corretti and colleagues (2002)  examined the FMD response to black 
tea, green tea and placebo 3-hours following ingestion, together with a 900 kcal high fat meal. Both 
black tea and green tea blunted the decrease in FMD that was observed following the high fat meal 
with placebo tea. Further studies in pathological subject groups have demonstrated similar findings. 
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Hodgson and colleagues (2005) observed increased FMD 4-hours following consumption of 3-cups of 
black tea with a high fat meal in individuals with coronary artery disease, although no effect of tea 
was identified when taken without the meal challenge. Black tea has also counteracted fat load FMD 
impairments in a randomised, double-blind study in hypertensive individuals where tea was consumed 
regularly for 8-days (Grassi et al., 2012b). Compared to placebo, black tea increased FMD at day 8 
compared to baseline, and also demonstrated an acute-on-chronic improvement in FMD 2-hours after 
ingestion, indicating a vasoprotective effect of tea on macrovascular function.  
 
Current evidence suggests that macrovascular function is generally improved following the 
consumption of both black and green tea. Tea has induced increased brachial artery FMD in both 
healthy individuals and in at-risk populations. Furthermore, these encouraging findings have been 
observed following acute and chronic tea consumption. Two meta-analyses suggest a beneficial effect 
of tea on FMD (Hooper et al., 2008; Ras et al., 2011), although several studies have been performed 
since they were published. Despite the encouraging data supporting an endothelial-dependent effect 
of tea, it is difficult to quantify precise doses of tea, since many studies (Duffy et al., 2001; Hodgson et 
al., 2002; Hodgson et al., 2005; Jochmann et al., 2008; Schreuder et al., 2014) have used brewed tea 
leaves and others do not report the tea preparation, which does not allow an accurate indication of 
flavonoid/catechin content for between study comparisons. As fat rich meals have demonstrated 
negative effects on vascular function and a reduction in FMD (Rudolph et al., 2007; Gosmanov et al., 
2010), the studies observing a counteracting effect of tea to an acute oral fat load suggest that it may 
exert a vasoprotective effect that may have implications for generalised cardiovascular health. Further 
investigation is warranted, however, to determine whether tea demonstrates such an effect following 
a longer term metabolic challenge.   
2.7.4 Tea and Cerebrovascular Function  
Flavonoids are suggested to help maintain and even improve cognitive function, possibly via improved 
vascular function (Mastroiacovo et al., 2015). To date, limited research has been undertaken exploring 
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the acute and chronic effects of flavonoids on cerebrovascular function. Despite tea being a major 
source of dietary flavonoids for much of the global population, only one study has examined the effect 
(acute) of tea on CBF. In a randomised, double-blind, four arm crossover study, Vidyasagar and 
colleagues (2013) investigated the effect of caffeinated black tea (capsules equivalent to 6 cups), 
decaffeinated black tea, caffeine and placebo on cerebrovascular reactivity to hypercapnia in healthy 
male adults. Arterial spin labelling BOLD-MRI was used to quantify changes in CBF at baseline and 2-
hours after administration of the test product. A significant global reduction in steady-state CBF was 
observed for both caffeinated tea and caffeine alone, suggesting that caffeine was responsible for the 
decreased CBF, as no effect was demonstrated for decaffeinated tea. Cerebral CO2 reactivity was also 
unaffected by tea, caffeine and decaffeinated tea in the same study (Vidyasagar et al., 2013).  
 
Further human studies have been performed examining the CBF effects of isolated compounds found 
in polyphenol-rich foods, such as EGCG and EC that are abundant in tea (Dower et al., 2015; Murray 
et al., 2015). A single low dose (135 mg) of capsular EGCG decreased CBF (measured by NIRS) during 
computerised cognitive task performance in healthy young adults, whereas a higher dose (270 mg) 
did not change CBF relative to placebo (Wightman et al., 2012). Several studies investigating cocoa 
flavanols are potentially relevant to tea, due to EC being present in both cocoa and tea. An acute dose 
of cocoa flavanols (494 mg; containing 89 mg of EC), consumed as a beverage, increased regional CBF 
(arterial spin labelling MRI) 2-hours post-ingestion, with increases observed in the anterior cingulate 
cortex (left parietal lobe) in healthy adults aged 55-65 years (Lamport et al., 2015). Similarly, an acute 
dose (450 mg) of flavanols increased grey matter CBF (fMRI) 2-hours post-ingestion in a pilot study of 
healthy young females (n=4) (Francis et al., 2006). In contrast, an acute dose (450 mg) of cocoa 
flavanols actually decreased CBF (measured by TCD) 2-4 hours post-consumption, likely related to the 
cocoa’s caffeine content (Lunt et al., 2004), with a return to baseline within 4-6 hours (Sorond et al., 
2008a). Regular (1-2 weeks) ingestion of cocoa-derived flavonoids (900 mg flavanols per day) 
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increased CBF through the MCA (via TCD) in elderly (65+ years) individuals (Sorond et al., 2008a). 
Similarly, daily consumption of a high flavanol (172 mg flavanols/day) cocoa beverage versus a low 
flavanol (13 mg flavanols/day) beverage for 5-days improved regional CBF during cognitive tasks in 
healthy young females, when measured via fMRI (Francis et al., 2006). Furthermore, 12-weeks of daily 
cocoa flavanols (900 mg containing 138 mg (−)-EC) increased CBF (fMRI) in the dentate gyrus region in 
the healthy elderly, when compared to a low flavanol (45 mg per day) control (Brickman et al., 2014).  
 
Current research is limited regarding the effects of tea, and tea-derived compounds, on 
cerebrovascular function. The single study that investigated the effect of tea (Vidyasagar et al., 2013) 
used a capsular test product, so the effect of a tea beverage remains unknown. The few previous 
studies of cocoa flavanols and isolated compounds have largely investigated the acute effects and, 
furthermore, across all studies, it is difficult to determine what impact habitual dietary flavonoid 
consumption may have had on these data. Given the varying doses of flavanols, it is also difficult to 
make accurate comparisons of study findings to elicit meaningful conclusions. Furthermore, current 
studies have only assessed steady-state CBF, rather than assess the effect of flavonoids on dynamic 
changes in CBF (e.g., cerebral autoregulation; a critical modulator of cerebral perfusion), which 
continuously occur throughout a day, or the effect of flavonoids on cerebral CO2 reactivity. Therefore, 
further studies are required to determine the cerebrovascular effects of tea consumption.  
2.7.5 Tea and Metabolic Function   
Several in vitro and in vivo studies have observed a reduction in fasting glucose and insulin in diabetic 
rats following green tea catechins (Quine & Raghu, 2005; Yamabe et al., 2006; Roghani & 
Baluchnejadmojarad, 2010; Samarghandian et al., 2017), although human trials investigating the 
effects of green tea and isolated green tea catechins have been inconsistent. Fukino and colleagues 
(2005)  observed no clear effects of a daily green tea beverage on glucose handling or insulin resistance 
in individuals with borderline diabetes following 2-months consumption. Furthermore, blood glucose 
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and insulin levels were unchanged in type 2 diabetic adults in a 4-week crossover trial of a daily green 
tea beverage versus water control (Ryu et al., 2006). Conversely, studies have observed reductions in 
haemoglobin A1c (HbA1c) in individuals with borderline (Fukino et al., 2008) and type 2 (Nagao et al., 
2009) diabetes, following 2- and 3-months consumption of a green tea beverage, respectively. 
Furthermore, 1500 mg green tea extract daily for 16-weeks in a double-blind, randomised, placebo-
controlled trial in type 2 diabetic patients demonstrated a decrease in insulin resistance (Liu et al., 
2014) and reductions in HbA1c and insulin (Hsu et al., 2011) compared to placebo.  
 
Several studies have examined the effect of tea in overweight or obese individuals, which are 
important populations to study given that obesity is one of the most important environmental risk 
factors for cardiometabolic disease. Chan and colleagues (2006) observed no significant effect on 
glucose metabolism following 3-months of capsular green tea versus placebo in a randomised, parallel 
study in obese females (25-40 yrs) with polycystic ovary syndrome. Furthermore, an 800 mg daily dose 
of EGCG for 8-weeks had no effect on glucose tolerance or insulin sensitivity in middle-aged (40-65 
yrs) overweight/obese males (Brown et al., 2009) and no effect was observed in sedentary males 
following 6-weeks of 800mg green tea catechins in a randomised, crossover trial (Brown et al., 2011). 
However, 300 mg daily EGCG supplementation combined with regular aerobic exercise in middle-aged 
(45-70 yrs) overweight/obese post-menopausal women for 12-weeks significantly reduced plasma 
glucose concentrations compared to placebo (Hill et al., 2007). Additionally, in a 6-month randomised, 
double-blind, placebo-controlled pilot study, consumption of a decaffeinated green tea beverage (960 
ml daily) in overweight, female breast cancer (stages I-III) survivors demonstrated a decrease in insulin 
(Stendell-Hollis et al., 2010). Further parallel design studies observed a non-significant reduction in 
glucose levels following green tea extract (Suliburska et al., 2012) and significant reductions in fasting 
serum glucose and insulin resistance (Bogdanski et al., 2012) following 3-months of green tea extract 
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(208 mg EGCG) versus placebo in obese and hypertensive obese, heterogeneous middle-aged adults, 
respectively.  
 
Few studies have examined the metabolic effects of tea in healthy individuals. Sone and colleagues 
(2011) observed no significant difference in fasting plasma glucose in a 9-week randomised controlled 
trial following green tea consumption (400 mg catechins/day), compared to a low-catechin (100 
mg/day) control, in heathy males and females aged 20-70 years. However, in postmenopausal 
females, reductions in glucose and insulin were reported following ingestion of capsular green tea 
catechins for 2-months compared to placebo, with no difference reported between the 400 mg and 
800 mg catechin doses (Wu et al., 2012). Furthermore, black tea demonstrated a reduction in 
postprandial glucose 2-hours following both low- and high-dose black tea polyphenols in 
normoglyaemic and prediabetic individuals in a randomised, double-blind, placebo-controlled 
crossover study, although no significant differences were observed for insulin between both tea doses 
and placebo (Butacnum et al., 2017). An earlier acute study, however, observed no reduction in 
glucose or insulin following ingestion of 300 ml green tea compared to water, in a crossover trial of 
young (22-35 yrs), healthy adults (Josic et al., 2010). Furthermore, in a 5-day controlled diet study 
comparing the effects of oolong tea, catechin-enriched oolong tea, polyphenol-enriched oolong tea, 
caffeine-enriched water and unsupplemented water, no significant differences were observed for 
fasting glucose or insulin measures in healthy adult males (Baer et al., 2011).   
 
Overall, findings from studies investigating the effects of tea on glucose metabolism and insulin 
sensitivity are equivocal. Differences between trials make it difficult to determine any tea-derived 
effects, largely due to the study design, variations in both the type and dose of tea product used and 
confounding influences from habitual dietary intake. Current evidence suggests that green tea 
consumption is associated with a reduction in fasting glucose in individuals who are at a greater risk 
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of CVD and metabolic syndrome e.g. overweight/obese, and that such effects are largely observed in 
studies where there is a greater consumption of catechins. However, few studies have standardised 
habitual dietary intake and limited consumption of polyphenol-rich foods, making it difficult to 
determine whether these may have influenced study outcomes. There is a clear lack of data in healthy 
individuals and further studies are required to examine the effects of tea ingestion on glucose handling 
and insulin sensitivity, ensuring that habitual dietary intake is monitored to reduce confounding 
influences and ensure that it is the tea-derived effects that are being assessed.  
 
2.8 Summary 
In summary, the incidence of CVD continues to increase globally, largely due to the rise in habitual 
overfeeding and physical inactivity, and therapeutic strategies need to be identified to help combat 
the economic burden of CVD. Tea consumption demonstrates encouraging benefits for cardiovascular 
health, although there is insufficient evidence for its effects on microvascular function and little is 
known about its effects on the cerebrovasculature. Current research suggests that tea may exert a 
vasoprotective effect and has counteracted the negative macrovascular effects of an acute oral fat 
load, although the cardiometabolic effects of tea following a longer-term metabolic challenge are 
unknown. 
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CHAPTER 3: GENERAL METHODS 
48 
 
The majority of the measurements and protocols undertaken in this thesis were utilised throughout 
Chapters 4-6. Therefore, the general information for the techniques used for the physiological 
measurements are described in this methods chapter, including the reliability and limitations of these 
techniques. The specific protocols and participant cohort used for each study are detailed within the 
respective methods section for each chapter.  
 
3.1 Participants 
The population groups differed between the individual studies regarding gender and age (please refer 
to Chapters 4-6). However, across all studies, all participants were healthy and non-smokers. 
Participants were recruited through local advertisement. Individuals with a medical history of 
hypercholesterolaemia (total cholesterol >6.5 mmol/l) (Reiner et al., 2011), cardiovascular disease 
and/or hypertension (systolic blood pressure ≥140 mmHg, diastolic blood pressure ≥90 mmHg) (NICE, 
2011; Yarmolinsky et al., 2015) were excluded. Individuals with food allergies, special dietary 
requirements, currently following a diet and/or those with dietary/vitamin supplements were 
excluded. Participants were not taking any vasoactive medications or supplements. All participants 
fasted for at least 6-hours and refrained from alcohol, food products high in polyphenols (dark 
chocolate, red wine), caffeine and exercise for 24-hours prior to testing (Thijssen et al., 2011). 
Participants were asked to refrain from drinking all types of tea for a period of one week prior to each 
laboratory visit, in addition to avoiding exceptional/irregular physical activity (e.g. marathon) in the 
preceding week. Sips of water (500 ml) were permitted prior to testing to ensure that participants 
were euhydrated. After being fully informed of the methods verbally and in writing, written informed 
consent was obtained from all participants. All studies conformed to the Declaration of Helsinki and 
were approved by the local research ethics committee.  
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3.2 Anthropometric Measurements 
Stature was measured in the freestanding position to the nearest 0.1 cm (seca stadiometer, model 
217, Birmingham, UK). Body mass was measured to the nearest 0.05 kg using calibrated electronic 
digital scales (seca, model 767, Germany). Using these variables, body mass index (BMI; mass (kg) / 
height (m)2) was calculated. Resting blood pressure (mmHg) and resting heart rate (beats/min) were 
determined from an average of three measures using an automated blood pressure monitor 
(Dinamap, G & E Medical, Tampa, Florida).  
 
3.3 Peripheral Vascular Function  
All vascular function assessments were conducted in a quiet, temperature-controlled laboratory (22-
24°C) (Cracowski et al., 2006; Thijssen et al., 2011) and at the same time of day to reduce any circadian 
influences on vascular function (Jones et al., 2010; Thijssen et al., 2011). Upon arrival in the laboratory, 
participants rested in a supine position for ~20-minutes to ensure accurate assessment of stable 
baseline mean arterial blood pressure (MAP) and heart rate (HR). MAP was subsequently determined 
(MAP = [ (2 x diastolic) + systolic ] / 3 ) from an average of three measures taken from the non-
dominant arm.  
3.3.1 Microvascular Function  
An index of forearm local cutaneous blood flow was obtained using the non-invasive techniques of 
laser Doppler flowmetry (LDF: Periflux System 5001, Perimed AB, Sweden) and full-field laser 
perfusion imaging (FLPI: Moor Instruments, UK). Participants assumed a comfortable, supine position 
on a bed throughout testing, with the head slightly elevated and the hand of each testing arm relaxed, 
supinated and supported by a vacuum cushion to minimise microcirculatory fluctuations resulting 
from motion artefact (Cracowski et al., 2006; Thijssen et al., 2011). If necessary, forearm measurement 
sites were shaved 24-hours prior to testing to avoid any inflammatory response that may affect 
cutaneous blood flow; the forearms were inspected prior to each trial to ensure that no skin damage 
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was present that may adversely influence cutaneous blood flow responses. Measurement sites were 
randomly chosen, avoiding visible veins, hair follicles and dermatological lesions (Cracowski et al., 
2006). Upon completion of the first experimental trial, the location of the LDF and FLPI assessment 
sites were marked on the skin, with digital photographs and measurements taken to the nearest 
millimetre using anatomical and skin-surface landmarks for reference, to ensure accurate re-selection 
of the probe placement site for the repeat trial(s). 
3.3.1.1 Laser Doppler Flowmetry (LDF)  
Laser Doppler flowmetry is a non-invasive technique that is routinely used to study microvascular 
function (Minson et al., 2001; Cracowski et al., 2006; Cracowski & Roustit, 2015), and is sensitive in 
detecting changes in skin perfusion over a period of time and in response to a physiological challenge 
or stimulus, such as local thermal hyperaemia (Cracowski et al., 2006). LDF is concerned with the 
reflection of a laser beam that undergoes a change in wavelength, or Doppler shift, when it detects 
moving red blood cells (Figure 3.1), the magnitude and frequency of which is related to the 
concentration and velocity of blood cells, respectively, and is recorded as a signal of red blood cell flux 
(RBCF) (Cracowski et al., 2006; Cracowski & Roustit, 2015). The measurement depth of LDF is 0.5-
1.0mm in individuals with normal skin morphology and measurements are continuous, providing high 
spatial and temporal resolution beyond that of venous occlusion plethysmography (Charkoudian & 
Stachenfeld, 2014).  
 
Figure 3.1 Laser Doppler assessment of skin blood flow (SkBF) where a beam of laser light is emitted 
and undergoes a change in wavelength when it detects moving red blood cells.  
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Following a 20-minute stabilisation period, the laser Doppler equipment was calibrated using two 
generic points, 0 and 250 PU with a zeroing disk and motility standard, respectively, according to 
manufacturer’s guidelines (Perimed AB, Järfälla, Stockholm, Sweden). Following sterilisation of the 
forearm, heating discs (Perimed 355, Perimed AB, Järfälla, Stockholm, Sweden) were placed ~5cm 
apart on the dominant forearm, into which 7-laser array probes (PF 413, Perimed AB, Järfälla, 
Stockholm, Sweden) were placed and firmly attached to the skin using adhesive stickers and medical 
tape. Following a 20-minute acclimation period, cutaneous blood flow was measured as RBCF at the 
chosen probe sites using a laser Doppler flowmeter (Periflux system 5000, Perimed AB, Järfälla, 
Stockholm, Sweden). The local heating discs were connected to a heating unit (Peritemp 4005 heater, 
Perimed AB, Järfälla, Stockholm, Sweden) which was manually controlled to perform the temperature 
stages of the local heating protocols. Laser Doppler flux was continuously recorded online at 250 Hz 
(LabChart 8.0, AD Instruments, Dunedin, New Zealand).  
 
 
 
Figure 3.2 Forearm of a subject with LDF probes in situ. 
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3.3.1.2 Local Heating Protocols  
Rather than assessing systemic microvascular function, using local thermal hyperaemia provides a 
more comprehensive assessment of microvascular reactivity and the complex neural and chemically-
mediated pathways underlying local microvascular function. There are a range of distinct rapid and 
gradual local heating protocols available for the assessment of cutaneous vascular function that all 
provide different patterns of vasodilation that likely relate to different vasodilator pathways. Baseline 
skin RBCF was recorded with the local heating disc temperature set at 33°C for 10-minutes for each 
measurement site. Subsequently, local skin temperature was increased according to four distinct 
heating protocols (Figure 3.3: please refer to Chapters 4 to 6 for the specific protocols used). 
Regardless of the protocol, local skin temperature is ultimately increased to 44°C; a temperature 
considered to elicit maximal cutaneous vasodilation (Kellogg et al., 1999; Charkoudian, 2003; McCord 
& Minson, 2005; Minson, 2010).  
Rapid 39°C (Choi et al., 2014). This recently introduced protocol (0.5°C per 5 s to 39°C, 30-min 
at 39°C, 20-min at 44°C) induces a rapid, transient axon-reflex followed by a gradual plateau. By 
holding the local temperature at 39°C, the plateau phase is largely NO-mediated and causes dilation 
that is equivalent to approximately 50% of the maximal response (Choi et al., 2014).  
Rapid 42°C (Minson et al., 2001). This classic local heating protocol (0.5°C per 5 s to 42°C, 30-
min at 42°C, 20-min at 44°C) induces a rapid, transient axon-reflex which is followed by a more gradual, 
sustained vasodilatory response. The plateau phase represents 80-90% of the maximal response, and 
is mostly (60-70%) NO-mediated (Kellogg et al., 1999; Minson et al., 2001).  
Gradual 42°C (Black et al., 2008b). This adapted, shortened version of the Slow 42°C local 
heating protocol increases local skin temperature to 42°C (0.5°C per 2-min 30 s to 42°C, 30-min at 
42°C, 20-min at 44°C) and induces a slow heating response without axon reflexes that is largely NO-
mediated (Black et al., 2008b).  
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Slow 42°C (Black et al., 2008b). This longer version of the former heating protocol induces a 
gradual, slow heating response without axon reflexes (0.5°C per 5-min to 42°C, 30-min at 42°C, 20-
min at 44°C) that is largely NO-mediated (Black et al., 2008b).  
 
 
Figure 3.3 Step-wise temperature increments with corresponding times for all four local heating 
protocols. Taken from (Roberts et al., 2017).  
 
3.3.1.3 Haemodynamics  
Heart rate and BP were recorded at the beginning and at the end of the 20-minute acclimation period 
using an automated sphygmomanometer (Dinamap V100, GE Healthcare, Buckinghamshire, UK; 
please refer to Chapters 4-6 for the position). Thereafter, mean arterial pressure (MAP, mmHg) and 
HR were recorded at 5-minute intervals throughout the local heating protocols. MAP was used to 
calculate cutaneous vascular conductance.  
3.3.1.4 Data Analysis  
Data analysis was performed blind. Artefact in the data, due to unwanted subject movement, was 
identified and removed prior to analysis. Baseline laser Doppler RBCF was averaged over a stable 10-
minute baseline period. For the Rapid 42°C and Rapid 39°C protocols, following initiation of heating, 
initial peak and nadir values were calculated over a stable 60-second period (Minson et al., 2001), with 
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the initial peak identified as the highest value and the nadir as the lowest value during the first 5-10 
minutes of local heating (van Duijnhoven et al., 2009). A clear nadir was not detected in all 
measurement traces, which is typical of this type of thermal provocation test. In those traces (~5%), 
data was included from a 60-second period, 1-minute after the initial peak. This value was always 
lower than the initial peak. RBCF was calculated over a stable 60-second period for the final minute of 
each temperature increment (34-41°C) of the Gradual 42°C and Slow 42°C local heating protocols. For 
each of the four protocols, Rapid 42°C, Rapid 39°C, Gradual 42°C and Slow 42°C, plateau phases during 
heating (42°C, 39°C and maximal 44°C) were averaged over the last 5-minutes of each phase (Figure 
3.4). Data at baseline, at the various temperature increments and at the plateau phases were also 
expressed as cutaneous vascular conductance (CVC) and also normalised to the maximal CVC achieved 
at 44°C.  
 
A.  
B.  
Figure 3.4 Exemplar skin blood flow traces for A. rapid and B. gradual local heating.  
 
3.3.1.4.1 Cutaneous Vascular Conductance  
Cutaneous vascular conductance (CVC) is important in studies of skin blood flow as it accounts for 
changes in skin blood flow resulting from variations in blood pressure (Minson et al., 2001; Cracowski 
et al., 2006; Dawson et al., 2015). Calculation of CVC enables comparison of values across 
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measurement sites for a given individual and/or between participants/trials (Kellogg et al., 1993). CVC 
was calculated as:  
CVC = RBCF (PU) / MAP (mmHg) 
where CVC (PU/mmHg) is cutaneous vascular conductance, RBCF (measured in perfusion units, PU) 
represents red blood cell flux and MAP is mean arterial pressure recorded in 5-minute intervals.  
3.3.1.4.2 Local Maximal Microvascular Function  
CVC values were also normalised to the maximal CVC (%CVCmax) achieved during heating of the skin to 
44°C which, in addition to CVC, is considered the preferred method of data expression in previous 
microvascular literature (Minson et al., 2002; Cracowski et al., 2006; Black et al., 2008b; Minson, 
2010). Normalised maximal cutaneous vascular conductance (%CVCmax) was calculated as:  
%CVCmax = (CVC / CVCmax) * 100  
where %CVCmax is cutaneous vascular conductance relative to maximal cutaneous vascular 
conductance, CVC is cutaneous vascular conductance and CVCmax is maximal cutaneous vascular 
conductance achieved during skin heating at 44°C.  
3.3.2 Macrovascular Function – Flow-Mediated Dilation  
Conduit artery endothelium-dependent function was measured using the FMD technique, which 
provides an assessment of peripheral conduit artery diameter following a brief period of distal limb 
ischaemia (Thijssen et al., 2011). Shear stress is the key physiological stimulus evoking endothelium-
mediated vasodilation during the FMD response (Melkumyants et al., 1989; Thijssen et al., 2011) and 
is associated with dose-dependent increases in artery diameter (Betik et al., 2004; Padilla et al., 2009). 
Increased shear stress is detected by cell membrane mechanoreceptors, following which a signalling 
cascade is activated and subsequently stimulates the production and release of vasoactive substances 
that diffuse across the endothelial cell membrane into the smooth muscle cell (Thijssen et al., 2011). 
Signal transduction in the smooth muscle cell causes a reduction in calcium concentration and 
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subsequently, vasorelaxation. Biological variability in between-subject FMD responses largely arises 
from differences in the transduction of the vasodilatory responses to the smooth muscle cells, in 
addition to the structural characteristics of the vessel wall, such as the wall-to-lumen ratio, potentially 
influencing the resultant diameter change (Thijssen et al., 2011). FMD assessment, therefore, provides 
a means assessing endothelial function via interrogation of such biological differences and allows the 
macrovascular impact of lifestyle factors, disease status, exercise training status and various 
interventions to be examined.  
 
Simultaneous assessment of the brachial artery, at the distal third of the non-dominant upper arm, 
and the femoral artery of the right leg was performed (Figure 3.5). The non-dominant arm was 
extended and positioned at an angle of ~80° from the torso, whilst the right leg was extended in a 
comfortable position. Rapid inflation and deflation pneumatic cuffs (D.E. Hokanson, Bellevue, WA, 
USA), connected to a rapid inflator (D.E. Hokanson, Bellevue, WA, USA), were positioned on the 
forearm, immediately distal to the olecranon process, and around the right thigh, proximal to the 
patella, to provide the stimulus for ischaemia (Thijssen et al., 2011). With a stable image obtained, the 
ultrasound parameters were set to optimise the longitudinal B-mode image of the lumen-arterial wall 
interface. Continuous Doppler velocity assessment was collected using the lowest insonation angle 
(<60°), which was standardised across all measures. Baseline images for the assessment of resting 
vessel diameter, shear rate and flow were recorded for 1-minute, following which the occlusion cuffs 
were inflated (>220 mmHg) for 5-minutes to completely block the arterial inflow. Diameter and 
velocity recordings resumed 30-seconds prior to cuff deflation and continued for 3-minutes 
thereafter, according to methodological guidelines (Woodman et al., 2001; Thijssen et al., 2011; 
Greyling et al., 2016). Peak brachial artery diameter, peak blood flow velocity and the time taken to 
reach these peaks post cuff release were recorded. Ultrasound images were recorded using 
specialised recording software (Camtasia Studio, Techsmith, USA). The reliability of FMD is largely 
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dependent upon the adherence to current methodological guidelines (Thijssen et al., 2011), which 
were followed closely for all assessments performed during the current research programme.  
 
 
Figure 3.5 Simultaneous assessment of brachial and femoral flow-mediated dilation (FMD).  
 
 
Figure 3.6 Schematic representation of diameter and shear-stress responses following cuff deflation, 
in response to a 5-minute ischaemic stimulus during FMD assessment. The grey area represents the 
shear rate area-under-the-curve (SRAUC), which is considered to be the main stimulus for peak 
diameter. Taken from (Thijssen et al., 2011).  
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3.3.2.1 Artery diameter and blood flow analysis  
Post-test analysis of brachial and femoral artery diameter and velocity was performed using custom-
designed edge-detection and wall-tracking software (Dicom Encoder, V.3.0.5 LabVIEW V.7.0, National 
Instruments Corporation), which is largely independent of investigator bias and provides continuous 
measurements of arterial diameter and blood flow velocity. The software is written in icon-based 
graphical programming language (LabVIEW V.7.0, National Instruments) and uses an IMAQ vision 
toolkit for image handling. Arterial diameter on the B-mode image and velocity on the Doppler strip 
were calibrated for each individual assessment. An optimal region of interest (ROI) was identified for 
analysis on the B-mode image, chosen according to the image quality depicting a clear distinction 
between the vessel walls and lumen (Figure 3.7). Within the selected ROI, a pixel-density algorithm 
measures the mean diameter changes according to changes in pixel density from the far- and near-
wall lumen-intima interface via a Rake routine, which measures 30 points per second throughout the 
analysis. The edge-detection algorithm assessed the peak velocity envelope from the Doppler gate 
which was placed in the centre of the artery. Mean diameter derived from the B-mode ROI was 
subsequently synchronised with the velocity derived from the Doppler ROI at 30 Hz.  
 
From the synchronised diameter and velocity data, blood flow (the product of cross-sectional area 
and Doppler velocity) and shear rate (four times the velocity divided by the diameter) were calculated 
at 30 Hz (Black et al., 2008a). Peak blood flow was taken over the initial 10-second post cuff deflation, 
with peak artery FMD defined as the percentage change of the post cuff deflation peak diameter from 
baseline diameter. Total shear rate (SRAUC) was calculated, which is considered to be the main 
stimulus of the FMD response, rather than peak shear rate. All data were written to file and retrieved 
for analysis in the custom-designed analysis software package. The edge-detection and wall-tracking 
software is semi-automated and provides significantly better reproducibility of diameter 
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measurements (coefficient of variation = 6.7%) compared to manual methods, whilst simultaneously 
reducing observer error (Woodman et al., 2001).  
 
A     B     
Figure 3.7 Ultrasound image of the brachial artery and blood flow velocity trace during A. baseline, 
and B. post cuff deflation during flow-mediated dilation (FMD).  
 
3.4 Haemodynamic Function 
3.4.1 Beat-to-Beat Arterial Blood Pressure  
Continuous beat-to-beat arterial BP was measured by finger photoplethysmography (Finometer Pro, 
Finapres Medical Systems, Biomedical Instruments, Amsterdam: The Netherlands). Developed by 
Wesseling and colleagues (1995), the Finometer uses the voltage-clamp method (Penaz, 1973) to track 
variations in intra-arterial pressure through clamping the diameter of the digital artery in a constant 
“unloaded” condition (Imholz et al., 1992; Imholz et al., 1998; Bogert & van Lieshout, 2005). The 
Finometer apparatus comprises of three main components; a main unit containing an air pump and 
electronics, a finger cuff with an in-built inflatable air bladder and infrared plethysmograph containing 
the light detector and light source, and a fronted unit with a fast-acting servo-controller system (Figure 
3.8A).    
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A  
B   
Figure 3.8 A. Finometer apparatus consisting of a finger cuff, fronted unit containing the servo-
controller and a main unit housing the air pump and electronics; and B. a cross-sectional view of the 
finger cuff and waveform.  
 
Finger photoplethysmography is based upon dynamic pulsatile unloading of the digital arterial walls, 
whereby an appropriately sized finger cuff ensures that the arterial diameter is kept constant/clamped 
at a specific diameter (set point), regardless of any changes to arterial pressure, during each heartbeat. 
An inbuilt infrared photo-plethysmograph detects changes in diameter and the servo-controller 
system detects the difference between the light detector signal and set point (Figure 3.8B), 
subsequently dispatching a signal to the unit microcontroller. Should arterial diameter increase during 
systole, the diameter change is prevented in the digital artery through immediate inflation of the 
finger cuff via increased air delivery to the inflatable bladder, thereby ensuring that the transmural 
pressure of the artery remains “unloaded” (maintained at zero), at which point the finger cuff pressure 
equates to the intra-arterial pressure (Bogert & van Lieshout, 2005). An in-built calibration system 
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(Physiocal, Finometer Medical Systems, Amsterdam: The Netherlands), consisting of a dynamic servo 
set point adjuster, ensures that the optimal unloaded diameter of the finger artery is defined and 
maintained, the optimal diameter being close to the average diameter at a pressure where the 
amplitude of pulsations in the plethysmogram is largest (Wesseling et al., 1995; Imholz et al., 1998; 
Bogert & van Lieshout, 2005).  
 
An appropriately sized finger cuff was placed around the mid-phalanx of the middle or index finger 
(according to closest fit) of the right hand, ensuring that the emission and detection light sensors were 
positioned symmetrically and that the cuff was securely fitted. A hydrostatic height correction unit 
(FMS Height Correction Unit), consisting of a liquid-filled tube attached at one end to a transducer and 
at the other end to an adjustable reference component, was used to correct hand height to heart 
level; the transducer and reference component were attached to the finger cuff and at heart level, 
respectively. Prior to commencement of data collection, a “zeroing” procedure was performed 
whereby the transducer and reference component were held together to ensure the height difference 
was 0 cm. The reference component was subsequently attached to the participant’s torso at heart 
level, thereby ensuring that any changes in vertical displacement of the finger cuff relative to heart 
level were corrected for. In participants experiencing cold hands and/or fingers, a warm compress was 
used to gently warm the hand and prevent peripheral vasoconstriction. During each experimental trial, 
the raw arterial pressure waveform was visualised and recorded online at 1 kHz (LabChart 8.0, AD 
Instruments, Dunedin, New Zealand), from which SBP, DBP and MAP (1/3 SBP + 2/3 DBP, mmHg) were 
calculated.  
 
Finger photoplethysmography is limited in that systolic blood pressure may be over-estimated, with 
both mean and diastolic pressure also being lower than intra-brachial pressure (Imholz et al., 1991; 
Imholz et al., 1998). These discrepancies in arterial pressure arise due to the variable arterial 
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waveforms throughout the arterial tree, causing augmentation between more proximal arteries, such 
as the brachial artery, and finger BP. The pressure gradient along the arterial tree and reflection as 
the pressure wave nears the periphery causes the shape of the pressure wave to change, thereby 
amplifying the wave and increasing systolic pressure (Imholz et al., 1998). Furthermore, mean and 
diastolic pressure tend to be lower in the hands than in the arm as a result of this pressure gradient. 
However, the photoplethysmographic technique is able to continuously track changes in the arterial 
waveform and several studies have investigated the differences in finger photoplethysmography 
versus invasive, intra-arterial measurements of blood pressure with little differences reported 
between the two methods during Valsalva (Imholz et al., 1988), head-up tilt (Jellema et al., 1996), 
pharmacological manipulation (Imholz et al., 1992), exercise (Silke et al., 1994) or during 
postoperative patient monitoring (Triedman & Saul, 1994). Finger photoplethysmography is also 
widely used in scientific research and is a useful tool in monitoring static and dynamic changes in blood 
pressure (Ainslie et al., 2008; Carter et al., 2014; Low et al., 2016). To verify and accurately calibrate 
the finger blood pressure (described previously), an automated blood pressure cuff (Dinamap, G & E 
Medical, Tampa, Florida) was worn on the contralateral upper arm to periodically monitor the finger 
photoplethysmography values.  
3.4.2 Electrocardiogram  
Heart rate was obtained from a 5-lead electrocardiogram (ECG; AD Instruments, Oxford, UK) which 
was recorded continuously (Francis, 2016). An antiseptic medical swab was used to clean each 
electrode site, prior to the application of the ECG electrodes (3M Red Dot Monitoring Electrode, St 
Paul, MN, USA; Figure 3.9). The ECG signal was continuously recorded online (LabChart 8.0, AD 
Instruments, Dunedin, New Zealand) and heart rate was calculated from the beat-to-beat R-R interval 
values using the formula: HR = 60 / R-R interval, where HR is in beats∙min-1 and R-R is in seconds.  
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Figure 3.9 5-lead electrode system.  
 
3.4.3 Cold Pressor Test 
Haemodynamic function can be evaluated using the cold pressor test (CPT), which measures blood 
pressure and HR in response to an external cold stimulus, typically a cold water ice slurry, and is a 
useful predictor of future hypertension (Godden et al., 1955; Victor et al., 1987; Kasagi et al., 1995; 
Zhao et al., 2012). In healthy individuals, the cold stress typically induces vascular sympathetic 
activation leading to vasoconstriction and a concomitant sustained increase in blood pressure, 
although the HR response demonstrates high inter-individual variability (Victor et al., 1987; Mourot et 
al., 2009). Blood pressure reactivity is calculated as the difference between the baseline and peak 
blood pressure during the cold stimulus, with greater or “hyper” reactivity corresponding with a 
greater risk of developing hypertension and CVD (Zhao et al., 2012). However, no best practice 
guidelines exist concerning what constitutes a “normal” or “hyper” response to the external cold 
stimulus and various thresholds are used by different research groups (Kasagi et al., 1995).  
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An index of coronary artery disease risk and cranial conduit artery endothelial function can be 
calculated through assessment of carotid artery reactivity (CAR%; carotid artery diameter), via an 
ultrasound scan of the carotid artery performed during the CPT (Rubenfire et al., 2000). During 
exposure to the cold stimulus, healthy individuals typically demonstrate vasodilation of the carotid 
artery, which is independent of carotid intima-media thickness (cIMT) (Rubenfire et al., 2000). Recent 
data demonstrates a good correlation between the response of the coronary arteries and CAR%, and 
that the presence of traditional cardiovascular risk factors, in addition to older age, is associated with 
lower CAR% (van Mil et al., 2017). Assessing CAR% via the CPT, therefore, represents a valuable 
method of assessing cardiovascular risk and the potential changes in CAR% following periods of altered 
lifestyle behaviours.  
 
Following a 20-minute supine rest, participants were comfortably positioned to enable them to easily 
move their left hand off the bed without excessive bodily movement. Participants were asked to 
slightly extend their neck to allow simultaneous ultrasound imaging of the left common carotid artery 
for the duration of the CPT. A 10 MHz multifrequency linear array probe, attached to a high-resolution 
2D duplex ultrasound machine (Terason u-Smart 3300, Teratech, Burlington, MA, USA) was used to 
assess the left common carotid artery reactivity (diameter and blood flow velocity). Following a 1-
minute baseline period, participants were instructed to immerse their left hand (up to the wrist) in 
iced slush (1-5°C) for 3-minutes. Participants were instructed to breathe normally throughout the CPT 
and to avoid breath holding/hyperventilation, whilst remaining as still as possible. The reproducibility 
of the CPT is generally considered to be stable following both short-term (Durel et al., 1993; Saab et 
al., 1993; Fasano et al., 1996) and long-term (Fahrenberg et al., 1987; Sherwood et al., 1997; 
Hassellund et al., 2010; Zhao et al., 2012) studies of <2-weeks and between 1 to 18-years, respectively.  
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Beat-to-beat arterial blood pressure and 5-lead ECG were recorded online throughout the CPT 
(LabChart 8.0, AD Instruments, Dunedin, New Zealand), from which SBP and DBP were exported in 10-
second intervals. BP reactivity was calculated as the difference between baseline BP and the peak BP 
recorded during the 3-minute hand immersion. Custom-designed edge detection software (described 
earlier in section 3.3.2.1) was used to analyse CAR%. Baseline diameter and blood flow were taken in 
10-second intervals for 1-minute prior to hand immersion. Post-immersion data was analysed in 10-
second intervals, from which peak diameter change (maximum dilation/constriction) and area-under-
the-curve (AUC) for the diameter change during the CPT (CARAUC) were calculated. Peak diameter 
change relates to the dilation or constriction of the carotid artery, with the directional change being 
determined by a positive or negative CARAUC, representing dilation or constriction, respectively. 
Typically, greater CAR% is observed in younger versus older individuals, and in healthy individuals 
compared to those exhibiting greater cardiovascular risk profiles (van Mil et al., 2017).  
 
3.5 Cerebrovascular Function  
Transcranial Doppler ultrasound (TCD) is a useful, non-invasive tool that provides high temporal 
resolution for measuring blood velocity in cerebral vessels, measured in centimetres per second (cm∙s-
1) (Willie et al., 2011). As vessel diameter is unknown, TCD is not a measure of blood flow per se, rather 
it measures blood velocity of an insonated vessel and gives a reliable index of blood flow, providing 
the angle of the Doppler probes remain constant (Giller et al., 1998; Schreiber et al., 2000; Ainslie & 
Duffin, 2009). Compared to other, often limited in availability and more expensive, methods of 
assessing cerebrovascular function, such as functional magnetic resonance imaging (fMRI), positron 
emission tomography (PET) and dynamic perfusion computer tomography (PCT), TCD is advantageous 
in being portable, allowing repeated measures and continuous monitoring of cerebral blood flow 
(CBF). Furthermore, having a temporal resolution (<0.1 s) enables rapid monitoring of changes in CBF, 
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particularly in assessing integrative cerebrovascular function through cerebral reactivity, 
autoregulation and neurovascular coupling (van Beek et al., 2008; Willie et al., 2011).  
 
A low-frequency (≤2 MHz) pulsed Doppler ultrasonic beam is emitted from the Doppler probe(s) and 
crosses the intact skull to insonate the basal cerebral arteries through relatively thin bone ‘windows’ 
(Moppett & Mahajan, 2004; D’Andrea et al., 2016). Reflection of the ultrasonic beam off moving red 
blood cells within the field of transmission is detected by the transducer within the Doppler probe(s) 
(Figure 3.9), with the resultant Doppler shift being proportional to red blood cell velocity (DeWitt & 
Wechsler, 1988; Willie et al., 2011). Assessment of cerebral perfusion is often difficult due to the 
natural skull barrier and transmission of the ultrasonic beam can be influenced by the structural 
characteristics of the cranial bones, with approximately 10-20% of individuals having inadequate 
transtemporal acoustic windows, often related to age, gender and other factors (Marinoni et al., 1997; 
D’Andrea et al., 2016).  
 
Figure 3.10 Schematic depicting the components of the Doppler ultrasound probe, consisting of two 
piezoelectric elements; an ultrasound transmitter and a receiver for the returning echoes of detected 
moving red blood cells.  
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The intracranial arteries of most notable clinical interest are the internal carotid artery (ICA), middle 
cerebral artery (MCA), anterior cerebral artery (ACA) and posterior cerebral artery (PCA) (Figures 3.11 
and 3.12). The MCA is the most frequently insonated artery due to the ease of access and signal quality 
obtained through the temporal window. The MCA originates from the ICA and supplies blood to many 
parts of the lateral cerebral cortex, carrying 50-60% of the ipsilateral ICA blood flow (Moppett & 
Mahajan, 2004). Furthermore, the MCA receives ~80% of the blood volume delivered to the Circle of 
Willis (Lindegaard et al., 1987) and is generally considered to represent blood flow to the brain 
(Moppett & Mahajan, 2004). MCA blood velocity is typically detected at a depth of 45-60 mm, with 
directional blood flow towards the Doppler probe(s) (Willie et al., 2011; Bouzat et al., 2014). Detailed 
descriptions of the techniques used for insonating the MCA have previously been documented 
elsewhere and are outlined in Table 3.1 (Moppett & Mahajan, 2004; Willie et al., 2011; D’Andrea et 
al., 2016). The angle of insonation is important in ensuring accurate measurement of MCAv and it 
should remain constant, as the observed velocity is inversely proportional to the cosine angle of 
incidence between the vessel and ultrasound beam (Moppett & Mahajan, 2004). The MCA provides 
relatively easy signal acquisition with a small insonation angle and an acceptable error of ~15% has 
been associated with insonation angles of up to 30° (Aaslid et al., 1982).  
 
Figure 3.11 Overview of the cerebral circulation.  
68 
 
  
Figure 3.12 Overview of the Circle of Willis that is responsible for delivering cerebral blood flow.   
Table 3.1 Typical patterns for identifying cerebral arteries with ‘normal’ Circle of Willis anatomy and 
without intracranial or vascular pathology. Adapted from Moppett and Mahajan (2004). 
Vessel Probe direction Depth (mm) Flow direction Ipsilateral carotid 
compression 
Contralateral 
carotid 
compression 
      
ACA 
 
Anterior 60-75 Away Flow reversal Increased 
velocity 
      
MCA 
 
Perpendicular  35-60 Toward Reduced velocity No change 
      
PCA Posterior 55-70 Toward No change or 
increased velocity 
No change 
      
Abbreviations; ACA, anterior cerebral artery; MCA, middle cerebral artery; PCA, posterior cerebral 
artery.  
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In this thesis, TCD ultrasonography was used to continuously measure changes in MCAv both at rest 
(steady-state) and in response to physical manoeuvres (repetitive sit-to-stand movements) that 
induce fluctuations in BP and alterations in arterial carbon dioxide tension (cerebrovascular reactivity). 
With the participant resting in a supine position, middle cerebral artery blood velocity (MCAv, 1 cm 
distal to the MCA-ACA bifurcation) was continuously measured through the temporal window 
bilaterally via TCD ultrasonography (Doppler-BoxX, DWL Compumedics, Germany). The temporal 
window was located in the region immediately superior to the zygomatic arch, anterior to the tragus, 
at which site acoustic gel was applied and a 2 MHz Doppler probe (DiaMon, DWL Compumedics, 
Germany) was positioned on each side and adjusted until optimal signals were identified and 
remained consistent, according to previous descriptions (Willie et al., 2011). An adjustable headband 
(DiaMon, DWL Compumedics, Germany) was used to securely position the Doppler probes to ensure 
that the same angle of insonation for continuous flow velocity measurement could be maintained and 
any subtle movements prevented for the duration of the assessment (Figure 3.13).   
 
Figure 3.13 Secure positioning of the Doppler probes using a headband.  
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Specific criteria were used to insonate the correct vessel (MCA), with an insonation depth initially 
being set at 50 mm and the Doppler probe being slowly manipulated perpendicular to the assumed 
vessel direction. Upon identifying a strong signal of blood flow towards the transducer, the signal was 
optimised through minimal corrective movements of the probe and adjustments to the signal gain. A 
Doppler spectral waveform demonstrated the blood flow velocity profile on the M-mode screen, 
which assisted in confirming identification of the MCA through mean and peak blood flow velocity 
values, reading >50 cm∙s-1 and ~80 cm∙s-1, respectively (Willie et al., 2011). However, the large 
variability in MCA peak blood velocity should be noted when identifying the MCA, as large variability 
is often inherent in specific patient groups and in ageing populations (Moppett & Mahajan, 2004). 
Standardisation of within-participant measures during repeated tests was achieved through recording 
the vessel depth, optimisation settings, mean and peak MCAv values, in addition to using the MCA-
ACA bifurcation as an anatomical landmark. The same researcher positioned the Doppler probes for 
repeat laboratory visits to ensure consistency of placement. Real-time MCAv was displayed and 
recorded online at 1 kHz (LabChart version 8.0, AD Instruments, Dunedin, New Zealand).  
3.5.1 Partial Pressure of End-Tidal Carbon Dioxide (PETCO2) 
Prior to each experimental session, an online gas analyser (ML206; AD Instruments, Dunedin, New 
Zealand) was calibrated with known oxygen and carbon dioxide (CO2) beta grade gas concentrations. 
End-tidal carbon dioxide (PETCO2) was collected via a sampling tube connected to a Hans Rudolph 
mouthpiece (Hans Rudolph 9060, Kansas, USA) at a flow rate of 200 mL∙min-1. Nasal airflow was 
occluded with a nose clip (Hans Rudolph 9015, Kansas, USA). PETCO2, mean CO2 and peak maximum 
cyclic CO2 responses for end tidal CO2 were recorded online (LabChart version 8.0, AD Instruments, 
Dunedin, New Zealand). 
3.5.2 Cerebrovascular Reactivity (CVR)  
The partial pressure of CO2 (PaCO2) is one of the principle regulators of CBF, with brain perfusion being 
highly sensitive to changes in CO2 (PaCO2) (Willie et al., 2014). Following a 1-minute baseline period 
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recording steady-state CBF, PETCO2, ECG and BP, cerebrovascular reactivity (CVR) was assessed in 
response to changes in PaCO2 via a hyperventilation exercise (approximately 30-breaths per minute 
for approximately 1-minute) to induce hypocapnia. This was followed by breathing 5% CO2 for 3-
minutes (Figure 3.14). The strength of the linear relationship between cerebrovascular conductance 
(CBVC) and PETCO2 was used as the index of CVR. Cerebrovascular CO2 reactivity was calculated both 
in absolute and relative (%) terms as the slopes of the linear regression between CBF (TCD) vs PETCO2 
and CBVC vs PETCO2.  
 
Throughout baseline and 5% CO2 breathing, common carotid artery (CCA) diameter and velocities 
were simultaneously recorded using a 10 MHz multi-frequency linear array probe attached to a high 
resolution 2D duplex ultrasound machine (Terason u-Smart 3300, Teratech, Burlington, MA, USA) to 
assess changes in carotid vasomotor activity. Prior to recording, the longitudinal B-mode image of the 
lumen-arterial walls was optimised and the lowest possible insonation angle (<60°) was used. 
Ultrasound images were recorded using specialised recording software (Camtasia Studio, Techsmith, 
USA), with analysis of CCA diameter and flow performed (BloodFlow Analysis, V.3.0.5 LabVIEW V.7.0, 
National Instruments Corporation; see General Methods, section 3.3.2.1). CCA blood flow (the product 
of lumen cross-sectional area and Doppler velocity) was analysed by averaging 1-minute of baseline 
data to that of the peak blood flow response and was calculated at 30 Hz. The relative increases (%) 
in carotid artery diameter, carotid blood flow and carotid vascular conductance (CarVC; ratio of carotid 
blood flow and mean arterial blood pressure) were calculated using baseline and peak data.  
 
LabChart version 8.0 (AD Instruments, Dunedin, New Zealand) was used to extract the raw MCAv, MAP 
and PETCO2 data in 10-second average bins into Microsoft Excel (Microsoft Office 2010, Microsoft 
Corporation). When bilateral MCAv was obtained, the values were averaged unless a significant 
difference was present between the two sites, in which case the strongest MCAv was used and 
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repeated in subsequent tests. To account for the relative time spent in each phase of the cardiac cycle, 
the weighted mean MCAv (cm/s) was calculated from the peak envelope of the velocity trace for each 
cardiac cycle using the following equation; Mean MCAv = 1/3 SMCAv + 2/3 DMCAv where SMCAv 
represents the systolic middle cerebral artery and DMCAv is the diastolic middle cerebral artery (Skow 
et al., 2013). Linear regression was performed to calculate reactivity slopes. The cerebrovascular 
conductance (CBVC) index allows for the contribution of arterial BP responsiveness towards changes 
in CBF (Willie et al., 2014). Therefore, flow conductance in the cerebral vasculature was calculated as: 
CBVC = mean MCAv / MAP, where CBVC is cerebrovascular conductance, mean MCAv is mean middle 
cerebral artery velocity and MAP represents mean arterial pressure.    
 
 
Figure 3.14 Exemplar waveforms for A. middle cerebral artery blood velocity (MCAv), B. mean arterial 
pressure (MAP) and C. end-tidal carbon dioxide (PETCO2) at baseline and during hypercapnia (5% CO2) 
to assess cerebrovascular reactivity, taken from a representative individual.  
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3.5.3 Cerebral Autoregulation  
Blood pressure is a critical component of cerebral blood flow regulation, with integrated changes in 
PaCO2 and BP occurring throughout the day, particularly during activities such as coughing, exercising 
and changing posture (Willie et al., 2014). Squat-stand manoeuvres were performed to elicit 
oscillations in BP and transfer function analysis was conducted on the beat-to-beat BP and MCAv mean 
signals to determine transfer function estimates of gain, phase and coherence. The transfer gain and 
phase reflect the relative amplitude and the time relationship between the changes in MAP and MCAv 
mean, respectively, over a specified frequency range. A high gain reflects reduced autoregulation. 
Transfer estimates of phase describe the temporal shift required to align the input signal (BP) with the 
output signal (MCAv mean). For a working autoregulation, output will lead input, whereas for less 
effective autoregulation, this phase difference will be reduced. The coherence function assesses the 
linear relationship between two variables; a coherence approaching 1 in a specific frequency range 
suggests a linear relationship between two signals within that frequency range, whereas a coherence 
approximating 0 may indicate a nonlinear relationship, severe extraneous noise in the signals, or 
simply no relationship between signals.  
 
The squat-stand manoeuvres were performed to elicit oscillations in BP within the high-pass filter 
frequency range (<0.20 Hz) of the cerebrovasculature. These large swings in BP increase the statistical 
reliability of the phase and gain metrics in a physiologically relevant manner; i.e., the amplitude of 
these swings represents challenges that the cerebrovasculature endures on a daily basis during 
coughing, postural changes, exercise, etc. The squat phase engages the muscles of the legs, thereby 
increasing the skeletal muscle pump resulting in a large transient increase in venous return and BP 
within 2-3 seconds. Upon standing, the muscles of the legs are relaxed, subsequently decreasing the 
pressure applied to the veins and enabling venous pooling to increase, resulting in a subsequent 
decrease in BP. These large swings in MAP are performed at frequencies within the high-pass filter 
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range (0.05 and 0.10 Hz) and are transmitted to the cerebrovasculature. The large oscillations result 
in greatly increased coherence values at the frequency of interest (e.g., >0.98). Squat-stand cycles 
were performed at 0.20 Hz (2.5-seconds squatting, followed by 2.5-seconds standing), 0.10 Hz (5-
seconds squatting, followed by 5-seconds standing; Figure 3.15) and/or 0.05 Hz (10-seconds squatting, 
followed by 10-seconds standing) for 5-minutes each, separated by a 5-minute rest to ensure that 
PETCO2 had returned to baseline values prior commencing the second set of squats. These frequencies 
were selected as they are within the range where cerebral autoregulation is thought to have its 
greatest influence on the cerebral pressure-flow dynamics. Please refer to Chapters 6 and 7 for the 
specific squat-stand manoeuvres and protocols used. 
 
 
Figure 3.15 Exemplar waveforms for A. middle cerebral artery blood velocity (MCAv), B. mean arterial 
pressure (MAP) and C. end-tidal carbon dioxide (PETCO2) during repeated squat-stand manoeuvres at 
0.10 Hz (5-s squat, 5-s stand), taken from a representative individual.  
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Data was extracted from LabChart (version 8.0, AD Instruments, Dunedin, New Zealand) every 0.1-
seconds and averaged across the 5-minute squat-stand period. Transfer function analysis was 
performed to assess the relationship between changes in MCAv and arterial BP using the variables 
MCAv, PETCO2 and MAP, according to methodological guidelines (Claassen et al., 2016). Transfer 
function estimates of gain, phase and coherence were calculated using MATLAB (MathWorks-Inc., 
Natick, MA) over three different frequencies; very low (0.02 – 0.07 Hz), low (0.07 – 0.20 Hz) and high 
(0.20 – 0.50 Hz) (Claassen et al., 2016).  
 
3.6 Statistical Analysis  
Data were stored and transformed within Microsoft Excel (Microsoft Office 2010, Microsoft 
Corporation), and statistical analyses were performed using the Statistical Package for Social Sciences 
Version 22.0 (SPSS, Chicago, IL, USA). Data were expressed as mean ± SD, unless otherwise stated. 
Statistical significance was delimited at P≤0.05 and exact P values are cited; P values of “0.000” 
provided by SPSS are reported as “<0.001”. Please refer to the methodology section in Chapters 4-7 
for the specific statistical analyses performed.  
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CHAPTER 4: REPRODUCIBILITY OF FOUR FREQUENTLY 
USED LOCAL HEATING PROTOCOLS TO ASSESS 
CUTANEOUS MICROVASCULAR FUNCTION 
77 
 
4.1 Introduction  
Microvascular dysfunction may predict the manifestation of future cardiovascular disease, preceding 
abnormalities in larger conduit arteries and arterioles (Levy et al., 2001; Bonetti et al., 2003; Ijzerman 
et al., 2003; Holowatz et al., 2007; Minson, 2010; Sena et al., 2013). The skin provides an easily 
accessible site to assess microvascular integrity through non-invasive methods, which can be used as 
an index of overall systemic vascular function. Control of the cutaneous microcirculation involves both 
neural and non-neural pathways (Johnson et al., 2014). Neurogenic reflexes and local chemical 
mediators, such as NO, contribute towards the vasodilatory effect mediated by the vascular 
endothelium during local skin heating (Houghton et al., 2006; Black et al., 2008b). Protocols that locally 
heat the skin are increasingly used in conjunction with laser Doppler flowmetry (LDF) to evaluate skin 
blood flow responses and microvascular function, particularly for comparing between healthy and 
diseased individuals and/or assessing responses to interventions. 
 
There are currently several local heating protocols that are widely used to assess cutaneous 
microvascular function (Minson et al., 2001; Black et al., 2008b; Choi et al., 2014). These protocols all 
aim to increase skin blood flow to maximal/near-maximal levels (39–42°C), but they vary in the rate 
at which the skin is heated (0.5°C per 5 s, 2-min 30 s or 5-min) and/or the plateau at which the 
temperature is set (39°C vs 42°C) (Minson et al., 2001; Black et al., 2008b; Pugh et al., 2013; Sprung et 
al., 2013; Choi et al., 2014; Dawson et al., 2015). Due to the differences in the plateau and the rate of 
skin heating, a different contribution of the vasodilator pathways to the local heating response is 
present. Rapid local heating (0.5°C per 5 s) induces a transient axon-reflex (~5–10 min), produced via 
activation of heat sensitive sensory nerves and adrenergic nerves, followed by a more gradual, 
sustained vasodilatory response (20–30 min) that is partly (60–70%) NO-mediated (Minson, 2010). A 
modification of this protocol, by maintaining the plateau phase at 39°C, is believed to lead to a larger 
contribution of NO to the plateau phase (Choi et al., 2014). Alternatively, gradually heating the skin 
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(0.5°C per 2-min 30 s or 5-min) evokes a largely NO-mediated vasodilatory response, without 
producing an axon-reflex (Black et al., 2008b; Dawson et al., 2015). Previous work found moderate to 
good inter-day reproducibility for all local heating protocols (Agarwal et al., 2010; Roustit et al., 2010; 
Tew et al., 2011a; Huang et al., 2013; Dawson et al., 2015), especially when data were expressed 
relative to maximal values (Roustit et al., 2010; Tew et al., 2011a; Dawson et al., 2015). However, no 
previous study examined the reproducibility of these local heating protocols within the same subjects 
and/or simultaneously. This latter aspect is of special importance, since simultaneous assessment of 
distinct heating protocols may achieve better insight due to the distinct dilator pathways involved. 
Therefore, the aim of this study was to simultaneously determine the inter-day reproducibility of four 
commonly used local heating protocols for assessing cutaneous microvascular function. Comparable 
reproducibility of all four protocols was expected, which would facilitate simultaneous use of multiple 
local heating protocols within the same study.  
 
4.2 Methods  
4.2.1 Participants  
Fifteen healthy, male participants were recruited through local advertisement. All participants were 
healthy and non-smokers (28 ± 5 yrs, height 1.79 ± 0.10 m, weight 78.3 ± 8.5 kg, BMI 25 ± 2 kg/m2, 
MAP 79 ± 5 mmHg). Individuals with a medical history of hypercholesterolaemia (total cholesterol >6.5 
mmol/l) (Reiner et al., 2011), cardiovascular disease and/or hypertension (systolic blood pressure 
≥140 mmHg, diastolic blood pressure ≥90 mmHg) (NICE, 2011; Yarmolinsky et al., 2015) were 
excluded. Participants were not taking any vasoactive medications or supplements. After being fully 
informed of the methods, written informed consent was obtained from all participants. The study 
conformed to the Declaration of Helsinki and was approved by the Research Ethics Committee of 
Liverpool John Moores University. 
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4.2.2 Experimental Design  
All participants attended two experimental trials which were 2–7 days apart. During each trial, 
baseline and maximal thermally stimulated forearm cutaneous blood flow was examined 
simultaneously at four different sites on the dominant forearm using LDF. At each site, separated by 
~5 cm, a different local heating protocol was adopted: 1. Rapid 39°C (Choi et al., 2014), 2. Rapid 42°C 
(Minson et al., 2001), 3. Gradual 42°C (Black et al., 2008b) and 4. Slow 42°C (Black et al., 2008b). The 
sites at the forearm were kept the same within subjects between the two testing days. 
Anthropometric measurements were recorded at visit 1. Heart rate and BP were recorded at the 
beginning and at the end of the 20-minute acclimation period, and thereafter at 5-minute intervals 
throughout the local heating protocols using an automated sphygmomanometer (Dinamap V100, GE 
Healthcare, UK) positioned on the contralateral arm. For details of the experimental procedures for 
these measurements, please refer to Chapter 3, General Methods. 
4.2.3 Statistical Analysis  
Data were expressed as mean ± SD and statistical significance was set at P≤0.05. Mixed model 
RMANOVA was used to compare local heating protocols and paired Student's t-tests were used to 
examine day-to-day systematic bias of each local heating protocol. Bland-Altman plots were 
constructed to demonstrate individual variability. The coefficient of variation (CV) was calculated to 
assess the inter-day reproducibility of CVC and %CVCmax at baseline, 39/42°C and 44°C. Prior to 
calculating the CV, a natural logarithmic transformation was applied to correct for heteroscedasticity 
of the data. For biological variables, a CV of <10% is considered good and <20% is acceptable (Scott et 
al., 1989). A two-way ANOVA was used to examine BP within each protocol and between test days 
(main effects of local temperature and visit). Data were stored and transformed within Microsoft Excel 
(Microsoft Office 2010, Microsoft Corporation), and statistical analyses were performed using SPSS 
22.0 (SPSS, Chicago, IL, USA).  
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4.3 Results  
Figure 4.1 shows representative skin blood flow traces for all local heating protocols, indicating the 
phases and associated local temperatures (33°C, 39/42°C and 44°C) that were used for analysis. There 
was a small but significant increase in MAP during the heating protocols (P=0.002), consistent with a 
circadian variation. This gradual increase in MAP was not different between trials (P=0.39) and no 
interaction effect was found between local temperature and trial (P=0.49). 
 
Figure 4.1 A. A representative forearm cutaneous arbitrary flux response for the four local heating 
protocols. Average flux was calculated over a stable 10-min period of baseline at 33°C (A) and the final 
5-min of the plateau phases during heating at 39/42°C (B and C, respectively) and 44°C (D). The spike 
(#) indicates artefact resulting from slight movement of the arm which was removed prior to analysis. 
B. Step-wise temperature increments with corresponding times for all four local heating protocols. 
Taken from (Roberts et al., 2017).  
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4.3.1 Baseline  
Baseline cutaneous blood flow was not different between days when expressed as arbitrary flux or 
CVC (all P>0.05, Table 4.1). Furthermore, when expressed as %CVCmax, cutaneous blood flow was not 
different between days for the heating sites for Rapid 39°C, Rapid 42°C, Gradual 42°C or Slow 42°C 
(Table 4.1). Inter-day variation of baseline cutaneous blood flow was 17.2–26.1% for flux, 17.4–24.8% 
for CVC and 18.6–29.2% for %CVCmax (Table 4.1), with no differences between local heating sites.  
 
Table 4.1 Baseline cutaneous blood flow results. Data is presented as mean ± SD. Inter-day 
reproducibility is presented as CV (± 95% CI): light grey shading indicates CV: >21%; mid grey shading 
indicates CV: 10-20%. 
 Trial 1  Trial 2  Between-day CV (%) Paired t-test 
Baseline (33°C)        
Rapid 39°C         
    Absolute flux (PU)  21 ± 10      20 ± 9  26.1 (19.1 - 41.3)  0.57 
    Absolute CVC (PU/mmHg)  0.26 ± 0.12 0.25 ± 0.11 24.8 (18.2 - 39.2) 0.66 
    Maximal CVC (%CVCmax)  9 ± 5 8 ± 4 29.2 (21.4 - 46.5) 0.51 
Rapid 42°C         
    Absolute flux (PU)        20 ± 9 19 ± 10 17.2 (12.6 - 26.8) 0.10 
    Absolute CVC (PU/mmHg)  0.26 ± 0.11 0.24 ± 0.13 17.4 (12.8 - 27.2) 0.26 
    Maximal CVC (%CVCmax)  8 ± 4 8 ± 5 19.3 (14.2 - 30.3) 0.66 
Gradual 42°C         
    Absolute flux (PU)        19 ± 8  20 ± 12 19.9 (14.6 - 31.2)  0.93 
    Absolute CVC (PU/mmHg)  0.24 ± 0.10 0.25 ± 0.15 20.8 (15.3 - 32.7) 0.79 
    Maximal CVC (%CVCmax)  7 ± 4 7 ± 4 18.6 (13.7 - 29.2) 0.89 
Slow 42°C         
    Absolute flux (PU)        25 ± 11  22 ± 10   21.1 (15.5 - 33.2)  0.30 
    Absolute CVC (PU/mmHg)  0.31 ± 0.14 0.28 ± 0.12 22.7 (16.7 - 35.7) 0.43 
    Maximal CVC (%CVCmax)        10 ± 4 9 ± 5 24.7 (18.2 - 39.1) 0.73 
 
4.3.2 Local Heating to Plateau (39°C/42°C)  
For all four protocols, inter-day cutaneous perfusion at the plateau phase was not different between 
days when expressed as arbitrary flux, CVC or %CVCmax (all P>0.05, Table 4.2). Lower inter-day 
reproducibility was found for the plateau phase of Rapid 39°C compared to Rapid 42°C, Gradual 42°C 
and Slow 42°C when data were expressed as flux, CVC or %CVCmax (Table 4.2). When data were 
presented as %CVCmax, CV was lower for Rapid 42°C, Gradual 42°C and Slow 42°C (Table 4.2). Bland-
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Altman plots demonstrated no obvious heteroscedasticity for the responses at the plateau phase 
(Figure 4.2).  
 
Table 4.2 Local heating cutaneous blood flow results. Data is presented as mean ± SD. Inter-day 
reproducibility is presented as CV (± 95% CI): light grey shading indicates CV: >21%; mid grey shading 
indicates CV: 10-20%; dark grey shading indicates CV<10%. 
 Trial 1  Trial 2  Between-day CV (%) Paired t-test 
Plateau Phase (39°C /42°C)        
Rapid 39°C         
    Absolute flux (PU) 138 ± 56 150 ± 57 20.6 (15.1 - 32.3) 0.20 
    Absolute CVC (PU/mmHg)   1.76 ± 0.67 1.93 ± 0.76 21.2 (15.6 - 33.4) 0.22 
    Maximal CVC (%CVCmax)   55 ± 16 57 ± 13 20.7 (15.2 - 32.6) 0.48 
Rapid 42°C         
    Absolute flux (PU) 233 ± 56 218 ± 45 13.1 (9.7 - 20.5)  0.15 
    Absolute CVC (PU/mmHg)   3.01 ± 0.73 2.80 ± 0.56 12.8 (9.5 - 20.0) 0.09 
    Maximal CVC (%CVCmax) 87 ± 8 86 ± 7 6.8 (5.0 - 10.5) 0.56 
Gradual 42°C         
    Absolute flux (PU) 240 ± 35 242 ± 54 15.2 (11.2 - 23.7)  0.87 
    Absolute CVC (PU/mmHg)   3.00 ± 0.51 3.07 ± 0.69 15.9 (11.7 - 24.9) 0.69 
    Maximal CVC (%CVCmax) 88 ± 4 90 ± 6 5.2 (3.9 - 8.1) 0.29 
Slow 42°C         
    Absolute flux (PU) 220 ± 47 231 ± 52 16.6 (12.3 - 26.0) 0.48 
    Absolute CVC (PU/mmHg)   2.61 ± 0.54 2.81 ± 0.63 18.2 (13.4 - 28.4) 0.26 
    Maximal CVC (%CVCmax)   81 ± 11 87 ± 11 10.6 (7.8 - 16.5) 0.09 
Maximal Plateau (44°C)        
Rapid 39°C         
    Absolute flux (PU) 255 ± 49    261 ± 61 12.9 (9.5 - 20.0)  0.66 
    Absolute CVC (PU/mmHg)   3.22 ± 0.60 3.37 ± 0.82 13.2 (9.8 - 20.6) 0.38 
Rapid 42°C         
    Absolute flux (PU) 274 ± 62    254 ± 42 13.7 (10.1 - 21.3)  0.11 
    Absolute CVC (PU/mmHg)   3.46 ± 0.75 3.26 ± 0.55 12.3 (9.1 - 19.2) 0.14 
Gradual 42°C         
    Absolute flux (PU) 274 ± 42    275 ± 60 14.6 (10.8 - 22.8)  0.96 
    Absolute CVC (PU/mmHg)   3.39 ± 0.50 3.41 ± 0.74 14.5 (10.7 - 22.6) 0.93 
Slow 42°C         
    Absolute flux (PU) 274 ± 47    268 ± 54 13.2 (9.8 - 20.6)  0.71 
    Absolute CVC (PU/mmHg)   3.21 ± 0.58 3.23 ± 0.61 15.0 (11.1 - 23.5) 0.89 
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Figure 4.2 Bland–Altman plots of the difference between days in %CVCmax against the mean of the 
measurements at the 39/42°C plateau for A. Rapid 39°C, B. Rapid 42°C, C. Gradual 42°C and D. Slow 
42°C. Middle horizontal line denotes mean value and upper and lower lines denote 95% limits of 
agreement. Linear regression demonstrated no evidence of proportional bias. Taken from (Roberts et 
al., 2017).  
 
4.3.3 Maximal Heating  
Perfusion, presented as flux of CVC, during maximal heating (44°C) was not different between days 
(Table 4.2). The maximum heating response resulted in a reproducibility of 12.3–15.0% when data 
were expressed as arbitrary flux and CVC (Table 4.2). This observation was valid across all four 
protocols. Bland-Altman plots demonstrated no obvious heteroscedasticity for the responses during 
maximal heating (Figure 4.3).  
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Figure 4.3 Bland–Altman plots of the difference between days in CVC against the mean of the 
measurements at 44°C for A. Rapid 39°C, B. Rapid 42°C, C. Gradual 42°C and D. Slow 42°C. Middle 
horizontal line denotes mean value and upper and lower lines denote 95% limits of agreement. Linear 
regression demonstrated no evidence of proportional bias. Taken from (Roberts et al., 2017). 
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4.4 Discussion  
The aim of this study was to explore the inter-day reproducibility of four commonly used (and 
simultaneously performed) local skin heating protocols for assessing cutaneous vascular function. 
Findings suggest that inter-day variation of baseline cutaneous blood flow demonstrated poor-to-
moderate reproducibility. Secondly, inter-day reproducibility of cutaneous blood flow responses to 
the plateau phase of the Rapid 42°C, Gradual 42°C and Slow 42°C protocols was moderate for flux and 
CVC, but good when data were presented after correcting for maximal perfusion (%CVCmax). In 
contrast, inter-day reproducibility of perfusion during the plateau phase of the Rapid 39°C protocol 
was moderate-to-poor. Finally, maximal inter-day cutaneous blood flow demonstrated moderate 
reproducibility for arbitrary flux and CVC across all protocols, which indicates that the maximum 
response was not affected by the preceding protocol of local heating. These observations have clinical 
impact for designing future studies, especially when multiple local heating protocols are being used 
simultaneously.  
 
Protocols that locally heat the skin in combination with LDF are frequently used to assess 
microvascular integrity and index overall systemic vascular function (Minson et al., 2001). Current 
protocols vary in methodology with fast (Minson et al., 2001; Choi et al., 2014) or gradual (Black et al., 
2008b; Dawson et al., 2015) rates of skin heating. Although studies have explored the reproducibility 
of individual heating protocols, the current study is the first to simultaneously assess reproducibility 
of multiple protocols. This is particularly important given that the simultaneous assessment of 
cutaneous vascular function using these distinct heating protocols may achieve better insight due to 
the distinct dilator pathways involved. Firstly, moderate to-poor reproducibility was identified for 
baseline perfusion, in agreement with previous research (Tew et al., 2011a; Dawson et al., 2015). It is 
important to acknowledge that the reproducibility of baseline perfusion was independent of the site 
of measurement (i.e. the four different sites that underwent the distinct heating protocols). Similarly, 
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maximal perfusion at 44°C also demonstrated good agreement between the four measurement sites. 
This demonstrates that the reproducibility of the LDF technique to assess baseline or maximal 
perfusion is not dependent on the site of measurement, but also was not affected by the local heating 
protocol (e.g. rapid or gradual). 
 
Although distinct heating protocols were used, a comparable reproducibility was expected for the 
plateau phase according to previous studies (Tew et al., 2011a; Dawson et al., 2015). In line with the 
hypothesis, but also in agreement with previous studies (Tew et al., 2011a; Dawson et al., 2015), 
moderate reproducibility was found for perfusion during the plateau phases of the Rapid 42°C, 
Gradual 42°C and Slow 42°C protocols. Again consistent with previous studies (Tew et al., 2011a; 
Dawson et al., 2015), expressing data as a percentage of maximal perfusion resulted in an 
improvement of reproducibility. As CVC data is typically normalised to maximum to account for the 
heterogeneity of cutaneous vessel density, this may explain the increased reproducibility when data 
were normalised to %CVCmax. The use of integrated probes in the current and aforementioned studies, 
which allow an examination of a greater surface area of skin, may have contributed to the good-to-
moderate reproducibility. Indeed, previous work on local heating using single point LDF probes report 
lower reproducibility (Agarwal et al., 2010; Roustit et al., 2010).  
 
Despite the good agreement between the rapid, gradual and slow heating protocols to 42°C, poorer 
reproducibility was reported for forearm cutaneous vascular responses to the rapid heating protocol 
to 39°C. The poorer reproducibility of the Rapid 39°C protocol cannot be simply explained by the speed 
of increasing local temperature, especially since reproducibility of the Rapid 42°C and Gradual 42°C 
protocols were similar. The Rapid 39°C protocol was developed in order to isolate NO-dependent 
dilation and/or allow a better assessment of perturbations that may improve microvascular function 
due to the levels of skin blood flow achieved at this local skin temperature (~50% maximum) compared 
87 
 
to those at 42°C (~90% maximum) (Choi et al., 2014). Differences in reproducibility between the Rapid 
39°C protocol and the other protocols may therefore relate to the differences in the level of skin blood 
flow achieved in the protocols. Skin blood flow was lower at the plateau phase of the Rapid 39°C 
protocol (i.e. ~50% of the maximum response) relative to the plateau phases of the Rapid 42°C, 
Gradual 42°C and Slow 42°C protocols (80–90% of the maximum response). Such levels may provide 
more space for variation in perfusion, despite correcting the level of perfusion for differences in the 
maximum perfusion at 44°C. One consequence of this observation is that a larger group size is required 
for the Rapid 39°C protocol compared to the other protocols to detect differences within subjects. 
 
Using data from the present study, the sample sizes required to show significant changes in CVC and 
%CVCmax at 39/42°C for within subject comparisons (e.g., pre and post interventions; Table 4.3) were 
calculated. Assuming a power of 80% (α=0.05), the Rapid 39°C protocol would require 54 subjects to 
detect a 5.0% change in %CVCmax at 39°C compared to 27 subjects at 42°C for the Rapid 42°C protocol. 
Again, assuming a power of 80% (α=0.05), the Gradual 42°C protocol would require 17 subjects to 
detect a 5.0% change in %CVCmax at 42°C and the Slow 42°C protocol would require 47 subjects. These 
sample size estimations demonstrate distinctly different requirements for studies that use both rapid 
and gradual local heating, possibly related to between protocol differences in underlying vasodilatory 
mechanisms. 
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Table 4.3. Estimated sample sizes required for a repeated measures study design using the Rapid 39°C, 
Rapid 42°C, Gradual 42°C and Slow 42°C local heating protocols to detect significant changes in skin 
blood flow assessed as CVC and %CVCmax at 39/42°C using the results from the reproducibility study.  
 
Power, % α-Error Change in CVC Sample size 
   Rapid 39°C Rapid 42°C Gradual 42°C Slow 42°C 
         
80 0.05 0.25 35 29 56 59 
80 0.05 0.50 11 9 16 17 
80 0.05 0.75 6 6 9 9 
80 0.05 1.00 5 4 6 6 
90 0.05 0.25 46 38 74 78 
90 0.05 0.50 13 11 20 21 
90 0.05 0.75 8 7 11 11 
90 0.05 1.00 5 5 7 7 
Power, % α-Error Change in %CVCmax Sample size 
   Rapid 39°C Rapid 42°C Gradual 42°C Slow 42°C 
       
80 0.05 2.5 208 99 58 180 
80 0.05 5.0 54 27 17 47 
80 0.05 7.5 25 13 9 22 
80 0.05 10.0 15 9 6 14 
90 0.05 2.5 278 132 77 240 
90 0.05 5.0 71 35 21 62 
90 0.05 7.5 33 17 11 29 
90 0.05 10.0 20 11 7 17 
 
The reproducibility of the Rapid 42°C, Gradual and Slow 42°C protocols were similar. Importantly, 
these local heating protocols induce skin vasodilation via different mechanisms. Whilst slowly heating 
the skin prevents significant axon reflexes and leads to a largely NO-mediated response, rapidly 
heating the skin activates the axon reflex and leads to a NO- and EDHF-mediated response (Johnson 
et al., 2014). The involvement of multiple vasoactive substances in the rapid heating response might 
have contributed to a larger variation in response to the Rapid 42°C local heating protocol. However, 
similar coefficients of variation were evident for the CVC and %CVCmax data in the Rapid 42°C and 
Gradual 42°C protocols. The specific underlying pathways leading to vasodilation in response to the 
distinct heating protocols may therefore provide useful synergistic insight into complementary 
vasodilatory mechanisms. Therefore, supported by the comparable reproducibility, it is suggested that 
measuring multiple local heating protocols is easy, applicable and feasible, but may also provide better 
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insight into the skin vasodilator mechanisms. An alternative approach would be to use the same 
heating protocol across multiple sites to minimise any between site differences. Averaging data across 
these sites would improve reliability and thereby reduce the sample size requirements. However, use 
of a single protocol is limited in only assessing one vasodilatory pathway, whereas a multi-protocol 
approach may elicit further mechanistic insight into vasodilatory responses observed.  
4.4.1 Limitations  
Inter-day reproducibility was assessed in a young, healthy population, thereby limiting extrapolation 
of our findings to individuals and patient groups with cardiovascular risk, such as older individuals, 
who commonly exhibit attenuated cutaneous blood flow responses to local heating (Minson et al., 
2002; Cracowski et al., 2006; Holowatz et al., 2007; Black et al., 2008b). However, young and older 
subjects demonstrated comparable reproducibility of local heating in a previous study (Tew et al., 
2011a). A further limitation is that females were excluded from this study to control for hormonal 
influences on vascular function (Charkoudian et al., 1999; Charkoudian & Johnson, 2000; Charkoudian, 
2001) and, therefore, the study findings are applicable to males only. 
 
In conclusion, this is the first study to simultaneously examine the inter-day reproducibility of four 
local heating protocols, which are currently frequently used to assess cutaneous blood flow in humans. 
The study findings suggest that the reproducibility of baseline forearm skin perfusion assessment is 
poor to moderate, and is independent of the site of measurement. The Rapid, Gradual and Slow 42°C 
protocols exhibited superior reproducibility, particularly when data is expressed as %CVCmax, 
compared to the Rapid 39°C protocol. The present study data supports the validity of repeated 
measures of cutaneous blood flow in response to local heating protocols, for use in epidemiological 
studies as an index of microvascular function. Furthermore, these data provide help in guiding future 
studies in calculating the sample sizes necessary to detect differences, especially since differences are 
present between the different protocols. The present data will, therefore, inform the assessment of 
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cutaneous microvascular function in subsequent chapters in using simultaneous local heating 
protocols to comprehensively interrogate the microvasculature, whilst also considering the sample 
size estimations as a guide to detect meaningful differences. 
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CHAPTER 5: ACUTE BLACK TEA CONSUMPTION 
IMPROVES CUTANEOUS VASCULAR FUNCTION IN 
HEALTHY MIDDLE-AGED HUMANS
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5.1 Introduction  
 
Cardiovascular disease (CVD) remains the leading cause of global mortality, representing ~30% of all 
deaths (WHO, 2016). The role of dietary factors on CVD risk has been frequently explored in recent 
years, with a high dietary flavonoid intake being associated with a reduction in CVD risk (Peterson et 
al., 2012). Tea, produced from the plant Camillia sinesis, is the major source of dietary flavonoids in 
many countries globally (Yahya et al., 2016) and can be found as catechins and flavanols in green tea 
and theaflavins, thearubigins and flavonols in black tea (Hodgson & Croft, 2010). Accordingly, several 
studies have revealed a strong, inverse relation between regular intake of tea and cardiovascular risk 
(Grassi et al., 2009b; Greyling et al., 2014).  
 
A frequently cited explanation for the cardioprotective effects of black and green tea ingestion relates 
to the reduction in blood pressure following chronic consumption (Grassi et al., 2009b; Greyling et al., 
2014; Grassi et al., 2015). Further research found that acute and regular tea ingestion improves NO-
mediated, endothelium-dependent dilation of conduit arteries (Duffy et al., 2001; Hodgson et al., 
2002; Hodgson et al., 2005; Grassi et al., 2009b; Schreuder et al., 2014). Both conduit and resistance 
vessels have demonstrated improved endothelial function following tea ingestion in both healthy 
individuals (Hodgson et al., 2002; Grassi et al., 2009b) and in those with CVD (Duffy et al., 2001). Thus, 
the general consensus is that regular tea ingestion improves blood pressure by virtue of a generalised 
improvement of endothelial function and lowering of peripheral vascular resistance (Duffy et al., 2001; 
Hodgson et al., 2002; Hodgson et al., 2005; Grassi et al., 2009b; Ras et al., 2011).  
 
Despite encouraging data supporting a beneficial effect of tea ingestion in larger (conduit) vessels, no 
previous study has robustly explored the effect of black tea on small vessels (skin microcirculation). 
Therefore, the aim of this study was to examine cutaneous vascular responses to local skin heating. 
Given the complexity of the cutaneous vascular system and contribution of distinct mechanisms for 
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skin dilation when gradually or rapidly heating the skin, a comprehensive approach was adopted using 
both rapid and gradual local skin heating protocols simultaneously. It was hypothesised that black tea 
ingestion would be associated with increased cutaneous microcirculation responses for both rapid 
and gradual heating protocols.  
 
5.2 Methods  
5.2.1 Participants  
Twenty middle-aged male (n=9) and post-menopausal female (n=11) participants were recruited 
through local advertisement. All participants were healthy and non-smokers (58 ± 5 yrs, height 1.70 ± 
0.1 m, weight 75.9 ± 16.1 kg, BMI 26 ± 4 kg/m2, baseline MAP 104 ± 8 mmHg). For details of the 
inclusion and exclusion criteria, please refer to Chapter 3, General Methods. After being fully informed 
of the methods verbally and in writing, written informed consent was obtained from all participants. 
The study conformed to the Declaration of Helsinki and was approved by the local research ethics 
committee.  
5.2.2 Experimental Design  
All participants performed two experimental trials (tea and control), 7-days apart in a randomised, 
controlled, double-blind, cross-over design (Figure 5.1). The crossover design was chosen to eliminate 
between-participant variability, taking into account a 6-day washout period between the two 
interventions to avoid any carry-over effects, which is in accordance with previous similar designed 
crossover tea vascular function studies (Grassi et al., 2009b; Grassi et al., 2015). Computer-generated 
randomisation was used to reduce potential selection bias. Participants were asked to adhere to all 
pre-test instructions regarding fasting, avoiding caffeine etc., as outlined in Chapter 3, General 
Methods (section 3.1). Anthropometric measurements were recorded at visit 1 (see Chapter 3, 
General Methods, section 3.2). Upon arrival to the laboratory, and 2-hours prior to microvascular 
assessment, participants ingested a tea drink (containing 300 mg flavonoids, 75 mg caffeine and 2.8 g 
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sucrose) or a taste and appearance matched placebo drink (0 mg flavonoids, 75 mg caffeine, 2.7 g 
sucrose, tea flavour and caramel colour), prepared by dissolving two sachets in 200 ml hot water. 
Participants subsequently rested for 2-hours prior to commencement of testing to match peak plasma 
concentrations of flavonoids and other metabolites such as phenolic acids, with testing of skin 
microcirculation.  
 
Figure 5.1. CONSORT diagram showing the flow of participants through each stage of the randomised 
trial. Taken from (Woodward et al., 2016).  
 
At each trial, baseline and thermally stimulated forearm cutaneous blood flow was examined 
simultaneously using rapid (to 39 and 42°C) and gradual (to 42°C) local heating protocols. Since these 
protocols reflect different dilator mechanisms and a distinct role of the NO-pathway, they provide 
complementary insight into the impact of black tea on the cutaneous microvasculature. Rapid local 
heating was performed at two different sites (i.e. two different local heating protocols) on the 
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dominant forearm and examined using LDF. Gradual local heating to 42°C was performed on the 
dominant forearm using LDF and on the contralateral (non-dominant) arm using laser speckle imaging 
via full-field laser perfusion imaging (FLPI) to provide whole forearm cutaneous microvascular function 
(Figure 5.2).  
 
The FLPI technique, also known as laser speckle contrast imaging, exploits the fact that the random 
speckle pattern that is generated when tissue is illuminated by laser light, changes when blood cells 
move within the region of interest (Briers et al., 2013). High levels of movement (fast flow) produce a 
more blurred pattern, associated with a reduction in contrast in that region. Low contrast therefore 
corresponds with high flow and high contrast corresponds with low flow. The strengths of this 
technique are that video frame rate blood flow images (up to 25 per second) enable the tracking of 
fast transient blood flow changes and provides high spatial and temporal resolution. This device works 
with a near infra-red laser diode (785 nm) and is able to scan skin surfaces from 5 mm x 7 mm to 15 
cm x 20 cm, to a depth of approximately 150-300 micron and is safe for human use.  
 
Following a 20-minute acclimation period, FLPI recordings were performed using a blood flow imaging 
system (moorFLPI-1, Moor Instruments, Axminster, UK) with a laser wavelength of 785 nm and 
sampling frequency of 25 Hz. A ~3 cm2 area of skin was measured, with the distance between the laser 
head and skin surface fixed at 15 cm (Mahé et al., 2011). A skin heater module (moorVMSHEAT, Moor 
Instruments, Axminster, UK) was used to manually set the incremental temperatures. Data were 
continuously recorded in moorFLPI V3.0 PC Software (Moor Instruments, Axminster, UK).  
 
Both LDF and FLPI provide non-invasive continuous measures of cutaneous blood flow (Roustit & 
Cracowski, 2012). By using a combination of these techniques, it is possible to simultaneously evaluate 
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superficial (<300 micron) and deeper (0.5-1.5 mm) skin blood flow via FLPI and LDF, respectively. 
Anthropometric measurements were recorded at visit 1. Heart rate and BP were recorded using an 
automated sphygmomanometer (Dinamap V100, GE Healthcare, UK) positioned on the ankle, 
corresponding to the same laterality as their dominant arm. For details of the experimental 
procedures for these measurements, please refer to Chapter 3, General Methods. 
 
 
 
Figure 5.2. Study overview and schematic depicting the stages of the local heating protocols. Light 
grey shading denotes local heating, mid grey shading represents the plateau and dark grey shading 
represents the maximal plateau. Taken from (Woodward et al., 2016).  
 
5.2.3 Statistical Analysis  
Data were expressed as mean ± SD and statistical significance was set at P≤0.05. For all protocols, 
linear mixed models (main effects of condition and time) were used to examine the impact of acute 
tea ingestion on blood pressure and forearm skin microcirculation. The repeated covariance type was 
Unstructured and Condition, Time and Condition*Time was specified as Fixed Effects (intercept was 
included) and as Estimated Marginal Means. Order was added as a covariate to control for the 
sequence of experimental trials (tea and placebo). The Test of Fixed Effects Condition*Time 
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interaction was interpreted. Significant main effects of Time or Condition or a Time*Condition 
interaction were followed up with a simple main effects analysis and the least significant difference 
(LSD) approach to multiple comparisons (Perneger, 1998). Data were stored and transformed within 
Microsoft Excel (Microsoft Office 2010, Microsoft Corporation), and statistical analyses were 
performed using SPSS 22.0 (SPSS, Chicago, IL, USA). 
 
5.3 Results  
One participant was removed from the Gradual 42°C LDF analysis for both experimental trials (due to 
probe failure) and five participants were removed from the Gradual 42°C FLPI analysis for both trials 
(linked to excessive movement artefacts), giving a population of n=19 and n=15, respectively. No 
participants were removed from the Rapid 39°C and Rapid 42°C analysis (both n=20). There was no 
order effect for any of the protocols (P-value range 0.20-0.87). Baseline MAP was not different 
between conditions (108 ± 11 mmHg vs 108 ± 11 mmHg, P=0.73) and showed no change across time 
(P=0.52). There were no differences in baseline cutaneous perfusion between trials for measurement 
sites that underwent Rapid 39°C or Rapid 42°C local heating for absolute flux, CVC or %CVCmax (Table 
5.1). Furthermore, the site that underwent Gradual 42°C local heating using LDF showed no difference 
in baseline cutaneous blood flow between trials for absolute flux, CVC or %CVCmax (Table 5.2). 
However, using FLPI, a significantly higher baseline perfusion was found after tea ingestion for 
cutaneous flux and CVC, but not for %CVCmax (Table 5.2).  
 
5.3.1 Rapid Local Heating: Impact of Tea  
5.3.1.1 Rapid 39°C  
Local heating induced a typical pattern of an initial peak, nadir and plateau in cutaneous blood flow. 
Therefore, a main effect of time was demonstrated for absolute flux, CVC and %CVCmax (Table 5.1). 
However, there was no effect of the intervention found or a time X intervention-interaction for 
absolute flux, CVC or %CVCmax (Table 5.1). 
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5.3.1.2 Rapid 42°C 
Local heating induced a typical pattern of an initial peak, nadir and plateau in cutaneous blood flow. 
Consequently, a main effect of time was demonstrated for absolute flux, CVC and %CVCmax (Table 5.1), 
whilst no main effect of intervention or time X intervention-interaction was found for absolute flux, 
CVC or %CVCmax (Table 5.1).  
5.3.2 Gradual Local Heating: Impact of Tea  
5.3.2.1 GradualLDF (42°C)  
Local heating induced a gradual, slow heating response with no detectable initial axon reflex-induced 
peak or nadir with a main effect of time (Table 5.2). A higher skin blood flow throughout the heating 
protocol was observed during the trial preceded by black tea for absolute CVC (P=0.04), with a trend 
towards significance when data were presented as absolute flux (P=0.06, Table 5.2). No effect of tea 
was found when CVC was normalised for maximum perfusion (%CVCmax, P=0.82, Table 5.2). No time X 
intervention interaction was found for absolute flux (P=0.93), CVC (P=0.95) or %CVCmax (P=0.98, Table 
5.2).  
5.3.2.2 GradualFLPI (42°C) 
Local heating induced a gradual, slow heating response with no detectable initial axon reflex-induced 
peak or nadir (Table 5.2). Tea ingestion was associated with a significantly higher absolute flux 
(P<0.001) and CVC (P<0.001), but not when CVC was normalised to maximum CVC (%CVCmax, P=0.35, 
Table 5.2). No time X intervention interaction was present for absolute flux (P=0.50), CVC (P=0.66) or 
%CVCmax (P=1.00, Table 5.2). 
Statistical analysis revealed no presence of a carry-over effect. 
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Figure 5.3 Cutaneous vascular conductance (CVC) responses across time points (baseline at 33°C, axon 
peak, axon nadir, plateau at 39/42°C and maximal plateau at 44°C) following rapid local heating for A. 
Rapid 39°C and B. Rapid 42°C in 20 healthy volunteers when heating was preceded by ingestion of 
placebo (open squares) or tea (solid triangles). Data are presented as means, with error bars 
representing SE. Taken from (Woodward et al., 2016). 
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Table 5.1 Laser Doppler flowmetry cutaneous blood flow responses to local heating for the Rapid 
39°C and Rapid 42°C protocols for placebo and tea interventions. 
  Intervention (mean ± SD) LMM 
Rapid 39°C Placebo Tea Time Tea Time*Tea 
Absolute flux(PU)      
    Baseline   22 ± 11   21 ± 8    
    Axon-reflex 108 ± 38   103 ± 50    
    Nadir   57 ± 25     52 ± 26 <0.001* 0.14 0.76 
    Plateau 39°C 136 ± 53   123 ± 70    
    Plateau 44°C 288 ± 61   263 ± 61    
      
Absolute CVC (PU/mmHg)      
    Baseline   0.21 ± 0.12     0.21 ± 0.10    
    Axon-reflex   1.03 ± 0.39     0.99 ± 0.47    
    Nadir   0.54 ± 0.25     0.50 ± 0.26 <0.001* 0.27 0.91 
    Plateau 39°C   1.29 ± 0.52     1.17 ± 0.65    
    Plateau 44°C   2.70 ± 0.67     2.52 ± 0.59    
      
Maximal CVC (%CVCmax)      
    Baseline   8 ± 4     8 ± 3    
    Axon-reflex   39 ± 15     39 ± 15    
    Nadir   20 ± 10     20 ± 10  <0.001* 0.76 0.99 
    Plateau 39°C   48 ± 15     46 ± 21    
Rapid 42°C      
Absolute flux(PU)      
    Baseline   22 ± 9    25 ± 16    
    Axon-reflex   199 ± 60  208 ± 60    
    Nadir   165 ± 64  177 ± 74 <0.001* 0.51 0.99 
    Plateau 42°C   252 ± 72  253 ± 67    
    Plateau 44°C   300 ± 79  302 ± 63    
      
Absolute CVC (PU/mmHg)      
    Baseline     0.21 ± 0.10    0.25 ± 0.16    
    Axon-reflex     1.90 ± 0.61    2.00 ± 0.61    
    Nadir     1.57 ± 0.64    1.71 ± 0.74 <0.001* 0.29 1.00 
    Plateau 42°C     2.39 ± 0.74    2.43 ± 0.66    
    Plateau 44°C     2.81 ± 0.81    2.91 ± 0.74    
      
Maximal CVC (%CVCmax)      
    Baseline     8 ± 3    8 ± 4    
    Axon-reflex     67 ± 11    68 ± 11    
    Nadir     55 ± 16    57 ± 19 <0.001* 0.65 0.95 
    Plateau 42°C   85 ± 8    83 ± 12    
Data are presented as mean ± SD. LMM, linear mixed model. *Main effect of time P<0.001 vs baseline.   
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Figure 5.4 Cutaneous vascular conductance (CVC) responses across time points (from baseline at 33°C 
to maximal plateau at 44°C) following gradual local heating using A. laser-Doppler flowmetry (LDF) 
and B. full-field laser perfusion imaging (FLPI) in 20 healthy volunteers when heating was preceded by 
ingestion of placebo (open squares) or tea (solid triangles). Data are presented as means, with error 
bars representing SE. *Main effect of condition P≤0.05 placebo vs tea, ^main effect of condition 
P<0.001 placebo vs tea. Taken from (Woodward et al., 2016).  
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Table 5.2 Cutaneous blood flow responses to local heating for the GradualLDF (42°C) and GradualFLPI 
(42°C) protocols for placebo and tea interventions. 
  Intervention (mean ± SD) LMM 
GradualLDF  (42°C) Placebo Tea Time Tea Time*Tea 
Absolute flux(PU)      
    Baseline   26 ± 11    24 ± 9    
    Plateau 42°C 268 ± 79    278 ± 61 <0.001* 0.06 0.93 
    Plateau 44°C 302 ± 84    319 ± 45    
      
Absolute CVC (PU/mmHg)      
    Baseline   0.25 ± 0.11      0.23 ± 0.09    
    Plateau 42°C   2.51 ± 0.76       2.61 ± 0.64 <0.001*   0.04^ 0.95 
    Plateau 44°C   2.80 ± 0.82       2.93 ± 0.51    
      
Maximal CVC (%CVCmax)      
    Baseline   9 ± 5       8 ± 3    
    Plateau 42°C 90 ± 7       89 ± 14 <0.001* 0.82 0.98 
GradualFLPI  (42°C)      
Absolute flux(PU)      
    Baseline 30 ± 9     36 ± 8    
    Plateau 42°C 197 ± 51     222 ± 50 <0.001* <0.001^ 0.50 
    Plateau 44°C 216 ± 65     253 ± 68    
      
Absolute CVC (PU/mmHg)      
    Baseline   0.29 ± 0.09       0.36 ± 0.07    
    Plateau 42°C   1.85 ± 0.55       2.10 ± 0.57 <0.001* <0.001^ 0.66 
    Plateau 44°C   2.01 ± 0.64       2.34 ± 0.72    
      
Maximal CVC (%CVCmax)      
    Baseline   17 ± 11     17 ± 8    
    Plateau 42°C   94 ± 10     91 ± 6 <0.001* 0.35 1.00 
Data are mean ± SD. LMM, linear mixed model. *Main effect of time P<0.001 vs baseline. ^Main effect of 
intervention; placebo vs tea P≤0.05.  
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5.4 Discussion  
The primary aim of this study was to test the hypothesis that a single dose of black tea ingestion 
improves cutaneous microcirculation following both rapid and gradual local skin heating. The study 
found that gradual local heating of the skin to 42°C induced a greater vasodilatory response following 
tea ingestion compared to placebo when expressed as absolute flux and CVC. The ability of tea to 
improve local gradual heating responses in the skin was reinforced by the observation that both LDF 
and FLPI, two distinct but accepted techniques to assess skin perfusion, detected this effect. 
Conversely, rapid local heating did not demonstrate a significant increase in cutaneous 
microcirculation with tea ingestion, either for the Rapid 39°C or Rapid 42°C protocols. Taken together, 
this study provides some further evidence that regular tea ingestion may mediate its potential 
cardiovascular benefits via improvements in (cutaneous) microvascular function.  
 
This study is the first to explore the acute effects of tea ingestion on the cutaneous microcirculation 
whilst adopting a rigorous protocol involving blind analysis of rapid and gradual heating protocols as 
well as two distinct, accepted techniques. This observation fits with the general observation of tea 
being able to enhance endothelial function in conduit vessels when assessed by FMD (Grassi et al., 
2009b; Schreuder et al., 2014). Taken together, these findings suggest that acute tea ingestion 
improves vascular function across the vascular tree, including skin microvessels, possibly via 
upregulation of vasodilator mechanisms. 
 
In contrast to gradual local heating, rapid heating of the skin did not alter cutaneous vascular function 
following tea ingestion when compared to placebo. Findings were similar for both rapid heating 
protocols (Rapid 39°C and Rapid 42°C). Interestingly, a recent observational study (Wasilewski et al., 
2016) found improved microvascular function following regular consumption of green tea (14-days) 
using rapid heating (whilst no measure of gradual heating was included). Important differences were 
present between studies, especially since this previous study did not include a placebo control, did 
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not fully adhere to guidelines for vascular assessment (e.g. control of menstrual cycle) (Thijssen et al., 
2011), and was limited by a lack of control of dietary habits (Grassi et al., 2009b). Furthermore, whilst 
our study investigated the acute (2-hour) effects of tea, they examined a protocol of 14-days of green 
tea. Despite the Rapid 39°C and Gradual 42°C protocols both being linked to the release of NO, 
distinctly different responses are clearly evident between the gradual and rapid heating protocols in 
the present study. Different vasodilator pathways directly influence the cutaneous microcirculation, 
including neurogenic reflexes and local chemical mediators (Minson et al., 2001; Black et al., 2008b; 
Dawson et al., 2015). The rate at which the skin is heated alters the contribution of these vasodilator 
pathways, with rapid (0.5°C per 5s) local heating inducing a transient axon-reflex mediated  
vasodilation that is produced via activation of heat sensitive sensory/nociceptive nerves releasing 
calcitonin gene-related peptide (CGRP) and substance P and adrenergic nerves releasing 
norepinephrine and neuropeptide Y (Minson et al., 2001; Johnson et al., 2014). This initial neurogenic 
response is followed by a more gradual, sustained vasodilation. In both phases, vasodilation occurs 
through complex pathways that lead to the production of NO and smooth muscle relaxation via 
hyperpolarization from endothelial derived hyperpolarisation factors (EDHFs) (Johnson et al., 2014), 
with a greater (but not exclusive) contribution of NO during the plateau phase (Minson et al., 2001; 
Choi et al., 2014). Furthermore, the relative contribution of NO to the vasodilation during the plateau 
phase of the rapid heating protocols depends upon the target heating temperature, as the heating 
response to 39°C seems to depend more on NO than the response to 42°C (Minson et al., 2001; Choi 
et al., 2014). These studies, therefore, demonstrate that the underlying mechanisms for cutaneous 
vasodilation differ based on the rate and maximum level of heating. The different vasodilator 
pathways for these heating protocols may contribute to the distinct findings in this study. From a 
methodological perspective, the differences between rapid and gradual local heating highlight the 
importance of using multiple heating protocols simultaneously when exploring the impact of an 
intervention on skin perfusion.  
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The higher vasodilatory responses that were observed following gradual heating of the skin were 
demonstrated for arbitrary flux and CVC values, for both LDF and FLPI techniques. However, the 
difference in responses between the tea and placebo trials was not significant when data were 
expressed as %CVCmax. The skin is commonly heated to 44°C to reach maximal vasodilation and 
expressing CVC as a percentage of maximal perfusion is often considered the preferred method of 
data expression (Cracowski et al., 2006), with improved reproducibility compared to flux or CVC 
(Dawson et al., 2015). Despite a main effect of tea on flux and CVC, post-hoc analyses revealed no 
differences between trials at 44°C (LDF: flux = 0.17 and CVC = 0.19; FLPI: flux = 0.09 and CVC = 0.08). 
However, the magnitude of differences in flux and CVC between tea and placebo are larger than one 
may expect based on day-to-day variation (Dawson et al., 2015). This provides some indication that 
the tea intervention may have altered cutaneous perfusion at 44°C local heating.  
5.4.1 Clinical Relevance  
Tea consumption is known to have cardiovascular benefits, including a reduction in blood pressure 
after short-to long-term intervention, possibly mediated (in part) by improved endothelial function of 
conduit vessels (Hodgson et al., 2002; Ras et al., 2011; Schreuder et al., 2014). In the present study, 
cutaneous microcirculation responses to gradual heating improved following tea ingestion. It may be 
speculated that these findings may have implications for individuals with microvascular complications 
and skin endothelial dysfunction, such as type 2 diabetes mellitus. Interestingly, consumption of tea 
has been associated with a reduced risk for type 2 diabetes mellitus (Yang et al., 2014). The study 
findings thus support the hypothesis that regular tea consumption may have potential benefit in such 
patient groups. Future studies are warranted to explore this hypothesis. 
5.4.2 Limitations 
Due to the modest sample size, the findings of the present study cannot be generalised towards the 
wider populace. Furthermore, although a middle-aged population was included, who are likely at an 
increased risk of CVD, the findings cannot be simply extrapolated to clinical groups. Moreover, the 
study population may have impaired endothelial function as blunted cutaneous NO-mediated 
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vasodilation has been demonstrated in older individuals (Black et al., 2008b), suggesting that young 
healthy volunteers may exhibit different results than the older population studied. Therefore, future 
work is required to explore the potential impact of acute as well as chronic tea ingestion on cutaneous 
vascular function in both individuals with compromised endothelial function and in young, healthy 
individuals. A further limitation is that plasma measures of flavonoids or NO compounds were not 
obtained and, therefore, the present study does not provide any biochemical or biomolecular insight 
into the mechanisms underlying the improvement in cutaneous microvascular function. However, it 
is important to emphasise that this was not the purpose of the study, particularly given that this is the 
first to explore the effects of acute tea ingestion on the cutaneous microcirculation. 
 
In conclusion, the study findings suggest that acute tea ingestion enhances cutaneous vascular 
function in a healthy, middle-aged population, when measured following gradual local heating to 42°C. 
Therefore, these data suggest that acute tea ingestion has a beneficial impact on vascular function at 
the microcirculatory level, which is likely achieved through a mechanism related to activation of 
endothelium-derived vasodilators. These improvements in cutaneous microvascular function may 
contribute to the potential cardiovascular health benefits of regular tea ingestion. Future studies are 
required to explore the acute and chronic effects of tea on individuals with increased CVD risk and in 
clinical populations with a priori endothelial dysfunction. Furthermore, given the detrimental impact 
of ‘unhealthy’ lifestyles on increasing CVD risk, further investigation is warranted to determine 
whether tea may exert a cardioprotective role on peripheral and cerebral vascular function in the 
context of an ‘unhealthy’ lifestyle.  
  
107 
 
CHAPTER 6: GREEN TEA ATTENUATES THE 
DELETERIOUS IMPACT ON PERIPHERAL VASCULAR 
FUNCTION AND INSULIN SENSITIVITY ASSOCIATED 
WITH AN UNHEALTHY LIFESTYLE  
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6.1 Introduction  
Cardiovascular related pathologies have emerged as a major public health burden over recent 
decades, with scientific evidence increasingly implicating modifiable lifestyle factors in the progression 
of cardiovascular risk towards overt CVD. Physical inactivity and poor dietary habits are major 
modifiable risk factors linked with detrimental changes to cardiometabolic health (Lavie et al., 2009; 
Booth et al., 2012). Physical inactivity has increased significantly in recent decades and is now one of 
the leading causes for global mortality (WHO, 2015). Low levels of leisure time physical activity are 
associated with increased risk for CVD (Hamburg et al., 2007; Thijssen et al., 2010; Boyle et al., 2013; 
Holwerda et al., 2015) and metabolic disease (Hamburg et al., 2007; Thyfault & Krogh-Madsen, 2011). 
In addition, food intake also impacts cardiovascular and metabolic health, with high fat (most likely 
trans) (Skeaff & Miller, 2009; Michas et al., 2014; de Souza et al., 2015), high calorie diets being 
strongly associated with long-term cardiovascular and metabolic disease risk (Hennig et al., 2001; Liu 
& Manson, 2001; Brons et al., 2009; Dow et al., 2015). Interestingly, even short-term (<7-days) high 
fat dietary interventions (e.g., >40% extra calories from fat) in healthy adults lead to increased baseline 
glucose levels (Brons et al., 2009), as well as postprandial increases in glucose and insulin (Parry et al., 
2017). Furthermore, habitual high fat dietary consumption is associated with impaired endothelial-
dependent vasodilation in sedentary adults (Dow et al., 2015) and a single high fat meal has 
demonstrated a postprandial decline in endothelial function in healthy adults (Vogel et al., 1997; Bae 
et al., 2001; Tsai et al., 2004). This work highlights the detrimental impact of both lowering physical 
activity levels and excessive food intake.  
 
Epidemiological research continues to link increased flavonoid ingestion with a reduction in 
cardiovascular events, including stroke and dementia (Commenges et al., 2000; Vita, 2005; Fisher et 
al., 2006; Malar & Devi, 2014). Furthermore, regular tea ingestion, a key source of flavonoids, has 
been shown to lower BP (Hodgson et al., 2012) and improve NO-mediated, endothelium-dependent 
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dilation of conduit arteries (Hodgson et al., 2002; Grassi et al., 2009b; Schreuder et al., 2014), 
particularly in the presence of cardiovascular pathology or following an  acute, single high fat meal 
(Corretti et al., 2002; Hodgson et al., 2005; Grassi et al., 2012b; Grassi et al., 2016). In addition, regular 
intake of tea is also associated with a lower risk for developing diabetes (Iso et al., 2006; Stote & Baer, 
2008; Jing et al., 2009; Park et al., 2014). For example, plasma glucose lowering effects have been 
observed in both type 2 diabetic individuals (Hosoda et al., 2003) and in healthy adults (Bryans et al., 
2007), suggesting that tea may improve metabolism, via changes in glucose handling and insulin 
resistance.  
 
In this study, it was speculated that tea may represent a potential approach in targeting the 
cardiovascular and metabolic impairments induced by a lifestyle characterised by too little physical 
activity and excessive calorie intake (e.g. the Western lifestyle, but also periods of forced unhealthy 
lifestyle (e.g., illness, injury)). The aim of this study was, therefore, to explore whether daily green tea 
consumption (equivalent to 6 cups/day) ameliorates the impairments in peripheral (conduit artery 
and skin microvessels) and cerebrovascular function and insulin sensitivity after a 7-day ‘unhealthy’ 
lifestyle, combining physical activity reduction (-50% steps per day) and overfeeding (+50% kcal per 
day, comprising 65% fat) in healthy male participants. It was hypothesised that daily consumption of 
green tea would abrogate changes in peripheral and cerebrovascular function following 7-days of 
reduced physical activity and increased calorie consumption.  
 
6.2 Methods  
6.2.1 Participants 
Twelve healthy male participants were recruited through local advertisement. All participants were 
healthy and non-smokers (29 ± 6 yrs, height 1.76 ± 0.1 m, weight 77.0 ± 10.0 kg, BMI 25 ± 2 kg/m2, 
baseline MAP 84 ± 8 mmHg). For details of the inclusion and exclusion criteria, please refer to Chapter 
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3, General Methods. Participants’ habitual activity levels were established through completion of an 
IPAQ questionnaire (Lee et al., 2011) and a 4-day self-reported diary. A hip-mounted pedometer (Digi-
walker SW-701, Yamax, Japan) and tri-axial accelerometer (GT3X BT+ model, Actigraphy, Pensacola, 
Florida, USA) were used to count the number of daily steps and to record all non-water based physical 
activity, respectively. The reliability of tri-axial accelerometry to estimate physical activity has been 
previously determined (Aadland & Ylvisåker, 2015). Subjects who recorded <8,000 steps per day were 
excluded from participation. During the 4-day physical activity assessment period, participants also 
recorded their daily dietary intake in a food diary to determine their habitual consumption. The 
activity and dietary data were subsequently used to calculate the physical activity reduction of -50% 
steps per day and overfeeding by +50% kcal per day. After being fully informed of the methods verbally 
and in writing, written informed consent was obtained from all participants. The study conformed to 
the Declaration of Helsinki and was approved by the local research ethics committee. The study was 
registered at clinicaltrials.gov (NCT02777853).  
6.2.2 Experimental Design  
All participants underwent two 7-day periods of lifestyle intervention, both consisting of physical 
activity reduction (-50% steps per day) and overfeeding (+50% kcal per day, comprising 65% fat), 
combined with either tea or placebo ingestion (Unhealthy Lifestyle + Placebo, UL-Placebo; or 
Unhealthy Lifestyle + Tea, UL-Tea), in a randomised, controlled, double-blind, crossover design (Figure 
6.1). Each period was separated by a 13-day washout to avoid any carry-over effects. In the week 
preceding each laboratory visit, participants were asked to refrain from drinking all types of tea (not 
including the test product) and to avoid all other food sources high in polyphenols, such as berries, 
dark chocolate, apples and red wine (Perez-Jimenez et al., 2010).  
 
111 
 
 
Figure 6.1. CONSORT diagram showing the flow of participants through each stage of the randomised 
trial (FMD, flow-mediated dilation; LDF, laser Doppler flowmetry).  
 
6.2.2.1 Lifestyle Intervention  
During each 7-day intervention period, participants were instructed to reduce their physical activity 
levels by 50%, comprising of a step reduction target and a reduction in the volume of other physical 
activities (i.e. gym, running, cycling) which were calculated from the 4-day habitual diary. The physical 
activity reduction was monitored via a hip-mounted accelerometer (GT3X BT+ model, Actigraphy, 
Pensacola, Florida, USA), in addition to self-reported step counts using a hip-mounted pedometer 
(Digi-walker SW-701, Yamax, Japan). Overfeeding was achieved through the provision of “snack 
boxes” with the equivalent of ~800-2000 kcal for participants to consume on a daily basis; kcal were 
calculated according to participants’ habitual dietary intake during the 4-day dietary diary. Participants 
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were instructed to maintain their normal diet during each 7-day intervention period, other than 
restricting foods and beverages high in polyphenols, such as berries, red wine, dark chocolate etc. 
Habitual dietary patterns were monitored through completion of self-reported food diaries (excluding 
the additional intake from the “snack boxes”).  
6.2.2.2 Tea Intervention  
During each 7-day intervention period, participants ingested three doses of an active green tea drink 
(UL-Tea) or a placebo tea drink (UL-Placebo) per day at regular intervals (morning, afternoon and 
evening), which participants were advised to take without, or at least 15-minutes before, a meal. 
Participants and researchers were blinded as to the test product. The crossover design was chosen to 
eliminate between-participant variability and computer-generated randomisation was used to reduce 
potential selection bias. The green tea was previously brewed with hot water in a large quantity, prior 
to being dried into a powder form. A product of similar colour and taste to the green tea, but not 
containing the presumed actives of tea (polyphenols) was used as the placebo tea drink (Table 6.1). 
Pre-weighted servings of the test products were supplied to the participants in laminated aluminium 
foil sachets (1 gram of tea powder per sachet) and participants were given instructions regarding the 
tea preparation; two sachets of tea powder to be completely dissolved in approximately 300 ml of 
boiling water, constituting a ‘dose’. It was stressed to the participants that no additives to the tea were 
permitted (milk, sugar, lemon etc.) and that the tea should be consumed whilst it was still hot. The 
difference in the maltodextrin content (19 kcal per day) between the active and placebo teas was 
adjusted for within the overfeeding provision. Participants were instructed to avoid all other types of 
tea, other than the test product that they were given.  
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Table 6.1 Composition of the active and placebo tea test products.  
 Placebo tea 
% on dry weight basis 
Active tea 
% on dry weight basis 
Gallocatechin (GC) 0.00 0.02 
Epicatechin gallate (ECG) 0.00 0.05 
Gallic Acid 0.00 0.16 
Catechin (C) 0.00 0.58 
Gallocatechin gallate (GCG)  0.00 0.92 
Epicatechin (EC) 0.00 1.53 
Catechin gallate (CG) 0.00 2.39 
Epigallocatechin (EGC) 0.00 4.07 
Epigallocatechin gallate (EGCG) 0.00 5.96 
Caffeine  0.00 3.90 
Maltodextrin             94.00                21.05 
Tea flavour  6.00 0.00 
 
6.2.2.3 Experimental Measures  
Participants attended the laboratory before and after each 7-day intervention (4 visits), after adhering 
to all pre-test instructions regarding fasting, avoiding caffeine etc., as outlined in Chapter 3, General 
Methods (section 3.1). Anthropometric measurements were recorded at visit 1, with body mass 
repeated at each subsequent visit (see Chapter 3, General Methods, section 3.2). During each visit, 
microvascular function, conduit artery endothelial function, haemodynamic function, cerebrovascular 
function, glucose handling and insulin sensitivity were examined. Baseline and thermally stimulated 
forearm cutaneous blood flow was examined simultaneously using rapid (to 39 and 42°C) and gradual 
(to 42°C) local heating protocols on the dominant forearm using LDF. Heart rate and BP were recorded 
using an automated sphygmomanometer (Dinamap V100, GE Healthcare, UK) positioned on the 
contralateral arm. Conduit artery endothelial function (FMD) was examined at the brachial (non-
dominant arm) and right femoral arteries. Cerebrovascular function was assessed via CO2 reactivity 
and dynamic cerebral autoregulation during squat-stand manoeuvres (SSM) at 0.10 Hz (5-second 
squat: 5-second stand) and 0.20 Hz (2.5-second squat: 2.5-second stand). For details of the full 
experimental procedures for all vascular measurements, please refer to Chapter 3, General Methods. 
Following completion of the vascular measures, participants underwent a mixed meal tolerance test 
(MTT).  
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Figure 6.2 Study overview depicting the various stages, restriction of dietary polyphenols and 
intervention periods, including the measures performed at each of the four laboratory visits.  
 
At the time of venous blood sampling, participants had fasted for ≥10-hours and refrained from 
vigorous exercise for the preceding 24-hours. Following sterilisation of the sampling site, a 20G 
cannula (Venflon Pro, BD, NJ, USA) was inserted into the antecubital vein of one arm. A three-way 
stopcock (BD Connecta, NJ, USA) was subsequently attached to enable multiple venous blood 
sampling and flushing of the cannula. Baseline samples were collected for glucose (5 ml) and insulin 
(6 ml), in silica and EDTA vacutainers, respectively, following which participants consumed a mixed 
meal (1200 kcal, comprising 60% carbohydrates, 33% fat and 7% protein; Table 3.2). Further 
postprandial blood samples were collected after 30, 60, 90, 120 and 180-min. Following each blood 
sample, isotonic saline (3 ml; B Braun, UK) was used to keep the cannula patent. All blood samples 
were centrifuged (1000 g for 10-min at 4°C) to obtain plasma samples, which were subsequently 
stored in aliquots at −80°C for later analysis.  
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Table 6.2 Macronutrient content of the mixed meal tolerance test (MTT).  
Food Item 
 
Quantity (g) kcal Carbohydrate (g) Fat (g) Protein (g) 
Chocolate spread sandwich       
    Thick white bread  150 g 357 66.9   3.3 12.9 
    Chocolate spread    90 g 513 51.8 32.4   2.7 
      
Medium banana  120 g 105 30.0   0.4   1.3 
      
White chocolate cereal bar    50 g 226  31.0   8.2    4.4 
      
Total  1201            179.7   44.3 21.3 
% of Total Calories                60%  33%   7% 
 
 
6.2.2.4 Data Analysis   
For details of the data analysis methods for all vascular measurements, please refer to Chapter 3, 
General Methods. Plasma glucose was determined using an ILab-600 semi-automatic 
spectrophotometric analyser and glucose hexokinase assay (Randox, London, UK). Plasma insulin 
concentrations were determined using a direct insulin ELISA kit (Invitrogen, UK) and insulin levels 
determined using a monochromator microplate reader (Clariostar, BMG LABTECH, Ortenberg, 
Germany).  
6.2.3 Statistical Analysis  
The effect size of the interventions could not be estimated or calculated due to the novelty of the 
study. Therefore the number of volunteers was based upon the sample size of earlier vascular studies 
(Hodgson et al., 2013; Grassi et al., 2015) and previous chapters contained within this thesis. Data 
were expressed as mean ± SD and statistical significance was set at P≤0.05. For all protocols, linear 
mixed models (main effects of condition and time) were used to examine the differences between 
Placebo and Tea interventions on vascular function and insulin sensitivity following 7-days of physical 
activity reduction and overfeeding. The repeated covariance type was Unstructured and Condition, 
Time and Condition*Time were specified as Fixed Effects (intercept was included) and as Estimated 
Marginal Means. The Test of Fixed Effects Condition*Time interaction was interpreted. Significant 
116 
 
main effects of Time or Condition or a Time*Condition interaction were followed up with a simple 
main effects analysis and the least significant difference (LSD) approach to multiple comparisons 
(Perneger, 1998). Data were stored and transformed within Microsoft Excel (Microsoft Office 2010, 
Microsoft Corporation), and statistical analyses were performed using SPSS 22.0 (SPSS, Chicago, IL, 
USA). 
 
6.3 Results 
Self-reported compliance to consuming the tea (3 cups per day for 7-days per intervention week) and 
additional food was 100%. Self-reported compliance to the physical activity reduction was 100%, and 
was subsequently verified via activity data downloaded from the hip-mounted accelerometer worn 
during each 7-day intervention period. Compared to baseline screening (11,103 ± 3385 steps), UL-
Placebo (5880 ± 1462 steps) and UL-Tea (5710 ± 1390 steps) demonstrated good compliance, with a 
47% and 49% step reduction, respectively. Habitual calorie consumption during the intervention 
weeks remained similar to baseline levels (2373 ± 864 kcal) for both UL-Placebo (2250 ± 771 kcal) and 
UL-Tea (2330 ± 779 kcal), indicating good compliance to the dietary intervention. Two participants 
withdrew from the study prior to completion. All remaining participants completed measures of BP, 
microvascular function and conduit artery endothelial function (both n=12). One participant was 
unable to complete the cold pressor test due to discomfort. Three participants were unable to 
complete tests of cerebrovascular function (hypercapnia and cerebral autoregulation) and a further 
three participants did not complete the cerebral autoregulation measures due to suboptimal TCD 
signals, leading to a population of n=9 and n=6, respectively. Due to problems associated with venous 
cannulation, one participant did not complete measures of glucose handling and insulin sensitivity 
(n=11).  
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Participants demonstrated a non-significant increase in total body mass following the UL-Placebo 
(77.4 ± 10.5 kg vs 78.1 ± 11.0 kg) and UL-Tea interventions (76.9 ± 9.0 kg vs 77.6 ± 10.6 kg, main effect 
of time; P=0.07). However, no significant difference was observed between UL-Placebo and UL-Tea 
conditions (P=0.31) and there was no interaction of condition and time (P=0.92).  
 
6.3.1 Metabolic Function  
In the basal state, prior to the mixed meal tolerance test, there were no significant differences in 
fasting glucose or insulin levels between pre-UL-Placebo and pre-UL-Tea conditions (Figure 6.3). 
Glucose displayed a typical initial increase and subsequent decrease during the 3-hour MTT (P<0.001). 
There was no main effect of time (pre vs post) (P=0.13) or condition (P=0.53) for glucose. There was a 
significant interaction of condition*time (P=0.03); following UL-Placebo, blood glucose was elevated 
at 60- and 90-minutes compared to pre-UL-Placebo, whereas a reduced blood glucose was 
demonstrated across all time points following UL-Tea (P=0.03, Figure 6.3).  
 
Insulin displayed a typical initial increase and subsequent decrease during the 3-hour MTT (P<0.001). 
There was no main effect of time (pre vs post) (P=0.41), but there was a main effect of condition 
(P=0.04) and a significant interaction of condition*time (P<0.001). Post-hoc analysis revealed that 
insulin levels were higher across all time points after 7-days of UL-Placebo, consistent with increased 
insulin resistance (Figure 6.3). Following UL-Tea, however, the insulin response was reduced and 
demonstrated an interaction of time*condition (P<0.001, Figure 6.3).  
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Figure 6.3 Mixed meal tolerance test (MTT) 180-minutes for postprandial glucose for A. Tea and B. 
Placebo, and insulin for C. Tea and D. Placebo interventions. Data are presented as means, with error 
bars representing SD. *Main effect of time (across 3-hour MTT) P<0.001; ^main effect of condition 
P≤0.05; #time*condition interaction P≤0.05; +time*condition interaction P<0.001.  
 
6.3.2 Microvascular Function  
Throughout the duration of the microvascular function assessment periods, MAP was lower post-UL-
Tea (84 ± 7 vs 82 ± 6) and was higher post-UL-Placebo (83 ± 5 vs 85 ± 5, time*condition interaction 
P=0.06). There was no main effect of condition (P=0.67). There were no differences in baseline 
cutaneous perfusion between pre-UL-Tea or pre-UL-Placebo trials for absolute flux, CVC or %CVCmax 
(Figures 6.4 to 6.6). Due to the impact of UL-tea on blood pressure, data below were only presented 
for CVC and %CVCmax. Furthermore, all local heating protocols induced the typical pattern of an initial 
peak, nadir and subsequent plateau during rapid heating, and absence of a peak and nadir with 
gradual heating.  
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6.3.2.1 Rapid Local Heating: Rapid 39°C   
When expressed as CVC, there was no main effect of time (P=0.84) or condition (P=0.24), but there 
was a close to significant interaction of condition*time (P=0.09), whereby a decrease in CVC responses 
to local heating was observed following UL-Placebo, whereas UL-Tea demonstrated a slight increase 
(Figure 6.4). When data were expressed relative to maximal data (%CVCmax), there was no main effect 
of time (P=0.36) or condition (P=0.93), nor were there any interactions of condition*time (P=0.86) and 
condition*time*temp (P=0.56).  
6.3.2.2 Rapid Local Heating: Rapid 42°C 
When expressed as CVC, there was no main effect of time (P=0.57) or condition (P=0.26) or an 
interaction of condition*time (P=0.18), but there was a close to significant interaction of 
condition*time*temp (P=0.09) whereby a decrease in CVC was observed following UL-Placebo, 
whereas UL-Tea demonstrated a slight increase (Figure 6.5). When data were expressed relative to 
maximal data (%CVCmax), there was no main effect of time (P=0.65) or condition (P=0.80), nor was 
there an interaction of condition*time*temp (P=0.22), but there was a significant interaction of 
condition*time (P=0.03) whereby %CVCmax was higher post-UL-Placebo but lower post-UL-Tea. 
6.3.2.3 Gradual Local Heating: Gradual 42°C  
When expressed as CVC, there was no main effect of time (P=0.75) or condition (P=0.78) or an 
interaction of condition*time (P=0.63), but there was a significant interaction of condition*time*temp 
(P=0.02) whereby no change in CVC was observed following UL-Placebo, whereas UL-Tea 
demonstrated a larger CVC to gradual local heating (Figure 6.6). When data were expressed relative 
to maximal data (%CVCmax), there was no main effect of time (P=0.18) or condition (P=0.21), nor were 
there any interactions of condition*time (P=0.20) or condition*time*temp (P=0.17).  
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Figure 6.4 Microvascular responses across time points (baseline at 33°C, axon peak, axon nadir, 
plateau at 39°C and maximal plateau at 44°C) following Rapid 39°C local heating for flux (A and B), CVC 
(C and D) and %CVCmax (E and F) for UL-Tea and UL-Placebo interventions, respectively, in 12 healthy 
male volunteers. Data are presented as means, with error bars representing SD. 
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Figure 6.5 Microvascular responses across time points (baseline at 33°C, axon peak, axon nadir, 
plateau at 42°C and maximal plateau at 44°C) following Rapid 42°C local heating for flux (A and B), CVC 
(C and D) and %CVCmax (E and F) for UL-Tea and UL-Placebo interventions, respectively, in 12 healthy 
male volunteers. Data are presented as means, with error bars representing SD. ^Condition*time 
interaction P≤0.05.  
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Figure 6.6 Microvascular responses across incremental temperature stages (baseline at 33°C, plateau 
at 42°C and maximal plateau at 44°C) following Gradual 42°C local heating for flux (A and B), CVC (C 
and D) and %CVCmax (E and F) for UL-Tea and UL-Placebo interventions, respectively, in 12 healthy 
male volunteers. Data are presented as means, with error bars representing SD. 
^Condition*time*temperature interaction P≤0.05.  
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6.3.3 Macrovascular Function  
6.3.3.1 Brachial Artery FMD  
Baseline brachial artery FMD was not different between pre-UL-Placebo and pre-UL-Tea (P=0.40). 
There was no main effect of time (P=0.20) or condition (P=0.97) and no interaction of time*condition 
(P=0.11, Figure 6.7). No main effect of time, condition or time*condition interaction was observed for 
time-to-peak, baseline diameter or SRAUC (Figure 6.7).  
6.3.3.2 Femoral Artery FMD  
Baseline femoral artery FMD was not different between pre-UL-Placebo and pre-UL-Tea (P=0.89). 
There was no main effect of time (P=0.10) or condition (P=0.21), but there was a significant interaction 
of time*condition (P<0.001). Post-hoc analysis found that femoral artery FMD decreased after UL-
Placebo (6.87 ± 3.41 % vs 4.96 ± 2.82 %), which was prevented during UL-Tea (6.72 ± 3.63 % vs 7.27 ± 
3.45 %, Figure 6.7). For time-to-peak, there was no main effect of time (P=0.77) but there was a main 
effect of condition (P=0.02), whereby time-to-peak was higher for pre- and post-UL-Placebo compared 
to UL-Tea (Figure 6.7). However, there was no interaction of time*condition (P=0.30). No main effects 
of time, condition, nor interactions of time*condition were observed for baseline diameter or SRAUC 
(all P>0.05, Figure 6.7).  
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Figure 6.7 Conduit artery endothelial function flow-mediated dilation (FMD%), time-to-peak, baseline 
diameter and shear rate area-under-the-curve (SRAUC) for the brachial artery (A, C, E and G, 
respectively) and femoral artery (B, D, F and H, respectively) for UL-Tea and UL-Placebo interventions. 
Data are presented as means, with error bars representing SD. ^Main interaction of time*condition 
P<0.001, *main effect of condition P≤0.05. 
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6.3.4 Cold Pressor Test/Haemodynamic Function  
Baseline carotid artery reactivity (CAR%) was not different between pre-UL-Placebo and pre-UL-Tea 
(P=0.78). There was no main effect of time (P=0.85), but there was a borderline main effect of 
condition (P=0.05) and a significant interaction of time*condition (P=0.04). Post-hoc analysis showed 
that CAR% decreased following UL-Placebo (5.08 ± 1.51 % vs 3.33 ± 4.25 %), which was prevented 
during UL-Tea (5.74 ± 5.31 % vs 7.52 ± 4.03 %, Figure 6.8). Similar findings were evident for AUC, which 
demonstrated no main effect of time (P=0.88), but there was a main effect of condition (P=0.04) and 
a close to significant interaction (P=0.09, Figure 6.8). Baseline SBP change was not different between 
pre-UL-Placebo and pre-UL-Tea (P=0.27). There was no main effect of time (P=0.27) or condition 
(P=0.10). The CPT-induced elevation in systolic and diastolic BP was not different across time, 
condition or time*condition between UL-Placebo and UL-Tea (all P>0.05, Figure 6.8).  
 
Figure 6.8 Cold pressor test derived carotid artery reactivity (CAR%, A), area-under-the-curve (AUC, 
B), systolic blood pressure (SBP, C) and diastolic blood pressure (DBP, D) changes for UL-Tea and UL-
Placebo interventions. Data are presented as means, with error bars representing SD. *Main effect of 
condition P≤0.05, ^time*condition interaction P≤0.05.  
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6.3.5 Cerebrovascular Function   
6.3.5.1 Hypercapnia  
MCAv increased during hypercapnia for all conditions, as evidenced by a main effect of time (P<0.001). 
Baseline to peak changes in MCAv demonstrated no main effect for time (P=0.67) or condition 
(P=0.95) and there was no time*condition interaction (P=0.91, Table 6.3). MCAv vs PETCO2 reactivity 
slopes were not different between UL-Placebo and UL-Tea, with no main effect of time (P=0.16), 
condition (P=0.63) or time*condition interaction (P=0.83). When expressed as relative changes, MCAv 
vs PETCO2 reactivity slopes demonstrated no main effect of time (P=0.30), condition (P=0.10) or a 
time*condition interaction (P=0.48, Table 6.5).  
 
No differences were observed in baseline MAP between UL-Placebo or UL-Tea and there was no main 
effect of time (P=0.22) or condition (P=0.74), nor any interaction of time*condition (P=0.36, Table 6.3). 
MAP increased during hypercapnia across all conditions (P=0.01), but no differences were observed 
between UL-Placebo or UL-Tea (P=0.10). MAP at peak MCAv demonstrated no main effect of time 
(P=0.27) or condition (P=0.80) and there was no time*condition interaction (P=0.30, Table 6.3). 
Absolute CBVC vs PETCO2 reactivity slopes demonstrated no main effect of time (P=0.38) or condition 
(P=0.91), nor any interaction of time*condition (P=0.37, Table 6.5). When expressed as relative 
changes, there were no differences observed between Placebo and Tea, with no main effect of time 
(P=0.38) or condition (P=0.77), and there was no time*condition interaction (P=0.84, Table 6.3).  
 
Baseline common carotid artery (CCA) diameter demonstrated no main effect of time (P=0.56), 
although there was a main effect of condition (P=0.01), but no time*condition interaction (P=0.76). 
CCA diameter increased during hypercapnia (P≤0.05). Peak CCA diameter during hypercapnia did not 
demonstrate a main effect of time (P=0.19), but a main effect of condition (P=0.02) was observed, 
however, there was no time*condition interaction (P=0.84). The change in CCA diameter 
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demonstrated no main effect of time (P=0.14), condition (P=0.12) and no time*condition interaction 
(P=0.99, Table 6.3). Furthermore, change in CCA diameter when controlling for baseline diameter did 
not demonstrate a main effect of time (P=0.46) or condition (P=0.90) and there was no time*condition 
interaction (P=0.46). There were no differences in the change in carotid blood flow during hypercapnia 
between UL-Placebo (23 ± 22 % vs 19 ± 17 %) and UL-Tea (20 ± 17 % vs 25 ± 24 %, P=0.98), with no 
main effect of time (P=0.80), and no time*condition interaction (P=0.60). The change in MAP during 
hypercapnia demonstrated no main effect of time (P=0.97); there was a borderline significant effect 
of condition (P=0.05), but there was no time*condition interaction (P=0.97, Table 6.5). No differences 
were evident for changes in CarVC between UL-Placebo (15 ± 17 % vs 11 ± 13 %) and UL-Tea (17 ± 15 
% vs 22 ± 24 %) with no main effect of time (P=0.94), condition (P=0.36) or time*condition interaction 
(P=0.50, Table 6.3). 
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Table 6.3 Cerebrovascular and common carotid artery (CCA) variables measured throughout 
hypercapnia for UL-Placebo and UL-Tea interventions.  
 Intervention (mean ± SD) Two-Way ANOVA P Values 
 
Pre-UL-
Placebo 
Post-UL-
Placebo 
Pre- 
UL-Tea 
Post- 
UL-Tea 
Time Condition T*C  
 
Cerebrovascular  Variables  
     
Baseline MCAv (cm·s-1)  70 ± 14  66 ± 12 68 ± 14 70 ± 8 0.91 0.57 0.14 
Change in MCAv (cm·s-1)  14 ± 11  14 ± 12 16 ± 16   14 ± 12 0.67 0.95 0.91 
Baseline PETCO2 (mmHg)        39 ± 4        40 ± 6        37 ± 5  38 ± 5 0.18  0.36   0.82 
Change in PETCO2 (mmHg)  4 ± 5  6 ± 3 8 ± 3   9 ± 2 0.60 0.86 0.73 
MCAv vs PETCO2 absolute 
(cm·s/mmHg-1) 
 3.30 ± 1.35  4.21 ± 1.87 3.81 ± 1.23   4.35 ± 1.15 0.16 0.63 0.83 
MCAv vs PETCO2 relative   
(% cm·s/% mmHg-1) 
 4.71 ± 2.51  5.71 ± 2.69 5.63 ± 1.68   6.23 ± 1.81 0.30 0.10 0.48 
Baseline MAP (mmHg)  85 ± 14  91 ± 16 90 ± 11   90 ± 19 0.22 0.74 0.36 
Change in MAP (mmHg)   2 ± 4  2 ± 3 6 ± 3   6 ± 3 0.98 0.06 0.90 
Baseline CBVC  
(cm·s/mmHg-1) 
 0.92 ± 0.33   0.84 ± 0.30 0.77 ± 0.19   0.83 ± 0.27 0.93 0.87 0.21 
CBVC: PETCO2 absolute 
(cm·s/mmHg-1/mmHg-1) 
 0.03 ± 0.04  0.02 ± 0.01 0.03 ± 0.01    0.03 ± 0.01 0.38 0.91 0.37 
CBVC: PETCO2 relative  
(% cm·s/mmHg-1/%mmHg-1) 
 1.37 ± 1.67  0.94 ± 0.75 1.29 ± 0.72   1.19 ± 0.42 0.38 0.77 0.84 
 
Common Carotid Artery Variables         
Baseline diameter (mm)  0.70 ± 0.06  0.72 ± 0.06  0.67 ± 0.06  0.68 ± 0.05 0.56   0.01* 0.76 
Change in diameter (%)   2 ± 2  3 ± 3 3 ± 3   4 ± 3s  0.14 0.12 0.99 
Baseline blood flow  
(mL/min-1) 
13.07 ± 3.96   16.04 ± 5.30   13.20 ± 3.76   13.28 ± 2.62  0.28 0.49 0.08 
Change in blood flow (%)   23 ± 22   19 ± 17 20 ± 17 25 ± 24 0.80 0.98 0.60 
Baseline CarVC  
(mL/min-1/mmHg-1) 
 0.15 ± 0.06   0.18 ± 0.06  0.15 ± 0.04  0.15 ± 0.05  0.42 0.33 0.28 
Change in CarVC  
(% mL.min/mmHg-1)  
 15 ± 17  11 ± 13  17 ± 15  22 ± 24  0.94 0.36 0.50 
Data are mean ± SD. T*C, time*condition interaction; MCAv, middle cerebral artery velocity; PETCO2, end-tidal carbon dioxide; 
MAP, mean arterial pressure; CBVC, cerebrovascular conductance; CarVC, carotid artery vascular conductance. *Main effect 
of condition P≤0.05. 
 
 
6.3.5.2 Cerebral Autoregulation: Squat-Stand Manoeuvres   
6.3.5.2.1 Squat-Stands at 0.10 Hz 
Gain: At the very low, low and high frequencies there were no main effects of time (all P>0.05), 
condition or interactions of time*condition (Table 6.4).  
Phase: At the very low, low and high frequencies there were no main effects of time (all P>0.05), 
condition or interactions of time*condition (Table 6.4). 
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Coherence: At the very low, low and high frequencies there were no main effects of time (all P>0.05), 
condition or interactions of time*condition (Table 6.4). 
6.3.5.2.2 Squat-Stands at 0.20 Hz 
Gain: At the very low, low and high frequencies there were no main effects of time (all P>0.05), 
condition or interactions of time*condition (Table 6.4).   
Phase: For the VLF, there was no main effect of time (P=0.33) and no main effect of condition (P=0.07), 
nor a time*condition interaction (P=0.34). At the LF, there was no main effect of time (P=0.94) or 
condition (P=0.94) and no interaction of time*condition was demonstrated (P=0.75). For the HF, no 
main effect of time was demonstrated (P=0.74), but there was a main effect of condition (P=0.01). 
However, there was no time*condition interaction (P=0.51, Table 6.4)  
Coherence: At the VLF, no main effect of time was observed (P=0.49) and there was no main effect of 
condition (P=0.74), nor a time*condition interaction (P=0.26). For the LF, there was no main effect of 
time (P=0.69) or condition (P=0.67). However, an interaction of time*condition was observed 
(P=0.04), whereby UL-Placebo was slightly increased (0.59 ± 0.25 vs 0.67 ± 0.17 cm·s-1·mmHg-1) and a 
slight reduction was demonstrated following UL-Tea (0.68 ± 0.14 vs 0.59 ± 0.14 cm·s-1·mmHg-1). At the 
HF, no main effect of time was demonstrated (P=0.94) and there was no main effect of condition 
(P=0.41), nor a time*condition interaction (P=0.62, Table 6.4). 
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Table 6.4 Gain, phase and coherence determined by transfer function at very low (VLF), low (LF) and 
high frequency (HF) during repeated squat-stand manoeuvres at 0.10Hz and 0.20 Hz whilst breathing 
normal ambient air for UL-Placebo and UL-Tea interventions.  
 Intervention (mean ± SD) Two-Way ANOVA P Values 
0.10 Hz Squat-stands  
Pre-UL-
Placebo 
Post-UL-
Placebo 
Pre- 
UL-Tea 
Post- 
UL-Tea 
Time Condition T*C  
Gain (cm·s-1·mmHg-1)        
    VLF  0.6 ± 0.2 0.4 ± 0.1 0.6 ± 0.1 0.7 ± 0.5 0.06 0.86 0.35 
    LF 0.8 ± 0.2  0.8 ± 0.1 0.9 ± 0.3 0.9 ± 0.2 0.70 0.20 0.23 
    HF 0.9 ± 0.4 0.8 ± 0.5 1.3 ± 0.7 1.1 ± 0.3 0.64 0.15 0.29 
Phase (radians)         
    VLF  41.9 ± 20.6  41.3 ± 14.3 29.9 ± 10.9 42.1 ± 25.6 0.50 0.37 0.24 
    LF    23.7 ± 9.9 21.9 ± 13.8 29.2 ± 20.5 23.0 ± 14.0 0.26 0.25 0.53 
    HF 34.1 ± 41.6 25.8 ± 43.8 39.7 ± 28.5 45.4 ± 44.3 0.78 0.61 0.89 
Coherence          
    VLF  0.5 ± 0.0 0.4 ± 0.1 0.3 ± 0.1 0.4 ± 0.1 0.58 0.44 0.13 
    LF 0.6 ± 0.1 0.5 ± 0.1 0.5 ± 0.1 0.6 ± 0.1  0.80 0.36 0.27 
    HF 0.3 ± 0.1 0.3 ± 0.1 0.2 ± 0.0 0.2 ± 0.1 0.62 0.43 0.25 
0.20 Hz Squat-stands         
Gain (cm·s-1·mmHg-1)        
    VLF  0.5 ± 0.1  0.5 ± 0.1  0.6 ± 0.1 0.6 ± 0.1 0.49 0.24 0.50 
    LF 0.6 ± 0.2  0.8 ± 0.2 0.9 ± 0.3 0.8 ± 0.2 0.74 0.39 0.08 
    HF 0.7 ± 0.2   0.9 ± 0.3 0.9 ± 0.4 0.8 ± 0.2 0.70 0.18 0.24 
Phase (radians)        
    VLF  65.6 ± 24.2 62.4 ± 39.0 45.7 ± 14.4 53.4 ± 15.5 0.33 0.07 0.34 
    LF    22.6 ± 9.6 22.6 ± 20.2 15.2 ± 16.9 15.9 ± 15.7 0.94 0.94 0.75 
    HF   8.0 ± 15.4 10.1 ± 12.2 10.4 ± 14.7 12.7 ± 11.0 0.74   0.01* 0.51 
Coherence          
    VLF  0.4 ± 0.2 0.4 ± 0.2 0.4 ± 0.1 0.4 ± 0.2 0.49 0.74 0.26 
    LF 0.6 ± 0.3 0.7 ± 0.2 0.7 ± 0.1 0.6 ± 0.1 0.69 0.67   0.04^ 
    HF 0.4 ± 0.2 0.4 ± 0.2 0.4 ± 0.2 0.4 ± 0.1 0.94 0.41 0.62 
Data are mean ± SD. T*C, time*condition interaction; VLF, very low frequency; LF, low frequency; HF, high frequency. *Main 
effect of condition P≤0.05, ^time*condition interaction P≤0.05. 
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6.4 Discussion  
The primary aim of the present study was to explore whether daily green tea consumption 
ameliorated changes in peripheral vascular function, cerebrovascular function and insulin sensitivity 
in healthy male adults, following a 7-day metabolic and physical inactivity challenge designed to 
represent a Western lifestyle. The novel findings of the study are that following 7-days of high fat 
overfeeding combined with physical activity reduction, a marked increase in the insulin and glucose 
responses to a mixed meal tolerance test were observed which are consistent with the development 
of insulin resistance, but also presence of impaired peripheral vascular function in peripheral and 
cranial arteries. Remarkably, daily consumption of green tea, equivalent to 6 cups per day, attenuated 
the observed impairments in insulin resistance and (peripheral and extracranial) vascular function. 
Following the lifestyle intervention, no effects were observed on cerebrovascular function. 
Collectively, findings from the present study support the hypothesis that 7-days of reduced physical 
activity and increased calorie consumption are associated with a decline in peripheral vascular 
function and reduced insulin sensitivity, and that these detrimental changes are partly mitigated 
through daily consumption of green tea.  
 
6.4.1 Metabolic Function  
The present study observed metabolic changes consistent with impaired glucose handling and a 
compensatory elevated postprandial insulin response following the unhealthy Western lifestyle 
intervention, with directionally opposite responses following daily consumption of green tea. Such 
findings are consistent with previous studies in demonstrating the deleterious impact of reduced 
physical activity and/or overfeeding on glycaemic control and insulin resistance, for example, bed rest 
interventions (Hamburg et al., 2007; Sonne et al., 2010) and bed rest interventions combined with a 
high saturated fat diet (Stettler et al., 2005), short-term (5-days) step-reduction models (Holwerda et 
al., 2015), and overfeeding (+50 kcal) studies (Brons et al., 2009). Consistent with current findings, a 
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model more closely mimicking a Western lifestyle that combines overfeeding with a reduction in 
physical activity induced impaired insulin sensitivity in young, healthy males after only 3-days, which 
was worse still after 7-days (Knudsen et al., 2012). Increased insulin secretion may precede the 
development of peripheral insulin resistance (Le Stunff & Bougneres, 1994) and, therefore, 
hyperinsulinaemia may be causally related to the development of insulin resistance following more 
prolonged periods of caloric excess, particularly with a high proportion of energy from fats (Adochio 
et al., 2009; Brons et al., 2009). The current findings demonstrate the development of an insulin 
resistant state in previously healthy humans after adoption of an unhealthy Western lifestyle for only 
7-days. Such profound findings reinforce previous observations that the initial stages of impaired 
insulin sensitivity are causally linked to the effects of high energy diets and physical inactivity.  
 
As impaired glycaemic control is an independent risk factor in the development of type 2 diabetes 
(Nathan et al., 2007), it is important to identify therapeutic strategies to improve glycaemic control 
and mitigate the negative impact of an unhealthy Western lifestyle. The present study suggests a 
protective role for green tea consumption, with daily ingestion not only attenuating elevated blood 
glucose levels, but even improving glucose handling and concomitantly enhancing insulin sensitivity. 
To date, limited intervention studies have been undertaken exploring the effect of tea ingestion on 
biomarkers of insulin sensitivity and risk factors for diabetes (Hosoda et al., 2003; Fukino et al., 2005; 
Ryu et al., 2006; Bryans et al., 2007), with inconsistent outcomes. Acute oolong tea consumption 
reduced plasma glucose in individuals with type 2 diabetes on oral antihyperglycaemic medication 
(Hosoda et al., 2003). Furthermore, in healthy individuals, Bryans and colleagues (2007) observed a 
reduction in postprandial plasma glucose, with a corresponding increase in insulin, following acute 
consumption of black tea, compared to water and water with caffeine. Conversely, a randomised 
controlled trial in individuals with borderline diabetes or overt diabetes who consumed green tea daily 
for 2-months demonstrated no difference in blood glucose, HbA1c, insulin resistance or inflammatory 
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markers, compared to a control group (Fukino et al., 2005). Similarly, daily green tea consumption for 
4-weeks was not associated with any change in insulin resistance or arterial stiffness in middle-aged 
individuals with type 2 diabetes (Ryu et al., 2006). Such observations suggest that green tea may exert 
a protective role in healthy individuals, but that the outcomes in diabetic populations may not be as 
encouraging. However, a lack of methodological rigor cannot be excluded, including lack of dietary 
restriction, self-selected tea strengths (Fukino et al., 2005), the type/dose of tea and unknown physical 
activity status. Further research is therefore warranted to determine whether tea may be an effective 
adjunct in the management of diabetes.  
 
6.4.2 Microvascular Function  
The present study is the first to examine microvascular function in relation to a Western lifestyle and 
observed impaired function after only 7-days. Previous studies have demonstrated the deleterious 
impact of physical inactivity on microvascular function (Shoemaker et al., 1998; Hesse et al., 2005), 
although studies have tended to involve prolonged periods of complete bed rest that are not wholly 
representative of a typical Western lifestyle. For example, impaired endothelium-dependent 
microvascular function and increased circulating endothelial cells, indicative of endothelial damage, 
were observed following prolonged 2-months bed rest (Demiot et al., 2007) and 5-days of bed rest in 
healthy adults demonstrated impaired forearm and calf reactive hyperaemia (Hamburg et al., 2007). 
Such inactivity models do not account for the dietary contributions towards an unhealthy lifestyle, 
which have seldom been investigated and, furthermore, no study has explored the combined effect 
of excess energy consumption and physical activity reduction as is typical of a Western lifestyle. In the 
present study, the lifestyle intervention (UL-Placebo) demonstrated a trend of decreased cutaneous 
blood flow, expressed as CVC, across all three local heating protocols, indicating impaired 
microvascular function. These findings suggest that adopting a Western lifestyle for even a short 
period has a deleterious impact upon microvascular function. Given that microvascular function is 
considered a surrogate for overall vascular health and that changes present in the microvasculature 
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typically precede and often predict the development of conduit artery atherosclerosis, current 
observations indicate that the impact of Western lifestyles manifest after only a few days. 
Furthermore, as forearm microvascular function was assessed rather than that of a lower limb, which 
may have been more applicable given the step-reduction, identifying microvascular impairments in 
the forearm is suggestive of lifestyle-induced systemic dysfunction that may have greater implications 
for cardiovascular health. 
 
Importantly, the present study also demonstrated a protective role for green tea on an unhealthy 
lifestyle, as evidenced by daily green tea consumption largely attenuating the impairment in 
microvascular function. Furthermore, in keeping with findings for acute black tea consumption in 
Chapter 5, green tea caused a greater effect following gradual local heating, with a significant increase 
in cutaneous blood flow following UL-Tea compared to UL-Placebo. As previously discussed (see 
Section 5.4, Chapter 5), the rate of local heating and maximum heating temperature produce different 
vasodilatory responses based upon neurogenic reflexes and local chemical mediators, such as NO. The 
observation that green tea attenuates, and even improves, cutaneous vascular function following 
gradual local heating, suggests that tea enhances endothelial function via upregulation of local 
chemical mediators, which is consistent with previous studies in conduit vessels (Grassi et al., 2009b; 
Schreuder et al., 2014). Given that the Rapid 39°C and Rapid 42°C protocols are also linked to the 
release of NO but to a lesser extent, the marginal improvements in cutaneous blood flow observed in 
the present study are consistent with green tea protecting microvascular function via a mechanism 
related to upregulation of NO. These observations support the suggestion highlighted in Chapter 5, in 
using multiple local heating protocols simultaneously to interrogate microvascular responses to 
interventions for mechanistic insight.  
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Despite a maintained/higher vasodilatory response for green tea in response to Gradual 42°C local 
heating for CVC in contrast to a reduction with UL-Placebo, no significant differences were observed 
when data were expressed as %CVCmax. These latter findings are likely explained by the changes in 
absolute CVC at maximal vasodilation (e.g., a maintenance/increase with UL-Tea and a reduction with 
UL-Placebo) that would result in similar %CVCmax responses.  As discussed in Chapter 5, %CVCmax is 
often the preferred method of data expression following local skin heating to 44°C to reach maximal 
vasodilation (Dawson et al., 2015) but consideration of absolute CVC is important and would indicate 
a higher absolute flow per se. Current findings are in keeping with the observations following acute 
black tea consumption in Chapter 5 and collectively, are suggestive of tea altering cutaneous perfusion 
at higher local skin temperatures e.g. at 39-44°C.  
 
6.4.3 Macrovascular Function  
Brachial artery FMD demonstrated little change following the lifestyle intervention, with no changes 
observed following UL-Placebo and a non-significant 1.45 % increase demonstrated following UL-Tea. 
In the femoral artery, however, a significant difference in FMD was observed between UL-Placebo and 
UL-Tea, with a ~2 % decline for UL-Placebo and UL-Tea both attenuating and slightly improving (+~0.5 
%) FMD. Given that a 1 % decline in FMD reportedly represents an 8 % risk of future cardiovascular 
events (Inaba et al., 2010), the current findings suggest that adoption of an unhealthy lifestyle for only 
seven days is associated with an elevated CVD risk, yet daily tea consumption mitigates the negative 
effects and is cardioprotective. As FMD is a reliable measure of NO-mediated endothelial function 
(Thijssen et al., 2011), current findings indicate that a direct effect of NO on the endothelium is likely 
responsible for both the lifestyle-induced impairment in vasoreactivity and for the mitigating effect of 
green tea, related to reduced shear-stress and NO upregulation, respectively. Reduced activity of the 
lower limbs is likely to result in a decrease in local shear stress which may subsequently reduce 
vasodilation through inhibition of eNOS (Hamburg et al., 2007). This mechanism explains the lifestyle-
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induced decline in femoral FMD, but not brachial FMD, in the present study, whereby the inactivity 
component targeted the lower limbs through step-reduction, with the upper limbs remaining largely 
active. Previous studies in lower limb inactivity models report similar findings, with no difference in 
brachial artery FMD (%) following 5-days of bed rest (Hamburg et al., 2007) or following 4-weeks of 
unilateral lower limb suspension (Bleeker et al., 2005a). Furthermore, Boyle and colleagues (2013) 
observed a ~3 % reduction in popliteal artery FMD following step-reduction in recreationally active 
men, although brachial artery FMD was unchanged. However, significant decreases in both brachial 
and femoral artery FMD were observed in a 5-day bed rest study of healthy adults, although the 
subject population was small (n=5) (Nosova et al., 2014).  
 
Few studies have examined the impact of overfeeding on macrovascular function, with the acute 
effects of a high fat load demonstrating impaired brachial FMD postprandially in adults (Plotnick et al., 
1997; Vogel et al., 1997; Bae et al., 2001; Plotnick et al., 2003). Diets high in fat (particularly trans) are 
associated with increased CVD risk (Skeaff & Miller, 2009; Michas et al., 2014; de Souza et al., 2015), 
largely attributed to endothelial dysfunction arising from increased oxidative stress and reduced NO 
bioavailability (Bae et al., 2001). Increasingly, tea consumption has demonstrated improved NO-
mediated endothelial function in both healthy and diseased humans (Ras et al., 2011), possibly arising 
from activation of eNOS (Loke et al., 2010), reduced oxidative stress (Łuczaj & Skrzydlewska, 2005) 
and/or an improved antioxidant and anti-inflammatory capacity (Neyestani et al., 2010). Several 
studies have observed attenuated/improved brachial artery FMD following acute tea ingestion 
compared to control, together with an oral fat load (Corretti et al., 2002; Hodgson et al., 2005; Grassi 
et al., 2012a), with the present study being the first to explore the effects of tea following a 7-day 
unhealthy lifestyle. Taken together, these findings are highly suggestive of a vasoprotective 
mechanism for tea consumption, although the precise pathways remain unclear.  
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6.4.4 Cold Pressor Test/Haemodynamic Function 
The CPT induces sympathetic activation that elevates HR, arterial BP and myocardial oxygen demand 
via the neurotransmitters epinephrine and norepinephrine (Victor et al., 1987). Assessment of carotid 
artery reactivity (CAR%) provides an index of coronary artery disease risk, with a vasodilatory response 
that counteracts the effects of the sympathetic activation considered to be a “normal” response in 
healthy individuals, and vasoconstriction indicating the presence of CVD risk (Rubenfire et al., 2000). 
However, the CPT can also be considered a test of cranial artery endothelial function, similar to FMD 
assessment of the peripheral arteries. Whilst the carotid artery vasodilatory mechanisms 
underpinning CAR% in response to the CPT are uncertain, they are suggested to involve endothelial-
dependent vasodilation via endothelium-derived relaxing factors, such as NO, whereas 
vasoconstriction arises from a direct effect of norepinephrine on smooth muscle cells (van Mil et al., 
2017). Findings from the present study demonstrated a decrease in CAR% associated with the 
unhealthy lifestyle, that was attenuated and improved by daily green tea consumption (P=0.04). 
Furthermore, the impairment in CAR% was accompanied by concomitant increases in basal BP, which 
were reversed following green tea, and, similarly, the magnitude of the elevation in BP during the CPT 
was greater after UL-Placebo compared with no change after UL-Tea, suggesting that BP reactivity was 
elevated after UL-Placebo. Such findings suggest that adoption of a Western lifestyle induces impaired 
vasodilation and elevated BP, even following a short period of 7-days. Furthermore, these observed 
changes on cranial artery function are consistent with those in the peripheral vasculature, in that UL-
Placebo demonstrated impaired peripheral vascular function which was partly prevented following 
UL-Tea. Collectively, these findings suggest that the Western lifestyle affects general vascular health 
and that these detrimental changes can be prevented by daily green tea consumption. However, 
whilst CAR% is a useful measure to establish CVD risk, it is seldom used and, therefore, limited 
comparisons of present findings can be made against previous research.  
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6.4.5 Cerebrovascular Function  
Excessive changes in CBF, e.g., hypoperfusion, have been linked to the development of 
cerebrovascular disease such as stroke and dementia (Roher et al., 2012), particularly a diminished 
vasodilatory response to CO2 (Gur et al., 1996; Claassen et al., 2009). Epidemiologic reports link a 
higher intake of dietary flavonoids with a reduction in the development of dementia (Commenges et 
al., 2000; Engelhart et al., 2002), likely related to direct effects of flavonoids on the vascular 
endothelium, given that endothelial dysfunction impairs cerebral vasodilatory capacity (Zimmermann 
& Haberl, 2003; Lavi et al., 2006). The present study, however, observed no significant changes in 
cerebrovascular function (CO2 reactivity and cerebral autoregulation) after the intervention per se, 
nor with any effect of green tea on the cerebrovasculature. Furthermore, no meaningful changes were 
observed in extracranial reactivity, assessed via CCA function, following the lifestyle intervention or 
daily tea consumption, thereby suggesting that the short-term inactivity/overfeeding intervention or 
green tea did not impair cerebrovascular function (CO2 reactivity and cerebral autoregulation). The 
lack of an effect may be due to several reasons. Firstly, the intervention was likely not severe enough 
or of sufficient duration to challenge the CCA or cerebrovasculature, particularly since the cerebral 
regulatory mechanisms differ from the peripheral vessels and the brain’s plasticity was likely adequate 
to cope with a short 7-day intervention. Previous bed rest studies have demonstrated significant 
reductions in transfer function gain after 18-days in young, healthy adults (Jeong et al., 2014) and 
altered autoregulation after 60-days (Greaves et al., 2007). It is also reasonable to assume that the 
small sample size influenced the cerebrovascular findings of the present study, as it is likely that any 
subtle changes in function were not detectable with such small numbers.  
 
Despite regular tea consumption being associated with a reduced risk of stroke (Arab et al., 2009), to 
date, only a single study has examined the effect of tea on CBF. In a randomised, double-blind, 
placebo-controlled study, Vidyasagar and colleagues (2013) assessed cerebrovascular reactivity to 
139 
 
hypercapnia in healthy males and observed reduced steady-state CBF following an acute dose of black 
tea equivalent to 6 cups. However, the authors suggest that caffeine was responsible for this change, 
rather than the tea per se, given that decaffeinated tea demonstrated no differences. Tea-derived 
flavonoids, such as EC and EGCG, have demonstrated variable outcomes, with a single low dose 
(135mg) of capsular EGCG reducing CBF (measured by NIRS) during computerised cognitive task 
performance in healthy humans, whereas a higher dose (270mg) did not change CBF relative to 
placebo (Wightman et al., 2012). As outlined above, the duration of the tea consumption and/or the 
dosage may not have been high enough to influence cerebrovascular function and the small sample 
sizes limit the interpretation of the findings.  Present findings are inconclusive regarding the effects of 
tea consumption, or lifestyle changes, on cerebrovascular function and further research is, therefore, 
required to determine whether the beneficial effects of tea seen in the peripheral vasculature are 
evident in cerebral vessels.  
6.4.6 Clinical Relevance and Perspectives  
The present study has produced several important observations. Principally, it is the first study to 
comprehensively explore the effects of regular tea consumption on vascular and metabolic function 
in the context of an unhealthy Western lifestyle. Importantly, current findings suggest that tea exerts 
a beneficial effect on function across the vascular tree that is protective against the deleterious impact 
of an unhealthy Western lifestyle. The present study has also demonstrated the adverse impact of an 
unhealthy lifestyle in inducing peripheral vascular dysfunction and insulin resistance in a cohort of 
previously healthy males after a period of only 7-days. As this lifestyle is increasingly adopted by 
portions of the general population on a daily basis, and many normally ‘healthy’ individuals often 
experience it during holidays and festivities, the current findings are widely applicable in establishing 
the detrimental impact of such a lifestyle upon cardiovascular health. Insulin resistance and vascular 
dysfunction share common underlying mechanisms, which are largely centred around endothelial 
dysfunction, in addition to contributions from oxidative stress, inflammatory factors and subcellular 
signalling pathways (Wheatcroft et al., 2003). The present study observed improved cutaneous 
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vascular function and conduit artery FMD following daily green tea consumption which suggest that 
tea exerts a protective effect on the vasculature at the level of the endothelium, and it may be 
speculated that this likely results from activation/upregulation of endothelium-derived vasodilators, 
such as NO. Tea, therefore, may represent an inexpensive therapeutic approach for improving 
cardiovascular health, particularly in relation to a Western lifestyle.  
6.4.7 Limitations  
There are several strengths of the current study that support its conclusions, such as the randomised, 
double-blind, within-subjects design and array of experimental measures that demonstrate a 
consistent trend. Furthermore, the lifestyle intervention represents a ‘real-life’ scenario and, 
therefore, the findings are applicable to Western populations. However, due to the explorative nature 
of the study, the sample size was modest, especially in the cerebrovascular function data set, so the 
present cerebral data may not be an accurate representation of the cerebrovascular response to tea. 
Participant compliance to the lifestyle intervention was assessed via self-reported food and activity 
diaries and, therefore, it is not possible to guarantee 100% compliance. However, physical activity was 
also monitored via accelerometers and the data downloaded supported full participant compliance 
for the inactivity element of the intervention. Furthermore, the dysfunction observed for the post-
intervention measures suggests that participants had adopted an altered lifestyle. Importantly, the 
translation of the present findings to longitudinal changes in vascular and metabolic function is 
unknown, given that the present lifestyle intervention was only for 7-days. A further limitation is that 
the present study does not provide any biochemical or biomolecular insight into the mechanisms 
underlying the observed improvements in peripheral vascular function and metabolic function 
following the tea intervention. However, plasma concentrations of flavonoids and NO compounds 
were not obtained as they were beyond the scope of the present study.  
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In conclusion, data from the present study suggests that adopting a Western lifestyle for 7-days is 
associated with a deleterious impact upon peripheral vascular function, with detrimental vascular 
changes observed in both microvascular and macrovascular beds, but also in peripheral and 
extracranial arteries. Furthermore, the Western lifestyle was associated with the promotion of insulin 
resistance in healthy, male adults. Importantly, the present study observed that daily consumption of 
green tea prevented the detrimental impact of a Western lifestyle on peripheral vascular function and 
insulin sensitivity. Such findings suggest that regular green tea consumption exerts a cardioprotective 
effect that may provide a simple, inexpensive, non-pharmacological therapeutic approach to help 
combat inactivity and dietary CVD risk factors associated with an unhealthy Western lifestyle.  
142 
 
CHAPTER 7: ACUTE EPICATECHIN INGESTION DOES 
NOT AFFECT CEREBROVASCULAR FUNCTION IN 
HEALTHY MEN
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7.1 Introduction  
Optimal cerebrovascular function requires maintenance of relatively constant perfusion, which is 
controlled via multiple integrated regulatory mechanisms, including perfusion pressure (BP; e.g., 
haemodynamics), the concentration of arterial blood gases (CO2 and O2), sympathetic nerve activity 
and cerebral metabolism (Willie et al., 2014). The cerebrovasculature also has an inherent ability to 
self-regulate (termed autoregulation); static regulation responds to gradual changes in perfusion 
pressure, whereas dynamic regulation occurs in response to an acute stimulus affecting perfusion 
lasting for a few seconds, such as coughing (Zhang et al., 1998). Subsequent reflex adjustments in 
cerebrovascular resistance ensure that adequate blood flow is maintained. Compromised steady-state 
CBF and blunted task-specific CBF increases, both indicative of impaired cerebrovascular health, are 
considered key causal factors in the development of cerebrovascular disease associated with ageing, 
such as stroke, impaired cognitive function and neurodegenerative diseases (Farkas et al., 2002; 
Parkes et al., 2004; Ruitenberg et al., 2005b; Sorond et al., 2008b; Bertsch et al., 2009; Schuff et al., 
2009). Unsurprisingly, CVD risk factors such as poor diet, physical inactivity and obesity that are 
present earlier in life are associated with an increased risk of stroke, cognitive decline and dementia 
in later life (Gorelick et al., 2011; Sharp et al., 2011) through endothelial dysfunction impairing 
cerebrovascular reactivity and overall CBF regulation (Lavi et al., 2006; Stephan et al., 2017).  
 
Dietary flavonoid intake is inversely correlated with CVD risk and incidence of stroke (Keli et al., 1996; 
Hollman et al., 2010), with a meta-analysis demonstrating a 21% reduction in stroke risk following 
consumption of ≥3 cups of black or green tea per day (Arab et al., 2009). Tea and its polyphenolic 
compounds have a potent impact on peripheral vascular function, such as observed in previous 
chapters (Chapters 5 and 6), which may contribute to the cardioprotective effects of regular dietary 
flavonoids. Possibly, in line with these observations on cardiovascular health, flavonoids may protect 
against cerebrovascular disease through a direct effect on cerebrovascular function. There is scant 
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research into the effects of flavonoids on cerebrovascular function however. Currently, only one study 
has examined the effect (acute) of tea on CBF, concluding that tea had no effect on cerebrovascular 
reactivity to hypercapnia (Vidyasagar et al., 2013). However, others found that cocoa flavanols, a 
product that also contains (-)-epicatechin such as that found in green tea, increased CBF 2-hours post-
ingestion in a pilot study of four young, healthy females (Francis et al., 2006) and in healthy older (55-
65-years) adults (Lamport et al., 2015). Furthermore, a 3-month high-flavanol dietary intervention 
containing (-)-epicatechin demonstrated enhanced dentate gyrus (hippocampus) function in healthy 
older adults compared to a low-flavanol diet (Brickman et al., 2014). Caffeine, another compound 
found in tea, has also demonstrated improved dynamic cerebral autoregulation 30-minutes after 
consumption (Sasaki et al., 2016), yet a further study observed a 20% global reduction in CBF post 
caffeine using positron emission tomography (Vidyasagar et al., 2013).  
 
Taken together, the conflicting limited results on the impact of tea on cerebrovascular health may 
relate to differences in intervention dosage, study population and/or experimental design, as well as 
the various compounds found in tea, for example, (-)-epigallocatechin-3-gallate (EGCG) and (-)-
epicatechin. More specifically, acute low-dose (135 mg) EGCG reduced CBF (measured by NIRS) but a 
higher dose (270 mg) demonstrated no effect relative to placebo (Wightman et al., 2012). (-)-
Epicatechin, present in both tea and cocoa, has exhibited improved peripheral vascular function 
(Dower et al., 2016b) and a protective effect on transient ischaemia-induced brain injury in mice (Shah 
et al., 2010). These findings, alongside the beneficial effects of flavanols that contain  (-)-epicatechin 
on cerebrovascular function outlined above (Francis et al., 2006; Brickman et al., 2014; Lamport et al., 
2015) suggest that (-)-epicatechin may represent a compound with potential beneficial effects on the 
cerebrovasculature. However, no study has directly examined the isolated impact of (-)-epicatechin 
on cerebrovascular function in humans. The aim of this study was, therefore, to examine the effect of 
acute oral (-)-epicatechin ingestion on cerebrovascular function in healthy adults. It was hypothesised 
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that acute (-)-epicatechin ingestion would be associated with increased cerebrovascular perfusion and 
function.  
 
7.2 Methods  
7.2.1 Participants 
Seven healthy male participants were recruited through local advertisement. All participants were 
healthy and non-smokers (32 ± 13 yrs, height 1.78 ± 0.04 m, weight 78 ± 7 kg, BMI 25 ± 1 kg/m2, 
baseline MAP 84 ± 7 mmHg). For details of the inclusion and exclusion criteria, please refer to Chapter 
3, General Methods. After being fully informed of the methods verbally and in writing, written 
informed consent was obtained from all participants. The study conformed to the Declaration of 
Helsinki and was approved by the local research ethics committee. 
7.2.2 Experimental Design  
Participants attended a familiarisation session <7-days prior to their first experimental trial, when they 
were fully briefed on the experimental protocols. Subsequently, all participants attended two 
experimental trials ((-)-epicatechin and placebo) in a randomised, controlled, double-blind, crossover 
design, each trial being separated by a 6-day washout period to avoid any carry-over effects. The 
crossover design was chosen to eliminate between-participant variability and computer-generated 
randomisation was used to reduce potential selection bias. In the week preceding each laboratory 
visit, participants were instructed to refrain from consuming dietary sources high in polyphenols, 
particularly tea, dark chocolate, apples, berries and red wine. Participants were asked to adhere to all 
pre-test instructions regarding fasting and avoiding caffeine, as outlined in Chapter 3, General 
Methods (section 3.1). Anthropometric measurements were recorded at visit 1 (see Chapter 3, 
General Methods, section 3.2). All assessments were conducted in a quiet, temperature-controlled 
laboratory (22-24°C) (Cracowski et al., 2006; Thijssen et al., 2011) and at the same time of day to 
reduce any circadian influences on vascular function (Jones et al., 2010; Thijssen et al., 2011).  
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During each trial, participants underwent assessment of baseline cerebrovascular function using TCD 
ultrasonography, comprising cerebrovascular CO2 reactivity and dynamic cerebral autoregulation via 
squat-stand manoeuvres, performed at 0.10 Hz (5-seconds squatting, followed by 5-seconds standing) 
and 0.05 Hz (10-seconds squatting, followed by 10-seconds standing) for 5-minutes each (see Chapter 
3, General Methods, section 3.5). Following completion of the baseline measures, participants 
immediately consumed an oral dose of the test product (2 x 50 mg capsules of (-)-epicatechin or 2 
capsules of colour-matched placebo) together with a glass of water, following which participants 
relaxed in the laboratory. 2-hours post-ingestion repeat measures of cerebrovascular function were 
performed (Figure 7.1).   
 
The 100 mg (-)-epicatechin dose was in line with previous intervention studies (46-150 mg) that 
observed the effects of pure (-)-epicatechin and cocoa flavanols (containing (-)-epicatechin) on the 
cerebral (Francis et al., 2006; Brickman et al., 2014; Lamport et al., 2015) and conduit (Engler et al., 
2004; Farouque et al., 2006; Faridi et al., 2008; Grassi et al., 2008b; Dower et al., 2015; Dower et al., 
2016b) vasculature. The (-)-epicatechin was isolated and purified according to procedures developed 
by ChromaDex (Irvine, CA, USA), whereby (-)-epicatechin was extracted from Acacia heart wood with 
aqueous alcohol and the crude extract was subsequently purified by preparative chromatography 
(Dower et al., 2015). This was followed by repeated fractional crystallisation from water. All solvents 
and equipment used were food grade. Identity was confirmed using nuclear magnetic resonance 
spectroscopy and mass spectrometry. High performance liquid chromatography was used to check 
purity and was 96.2% for (-)-epicatechin (water 0.3%). Non-transparent capsules were used to 
encapsulate the supplements, which were matched for size and colour, using microcrystalline 
cellulose as an excipient and 1% colloidal silicium dioxide. Variation in contents was within 3.7% 
(SD/mean*100%) for epicatechin. The placebo capsules contained microcrystalline cellulose (Dower 
et al., 2015).  
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Figure 7.1 Timeline of study. Participants received the treatments (pure epicatechin and placebo) in a 
randomised, crossover design, each treatment being separated by a 6-day washout period. The 
treatments were consumed immediately after the baseline measurements were completed and 
measurements were repeated 2-hours following ingestion.  
 
7.2.3 Statistical Analysis  
Data were expressed as mean ± SD and statistical significance was set at P≤0.05. Linear mixed models 
(main effects of condition and time) were used to examine the differences between (-)-epicatechin 
and placebo interventions on cerebrovascular function. The repeated covariance type was 
Unstructured and Condition (placebo vs (-)-epicatechin), Time (baseline vs +2-hours) and 
Condition*Time were specified as Fixed Effects (intercept was included) and as Estimated Marginal 
Means. Significant main effects of Time or Condition or a Time*Condition interaction were followed 
up with a simple main effects analysis and the least significant difference (LSD) approach to multiple 
comparisons (Perneger, 1998). Data were stored and transformed within Microsoft Excel (Microsoft 
Office 2010, Microsoft Corporation), and statistical analyses were performed using SPSS 22.0 (SPSS, 
Chicago, IL, USA). 
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7.3 Results  
7.3.1 Resting values 
No differences were observed in resting MAP between placebo or (-)-epicatechin and there was no 
main effect of time across the 2-hour intervention (P=0.06), condition (P=0.89) or interaction of 
time*condition (P=0.40, Table 7.1). Resting MCAv demonstrated no differences between placebo or 
(-)-epicatechin, and no main effects of time, condition or time*condition interactions for MCAv (all 
P>0.05, Table 7.1). Resting common carotid artery (CCA) diameter demonstrated no differences across 
time, condition or time*condition (all P>0.05, Table 7.1). 
7.3.2 Hypercapnia  
MCAv increased during hypercapnia for all conditions (placebo and (-)-epicatechin). The peak changes 
in MCAv demonstrated no main effect of time (P=0.56) or condition (P=0.87) and there was no 
time*condition interaction (P=0.77, Table 7.1). MCAv vs PETCO2 reactivity slopes were not different 
between placebo and (-)-epicatechin, with no main effect of time (P=0.10), condition (P=0.75) or 
time*condition interaction (P=0.75). When expressed as relative changes, MCAv vs PETCO2 reactivity 
slopes demonstrated no main effect of time (P=0.08), condition (P=0.92) or a time*condition 
interaction (P=0.80, Table 7.1).  
 
MAP increased during hypercapnia with no main effect of time (P=0.36) or between placebo and (-)-
epicatechin (P=0.34). The peak changes in MAP demonstrated no differences across time, condition 
or time*condition (all P>0.05, Table 7.1). No differences were observed for resting CBVC and the peak 
changes in CBVC demonstrated no differences across time, condition or time*condition (all P>0.05, 
Table 7.1). Absolute CBVC vs PETCO2 reactivity slopes demonstrated a main effect of time (P=0.01), 
with a subtle reduction after 2-hours (placebo; 0.02 ± 0.01 vs 0.02 ± 0.02 cm.s-1.mmHg:mmHg-1; (-)-
epicatechin; 0.03 ± 0.02 vs 0.02 ± 0.02 cm.s-1.mmHg:mmHg-1). However, there was no main effect of 
condition (P=0.46) nor a time*condition interaction (P=0.43, Table 7.1). When expressed as relative 
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changes, a main effect of time was confirmed (P=0.02), whereby 2-hours post ingestion, a reduction 
was demonstrated for both placebo and (-)-epicatechin (Figure 7.2). However, there was no main 
effect of condition (P=0.26) and no time*condition interaction (P=0.31, Table 7.1). 
 
The peak change in CCA diameter demonstrated no main effect of time (P=0.89), condition (P=0.10) 
and no time*condition interaction (P=0.79, Table 7.1). No significant differences were observed for 
the absolute change in carotid blood flow during hypercapnia between placebo (18 ± 20 % vs 35 ± 37 
%) and (-)-epicatechin (14 ± 22 % vs 10 ± 20 %, P=0.29), with no main effect of time (P=0.28), and no 
time*condition interaction (P=0.16). The change in MAP during hypercapnia demonstrated no main 
effect of time (P=0.50) or condition (P=0.57), nor a time*condition interaction (P=0.68). No differences 
were evident for carotid artery vascular conductance (CarVC) at baseline or during hypercapnia across 
time, between conditions or time*condition (all P>0.05, Figure 7.3).  
 
 
Figure 7.2 Cerebrovascular CO2 reactivity as the relative change (%) between CBVC:PETCO2  for A. (-)-
epicatechin and B. placebo interventions. Data are presented as means, with error bars representing 
SD, and individual responses. *Main effect of time P≤0.05.  
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Table 7.1 Cerebrovascular and common carotid artery (CCA) variables during hypercapnia for placebo 
and (-)-epicatechin interventions.  
 Intervention (mean ± SD) Linear Mixed Model P Values 
 
Pre- 
placebo 
2-h  
placebo 
Pre-  
epicatechin 
2-h  
epicatechin  
Time Condition T*C  
 
Cerebrovascular  Variables  
     
Baseline MCAv (cm·s-1)    68 ± 11 70 ± 6    66 ± 10  67 ± 12  0.29 0.39 0.73 
Change in MCAv (cm·s-1)  16 ± 8 14 ± 9 15 ± 7 14 ± 11 0.56 0.87 0.77 
Baseline PETCO2 (mmHg)   37 ± 5 38 ± 4 39 ± 6       37 ± 7 0.47  0.94  0.27 
Change in PETCO2 (mmHg)    7 ± 2   6 ± 2   6 ± 3 7 ± 5 0.85 0.94 0.24 
MCAv:PETCO2 absolute 
(cm·s/mmHg-1) 
   2.80 ± 1.21   2.32 ± 1.64   2.88 ± 1.62 2.03 ± 1.42 0.10 0.75 0.75 
MCAv:PETCO2 relative  
(% cm·s/% mmHg-1) 
   4.18 ± 1.84   3.31 ± 2.20   4.32 ± 2.18 3.24 ± 2.52 0.08 0.92 0.89 
Baseline MAP (mmHg)         77 ± 8  87 ± 11   79 ± 10       85 ± 7  0.06 0.89 0.40 
Change in MAP (mmHg)     1 ± 3  6 ± 6   3 ± 3  1 ± 4 0.36 0.34 0.14 
Baseline CBVC (cm·s/mmHg-1)    0.88 ± 0.14   0.82 ± 0.13   0.85 ± 0.14  0.80 ± 0.19 0.11 0.40 0.82 
Change in CBVC (%)          21 ± 7  16 ± 13   25 ± 11  22 ± 18 0.27 0.34 0.86 
CBVC:PETCO2 absolute (cm·s/ 
mmHg-1/mmHg-1) 
   0.02 ± 0.01  0.02 ± 0.02   0.03 ± 0.02   0.02 ± 0.02   0.01* 0.46 0.43 
CBVC:PETCO2 relative  
(% cm·s/mmHg-1/%mmHg-1) 
   1.01 ± 0.26  0.72 ± 0.83   1.57 ± 0.85  0.82 ± 0.70   0.02* 0.26 0.31 
 
Common Carotid Artery Variables         
Baseline diameter (mm)   0.68 ± 0.02  0.68 ± 0.03   0.67 ± 0.02   0.68 ± 0.02 0.13 0.65 0.71 
Change in diameter (%)    0 ± 2  1 ± 2         -1 ± 3       -1 ± 1  0.89 0.10 0.79 
Baseline blood flow  
(mL/min-1) 
  10.34 ± 2.15      8.84 ± 2.14   10.19 ± 2.76    9.66 ± 4.60  0.29 0.72 0.61 
Change in blood flow (%)    18 ± 20    35 ± 37 14 ± 22  10 ± 20 0.28 0.29 0.16 
Baseline CarVC  
(mL·min/mmHg-1) 
 0.14 ± 0.04    0.10 ± 0.03  0.13 ± 0.04   0.12 ± 0.07  0.12 0.62 0.55 
Change in CarVC  
(% mL·min/mmHg-1)  
 10 ± 20   27 ± 33    7 ± 24    6 ± 17  0.30 0.29 0.09 
Data are mean ± SD. T*C, time*condition interaction; MCAv, middle cerebral artery velocity; PETCO2, end-tidal carbon dioxide; 
MAP, mean arterial pressure; CBVC, cerebrovascular conductance; CarVC, carotid artery vascular conductance. *Main effect 
of time P≤0.05.
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Figure 7.3 Carotid artery vascular conductance (CarVC) reactivity to 5% CO2 expressed as the relative 
change (%) in CBVC for A. (-)-epicatechin and B. placebo interventions. Data are presented as means, 
with error bars representing SD, and individual responses.  
 
7.3.3 Cerebral Autoregulation: Squat-Stand Manoeuvres  
7.3.3.1 Squat-Stands at 0.05 Hz 
Gain: At the VLF, a main effect of time (P=0.04) was demonstrated with a subtle increase at 2-hours 
(placebo; 0.7 ± 0.2 vs 0.8 ± 0.2 cm·s-1·mmHg-1; (-)-epicatechin; 0.7 ± 0.1 vs 0.7 ± 0.1 cm·s-1·mmHg-1). 
However, no effect of condition (P=0.70) was observed and there was no time*condition interaction 
(P=0.33). At the low and high frequencies, there were no main effects of time, condition or interactions 
of time*condition (all P>0.05, Table 7.2).  
Phase: At the very low, low and high frequencies there were no main effects of time (all P>0.05), 
condition or interactions of time*condition (Table 7.2). 
Coherence: At the very low, low and high frequencies there were no main effects of time (all P>0.05), 
condition or interactions of time*condition (Table 7.2). 
7.3.3.2 Squat-Stands at 0.10 Hz 
Gain: At the VLF, no main effect of time (P=0.62) was demonstrated, but a main effect of condition 
(P=0.03) was observed, whereby Gain was slightly higher for placebo (baseline; 0.7 ± 0.2; 2 hr;  0.8 ± 
0.2 cm·s-1·mmHg-1) compared to (-)-epicatechin (baseline; 0.6 ± 0.2; 2 hr; 0.6 ± 0.2 cm·s-1·mmHg-1). 
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There was no time*condition interaction (P=0.20). At the low and high frequencies, there were no 
main effects of time, condition or interactions of time*condition (all P>0.05, Table 7.2).  
Phase: For the VLF, there was no main effect of time (P=0.65), but a main effect of condition (P=0.04) 
was demonstrated. However, there was no time*condition interaction (P=0.34, Table 7.2). At the low 
and high frequencies there were no main effects of time, condition or interactions of time*condition 
(all P>0.05, Table 7.2). 
Coherence: At the very low, low and high frequencies there were no main effects of time, condition or 
interactions of time*condition (all P>0.05, Table 7.2). 
 
Table 7.2 Gain, phase and coherence determined by transfer function analysis at very low (VLF), low 
(LF) and high frequency (HF) ranges during repeated squat-stand manoeuvres at 0.05Hz and 0.10 Hz 
for placebo and (-)-epicatechin interventions.  
 Intervention (mean ± SD) Linear Mixed Model P Values 
0.05 Hz Squat-stands  
Pre- 
placebo 
2-h  
placebo 
Pre-
epicatechin 
2-h 
epicatechin 
Time Condition T*C  
Gain (cm·s-1·mmHg-1)         
    VLF  0.7 ± 0.2 0.8 ± 0.2 0.7 ± 0.1 0.7 ± 0.1   0.04* 0.70 0.33 
    LF 0.8 ± 0.2  0.9 ± 0.3 0.9 ± 0.2 0.9 ± 0.1 0.54 0.82 0.36 
    HF 0.8 ± 0.2 0.9 ± 0.3 0.8 ± 0.1 0.9 ± 0.2 0.25 0.93 0.61 
Phase (radians)         
    VLF  55.7 ± 18.9  53.4 ± 23.7 52.9 ± 16.9 47.5 ± 13.7 0.52 0.33 0.59 
    LF    19.7 ± 12.1 24.6 ± 14.9 21.5 ± 13.5 12.9 ± 16.2 0.68 0.16 0.13 
    HF 16.8 ± 12.2 22.0 ± 24.2 13.9 ± 11.1 14.1 ± 18.0 0.65 0.47 0.74 
Coherence          
    VLF  0.9 ± 0.1 0.9 ± 0.1 0.9 ± 0.1 0.9 ± 0.1 0.83 0.06 0.46 
    LF 0.6 ± 0.2 0.7 ± 0.2 0.6 ± 0.1 0.6 ± 0.1  0.61 0.65 0.39 
    HF 0.4 ± 0.2 0.4 ± 0.1 0.3 ± 0.1 0.4 ± 0.1 0.67 0.42 0.20 
0.10 Hz Squat-stands         
Gain (cm·s-1·mmHg-1)        
    VLF  0.7 ± 0.2  0.8 ± 0.2  0.6 ± 0.2 0.6 ± 0.2 0.62   0.03^ 0.20 
    LF 1.0 ± 0.4  1.0 ± 0.2 0.9 ± 0.2 0.9 ± 0.2 0.58 0.19 0.92 
    HF 0.9 ± 0.3   1.1 ± 0.3 1.1 ± 0.4 0.9 ± 0.2 0.98 0.72 0.29 
Phase (radians)        
    VLF  56.9 ± 20.1 47.7 ± 10.1 54.2 ± 13.9 62.4 ± 24.6 0.65   0.04^ 0.34 
    LF    31.2 ± 18.4 33.6 ± 17.5 31.9 ± 19.9 29.2 ± 16.9 0.98 0.69 0.43 
    HF   21.3 ± 19.2 20.1 ± 27.0 32.0 ± 52.0 11.3 ± 49.0 0.31 0.95 0.35 
Coherence          
    VLF  0.4 ± 0.1 0.4 ± 0.1 0.4 ± 0.1 0.4 ± 0.2 0.40 0.60 0.77 
    LF 0.6 ± 0.1 0.5 ± 0.2 0.6 ± 0.1 0.6 ± 0.1 0.70 0.09 0.67 
    HF 0.3 ± 0.1 0.3 ± 0.1 0.3 ± 0.1 0.3 ± 0.1 0.40 0.37 0.77 
Data are mean ± SD. T*C, time*condition interaction. *Main effect of time P≤0.05; ^main effect of condition P≤0.05. 
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7.4 Discussion  
The primary aim of this exploratory study was to test the hypothesis that acute (-)-epicatechin 
ingestion improves cerebrovascular function in healthy adults. The study found no differences in 
cerebrovascular function 2-hours following ingestion of a single dose of (-)-epicatechin compared to 
placebo, with no effect of (-)-epicatechin on cerebrovascular responses to CO2 or dynamic 
autoregulation, assessed via squat-stand manoeuvres. This is the first study to examine the acute 
impact of (-)-epicatechin on cerebrovascular function in humans using a range of functional tests. 
Current findings suggest that acute ingestion of (-)-epicatechin does not induce any immediate 
functional changes in the cerebrovasculature in healthy male individuals.  
 
Despite previous studies observing encouraging effects of acute tea consumption on peripheral 
vascular function, there is a distinct lack of research examining the impact of tea and its isolated 
compounds on the cerebrovasculature that have used a variety of methods to interrogate 
cerebrovascular function. It is, therefore, difficult to compare current findings against the existing 
research base. This topic is of particular interest since cerebrovascular disease and stroke account for 
the greatest proportion of cardiovascular related deaths globally (Roger et al., 2012) and dietary 
behaviours present a relatively easy opportunity to modify cerebrovascular disease risk. Although 
examining cerebrovascular function is challenging, CO2 reactivity and cerebral autoregulation provide 
useful methods of assessment, given that the principle regulators of cerebral perfusion are arterial 
blood gases, such as CO2, and blood pressure (Willie et al., 2014). The present study found no effect 
of a single dose of (-)-epicatechin 2-hours after ingestion compared to placebo, either on 
cerebrovascular responses to CO2 or dynamic autoregulation. CO2 reactivity may act as a surrogate of 
cerebrovascular endothelial function (Lavi et al., 2006), similar to the role of FMD in assessing 
endothelial function in the peripheral vasculature. NO is suggested to contribute towards the 
regulation of the cerebral circulation (Iadecola et al., 1994; Lavi et al., 2003), although it is unclear 
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whether the NO is derived from the endothelium or neuronal pathways (Lavi et al., 2006). 
Nevertheless, impaired CO2 reactivity has been observed in individuals with peripheral endothelial 
dysfunction, with no apparent effect on pressure-dependent CBF autoregulation (mechanoregulation) 
(Lavi et al., 2006), thereby suggesting a role for the vascular endothelium in cerebrovascular function. 
Furthermore, adequate cerebral reactivity to hypercapnia appears to be dependent upon the integrity 
of the vascular endothelium (Silvestrini et al., 2000; Lavi et al., 2003). Given that (-)-epicatechin is the 
most abundant flavan-3-ol in cocoa (Dower et al., 2016a; Dower et al., 2016b), in addition to its 
presence in green tea, and is suggested to be (partly) responsible for mediating cocoa-induced 
improvements in peripheral vascular function (Schroeter et al., 2006), it was reasonable to surmise 
that (-)-epicatechin may induce similar changes in the cerebrovasculature. However, the present study 
observed no differences in cerebrovascular function in response to hypercapnia, with no changes 
evident for autoregulation, suggesting that (-)-epicatechin does not affect the cerebrovasculature 
presumably via a direct effect on the endothelium.  
 
In keeping with the concept that (-)-epicatechin does not influence cerebrovascular endothelial 
function, previous studies also demonstrated no significant improvements in peripheral vascular 
function (FMD) following acute (2-hours) (Dower et al., 2016b) or regular (4-weeks) (Dower et al., 
2015) ingestion of (100mg (-)-epicatechin) in healthy adult males. As an alternative explanation, the 
cardioprotective effects of (-)-epicatechin may relate to improved insulin resistance rather than a 
direct effect on the vasculature (Dower et al., 2015). (-)-Epicatechin and insulin are considered to exert 
similar protective effects on erythrocyte osmotic fragility and in increasing glucose uptake, but act by 
different mechanisms according to their different binding sites (Rizvi et al., 1995). NO appears to be 
the primary molecule responsible for the protective effects of (-)-epicatechin, with increased 
bioavailability suggested to modulate inflammation and reduce the formation of reactive oxygen 
species (Grassi et al., 2013b), although the precise mechanisms remain unclear. Insulin acts as a 
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neuroregulatory peptide and plays an important role in brain metabolism, memory and cognition, but 
is not considered a regulator of cerebrovascular function (Gray et al., 2014). Therefore, it is perhaps 
unsurprising that the present study observed no differences in cerebrovascular function, and that 
previous effects in the peripheral vasculature may relate to an insulin-like action, given that these 
vessels are more dependent upon the liberation of NO by insulin-activated eNOS.  
 
Regular tea consumption is associated with modest 1-2 mmHg reductions in BP (Greyling et al., 2014) 
that may have implied an effect of (-)-epicatechin on the cerebrovasculature through pressure-
dependent CBF regulation (mechanoregulation). However, the present study observed no significant 
differences in MAP over time or between conditions, and no changes in the findings when CBF was 
expressed relative to MAP (CBVC). It is likely that any potentially small changes in MAP induced by (-
)-epicatechin ingestion were unlikely to be apparent, particularly given the small sample size. Similarly, 
if the beneficial effects of tea are due to a direct effect on the vascular endothelium arising from NO-
mediated mechanisms, no changes in MAP may be observed (Lavi et al., 2006).  
 
Cerebral autoregulation assessed via squat-stand manoeuvres at 0.05 Hz and 0.10 Hz (i.e. 3- and 6-
squats per minute, respectively), did not demonstrate any changes in the oscillations between CBF 
and MAP (transfer function determined gain and phase) following acute (-)-epicatechin ingestion. The 
mechanisms of cerebral autoregulation include mechanoregulation (see above), NO pathways (see 
above), myogenic (vascular smooth muscle), neurogenic (α-adrenergic sympathetic nerves) and 
metabolic (local blood gases) regulation (see above).  The present chapter’s results suggest that acute 
(-)-epicatechin ingestion does not affect dynamic cerebral autoregulation. These, as well as the CO2 
reactivity, findings are consistent with findings of the previous chapter (Chapter 6) in that ingestion of 
a dietary flavonoid has demonstrated no direct impact on the cerebrovasculature. As the brain is a 
highly complex organ and is tightly regulated through multiple interrelated mechanisms, it is possible 
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that the brain’s plasticity or redundancy is able to cope with subtle changes and that a much greater 
stimulus is required to induce any functional variations. Furthermore, the regulatory mechanisms 
underpinning cerebrovascular function are incompletely understood so as our collective 
understanding continues to advance, future studies may be able to identify subtle differences that are 
possibly currently undetected.  
 
The present study findings are in keeping with the only study to date that has directly investigated the 
cerebrovascular effects of tea, whereby acute black tea consumption demonstrated no effect on 
cerebrovascular reactivity to hypercapnia (ASL-MRI) in healthy male adults (Vidyasagar et al., 2013). 
However, no previous study has specifically examined the effects of green tea or (-)-epicatechin on 
cerebrovascular function. EGCG, another catechin that is abundant in green tea (Murray et al., 2015), 
demonstrated decreased CBF (measured by near-infrared spectroscopy; NIRS) during computerised 
cognitive task performance in healthy humans following a single low dose (135 mg), whereas a higher 
dose (270 mg) did not change CBF relative to placebo (Wightman et al., 2012). Improved 
cerebrovascular function has been observed following the ingestion of cocoa flavanols (containing (-
)-epicatechin), whereby increased regional CBF (ASL) was demonstrated 2-hours post-ingestion (cocoa 
flavanols containing 89mg of (-)-epicatechin) in the healthy elderly (Lamport et al., 2015). Similarly, an 
acute dose (450mg) of flavanols ((-)-epicatechin content unknown) increased grey matter CBF (fMRI) 
2-hours post-ingestion in healthy young females (Francis et al., 2006) and increased CBF was observed 
following regular (1-12 weeks) ingestion in older individuals (Fisher et al., 2006; Sorond et al., 2008a; 
Brickman et al., 2014). It is possible that the differences in the test product (tea, (-)-epicatechin, EGCG, 
cocoa flavanols) may be responsible for the variable observations of the aforementioned studies. 
However, given the paucity of studies to date, it is difficult to establish whether there are distinct 
differences between the effects of tea and tea-derived flavonoids. Furthermore, it is unlikely that the 
timing of administration was a factor in the present study, as 2-hours was consistent with suggestions 
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regarding peak bioavailability (Clifford et al., 2013) and previous studies (Francis et al., 2006; Lamport 
et al., 2015; Dower et al., 2016b). 
 
It is possible that the acute dose of (-)-epicatechin in the present study was insufficient to affect the 
cerebrovasculature, particularly since it is difficult to ascertain the exact (-)-epicatechin content of 
some previous cocoa flavanol studies. In keeping with the present study, peripheral vascular function 
(FMD) demonstrated no significant effect of 100 mg (-)-epicatechin, yet dark chocolate containing 150 
mg (-)-epicatechin significantly improved FMD (Dower et al., 2016b), although a smaller 70 mg (-)-
epicatechin dose acutely increased FMD and NO in a pilot study in only three individuals (Schroeter et 
al., 2006). However, the lack of cerebrovascular (-)-epicatechin studies makes accurate comparison of 
dose administration difficult. Variations in the cerebrovascular assessment methods between the 
present and previous cerebral studies likely also contribute to differences in findings. Previously, 
differences in CBF were demonstrated using techniques such as ASL or fMRI, that are more sensitive 
in detecting changes in global and regional perfusion rather than using MCAv via TCD, as in the present 
study. It is, therefore, possible that subtle changes in cerebrovascular function were not detected in 
the present study, but may have been observed using alternative techniques that assess regional 
perfusion.    
 
Older individuals are likely to exhibit compromised cerebrovascular function associated with ageing 
(Parkes et al., 2004; Bertsch et al., 2009), which may partly explain the improved (-)-epicatechin-
induced cerebrovascular function found in previous studies (Fisher et al., 2006; Sorond et al., 2008a; 
Brickman et al., 2014; Lamport et al., 2015) and no differences observed in the healthy male adults 
examined in the present study. The present cohort likely had near-optimal cerebrovascular function 
and individuals with chronic cerebrovascular dysfunction a priori (such as the elderly or individuals 
with CVD risk factors) may be more likely to exhibit changes following ingestion of tea or tea-derived 
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flavonoids. Consistent with this, (-)-epicatechin intake was associated with a 46% lower risk of CVD 
related mortality in men with prevalent CVD, compared to no such risk reduction in healthy men in a 
prospective cohort study (Dower et al., 2016a). However, further studies in at-risk and elderly 
populations are required to corroborate this suggestion.  
 
7.4.1 Clinical Relevance and Perspectives  
Findings from the present study suggest that acute (-)-epicatechin ingestion is not associated with 
improved cerebral CO2 reactivity or dynamic autoregulation in healthy younger individuals. However, 
the long-term effects remain unclear and, furthermore, its effects in a population exhibiting impaired 
cerebrovascular function are unknown. This remains of special importance given previous 
observations in population studies that found that (-)-epicatechin intake is associated with lower risk 
for CVD-related mortality. Further studies are therefore warranted to explore the longitudinal effects 
of (-)-epicatechin and whether it has an impact upon individuals with existing (endothelial) 
dysfunction.  
 
7.4.2 Limitations  
Given that regulation of the cerebrovasculature is highly complex and involves multiple mechanisms, 
subtle changes in function following (-)-epicatechin ingestion may not have been detected in the 
current cohort given the small sample size. Inherent methodological considerations of TCD may have 
influenced the findings of the present study, as it is not possible to ensure complete accuracy in 
insonating the same part of the MCA for each set of measures. However, every effort was made to 
document Doppler probe positions and to record velocity and depth values for subsequent laboratory 
measures. It is assumed that during TCD the vessel diameter does not change which may have 
influenced the data obtained during hypercapnia. Nevertheless, the absolute CO2 reactivity data was 
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indicative of similar cerebrovascular responses, suggesting that the MCA likely dilated to a similar 
extent following both (-)-epicatechin and placebo.  
 
In conclusion, the present exploratory study suggests that acute ingestion of (-)-epicatechin does not 
affect cerebrovascular function, as assessed by CO2 reactivity and dynamic autoregulation. The 
present findings are consistent with those of Chapter 6, in that the cerebrovasculature does not exhibit 
any changes in function following the ingestion of either the isolated compound (-)-epicatechin or tea 
per se. However, further investigation is warranted to examine the longitudinal effects of (-)-
epicatechin on the cerebrovasculature, particularly in cohorts that may be more susceptible to 
changes in the cerebrovasculature.  
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CHAPTER 8: SYNTHESIS OF FINDINGS 
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8.1 Aims and Objectives  
The research described within the present thesis was designed to explore the impact of tea ingestion 
on peripheral, central and cerebral micro- and macrovascular function in humans. Furthermore, the 
studies specifically examined NO-mediated endothelial function in both the cutaneous microvessels 
and conduit arteries and, for the first time, explored the impact of an unhealthy lifestyle intervention 
on multiple measures of vascular health and insulin resistance, along with the impact of regular green 
tea consumption on these measures of vascular health and insulin resistance. Similarly, work 
contained within this thesis provides the first observations of regular green tea consumption on the 
cerebrovasculature and the acute effect of the tea-derived catechin (-)-epicatechin on cerebrovascular 
function.  
 
8.2 Major Findings  
8.2.1 Simultaneous use of Local Heating Protocols in Examining Cutaneous Microvascular Function 
The reproducibility study detailed in Chapter 4 found that the Rapid 42°C and Gradual 42°C local 
heating protocols provide superior reproducibility to other local heating protocols, such as Rapid 39°C, 
when assessing cutaneous microvascular function. Furthermore, the data of Chapter 4 provides useful 
sample size estimations to detect meaningful differences in future studies using local thermal 
hyperaemia. Combined with the observations of Chapters 5 and 6, whereby acute and regular 
consumption of black and green tea, respectively, demonstrated enhanced microvascular function, 
these findings collectively support the simultaneous use of multiple local heating protocols to 
interrogate the microvasculature and achieve better mechanistic insight for use in future 
epidemiological studies and clinical trials. In addition, current findings suggest that differences in 
cutaneous microvascular function are more likely to be detected with the local heating protocols that 
have the smallest variation (Rapid 42°C and Gradual 42°C).  
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8.2.2 Tea and Cutaneous Microvessel Endothelial Function  
Chapter 5 demonstrated that acute (2-hour) black tea consumption enhanced cutaneous vascular 
function in healthy, middle-aged individuals compared to placebo. Two distinctly different techniques 
(LDF and FLPI) detected these effects using gradual local heating, thereby reinforcing the observed 
microvascular effects of acute black tea consumption. However, no differences were detected 
following rapid local heating using LDF. Furthermore, in Chapter 6, green tea also demonstrated a 
cardioprotective role in that daily consumption for 7-days largely attenuated the reduction in 
cutaneous blood flow in response to gradual, but not rapid, heating following an unhealthy lifestyle. 
As gradual local heating is largely NO-mediated (Black et al., 2008b), current findings suggest that the 
microvascular benefits of tea consumption are likely achieved through a mechanism related to 
activation of endothelium-derived vasodilators, such as NO. Given that the rapid local heating 
protocols are predominantly NO-mediated, but to a lesser extent than gradual local heating, and that 
tea attenuated the unhealthy lifestyle-induced impairment in microvascular function in Chapter 6, 
reinforces the concept that NO plays an important protective role in the microvasculature.  
8.2.3 Short-term Lifestyle Intervention and its Effects on Vascular and Metabolic Function   
Chapter 6 demonstrated the deleterious impact of an unhealthy Western lifestyle, characterised by a 
high energy diet and physical inactivity, inducing peripheral vascular dysfunction and insulin resistance 
after a period of only 7-days. Importantly, as such sedentary lifestyles reflect the habitual behaviour 
of an ever-increasing number of individuals in developed countries, and others experience such a 
lifestyle during holidays and festivities, these observations are widely applicable. Furthermore, as the 
profound impact of excess calorie consumption and physical inactivity was observed after only a few 
days in a cohort of previously healthy male adults, current findings demonstrate the significant 
negative impact of this lifestyle on cardiovascular health. The ability of the lifestyle model adopted in 
Chapter 6 to induce immediate changes in peripheral vascular function and metabolic function 
highlights its value and relevance as a tool in evaluating lifestyle-induced changes and the impact of 
interventions to enable the development of strategies to combat such negative consequences.  
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8.2.4 Tea and Conduit Artery Endothelial Function  
Consistent with the findings in the microvasculature, Chapter 6 found that tea was also associated 
with a cardioprotective role in conduit vessels, as daily green tea consumption attenuated the decline 
in conduit artery endothelial-dependent function following a 7-day lifestyle intervention in healthy 
males. These changes were present in the femoral artery which was likely to have been impacted by 
the physical activity reduction to a greater extent than the brachial artery. However, the brachial 
artery did demonstrate a non-significant increase in FMD following daily green tea consumption, again 
suggesting a role for tea in improving conduit artery endothelial function. As direct measures of 
endothelial function in the micro- and macrovasculature provide independent prognostic value in 
evaluating overall cardiovascular health and CVD risk (Green et al., 2011), current findings support the 
role of tea as a cardioprotective strategy in reducing CVD risk amongst the general population.  
 
Chapter 6 also demonstrated that extra-cranial artery function, assessed by carotid artery reactivity 
to the CPT, was impaired following the unhealthy lifestyle, with a concomitant increase in both the 
basal and peak BP during the CPT. These findings suggest that the unhealthy lifestyle induces systemic 
maladaptation, as the deleterious impact is not confined to the peripheral vasculature. Importantly, 
daily green tea consumption attenuated the decline in carotid artery reactivity, thus supporting the 
cardioprotective role of tea throughout the vascular tree.  
8.2.5 Tea and Cerebrovascular Function  
Contrary to the beneficial effects of tea observed on peripheral vascular function, Chapter 6 observed 
no differences in cerebral reactivity or dynamic autoregulation in response to daily green tea 
consumption during a 7-day lifestyle intervention. Furthermore, acute (2-hour) ingestion of the tea-
derived catechin (-)-epicatechin demonstrated no impact upon the cerebrovasculature in response to 
similar measures in Chapter 7. The combined observations on cerebrovascular function suggest that 
tea may not impact the cerebral vessels in the same way as the micro- and macro-vessels, or that the 
164 
 
brain requires much greater stimuli (e.g., inactivity, diet and/or polyphenols) to induce functional 
changes.  
8.2.6 Tea and Insulin Resistance   
Chapter 6 demonstrated that green tea was associated with a protective role on metabolic function 
in healthy male adults. Following short-term (7-day) lifestyle-induced insulin resistance, daily green 
tea ingestion not only attenuated elevated blood glucose levels, but also improved glucose handling 
and concomitantly enhanced insulin sensitivity. This study, therefore, highlights the ability of green 
tea to mitigate impairments in metabolic function and its use as a potential adjunct in combating the 
deleterious impact of high energy, sedentary lifestyles.  
 
8.3 General Discussion  
The skin is the human body’s largest organ and represents an easily accessible vascular bed to assess 
peripheral microvascular reactivity, also providing a model to investigate underlying mechanisms in 
various diseased states (Levy et al., 2001; Sokolnicki et al., 2007; Levy et al., 2008). The findings from 
Chapters 4, 5 and 6 support this notion, but further demonstrate the value of using multiple local 
heating protocols simultaneously. Interrogating the microvessels using a combination of local heating 
protocols provides a means of discovering the underlying mechanisms that are responsible for 
changes in function following intervention studies. Specifically, use of rapid and gradual local heating 
protocols exhibited different cutaneous responses to local heating in Chapters 5 and 6 that 
investigated the effects of acute and regular tea consumption, respectively. The data presented in 
Chapter 5 revealed that middle-aged healthy individuals exhibited increased cutaneous microvascular 
function 2-hours following black tea ingestion compared to placebo, as demonstrated following 
gradual local heating that is largely NO-mediated. Given that rapid local heating did not exhibit any 
such differences between tea and placebo, these findings highlight the importance of interrogating 
the cutaneous microvessels via multiple protocols. Similarly, the data presented in Chapter 6 further 
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supports this approach, as gradual local heating again demonstrated tea-induced increases in 
cutaneous vasodilation, whereas rapid local heating observed no changes between pre- and post-tea, 
compared to a reduction in vasodilation following placebo. It is possible that the studies in Chapters 5 
and 6 were statistically underpowered to detect differences pre- vs post-tea with rapid local heating, 
according to the findings and sample size estimations contained within Chapter 4. However, the 
observed differences between rapid and gradual local heating protocols may also be due to essential 
differences in the underlying mechanisms. Despite rapid local heating protocols also being NO-
mediated, but to a lesser extent than gradual heating, they also activate axon-reflexes and are partly 
mediated by EDHFs (Johnson et al., 2014). Consequently, rapid local heating provides complementary 
mechanistic insight when used in conjunction with gradual heating.  
 
Assessing cutaneous microvascular function is logical when examining the cardiovascular impact of 
interventions, since the skin represents a valid model of generalised microvascular (dys)function 
(Holowatz et al., 2008) and is regarded as an earlier sentinel of CVD than the macrovasculature 
(Roustit & Cracowski, 2012). Chapter 5 demonstrated acute (2-hour) improvements in cutaneous 
microvascular function in response to black tea consumption that is encouraging, given that this 
vascular bed is associated with some of the earliest manifestations of CVD and diabetes in multiple 
organ systems (Cade, 2008). Similarly, the lifestyle intervention adopted in Chapter 6 demonstrated a 
deleterious impact in the microvasculature after only 7-days that was not present in all of the 
examined conduit arteries, again suggesting that detrimental changes first manifest in the cutaneous 
microvasculature which is, therefore, a crucial component of the vascular tree.  
 
Chapter 6 demonstrated that a short lifestyle intervention had a significant deleterious impact on 
several markers of cardiovascular health. Previously, no research has examined the impact of such a 
lifestyle intervention on vascular health in a range of vascular beds simultaneously. The 
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comprehensive vascular assessment and observations in Chapter 6 are indicative of lifestyle-induced 
systemic changes in vascular function. Many individuals adopt such a lifestyle for much more 
prolonged durations than in Chapter 6 and others who are generally active and consume eucaloric 
diets, adopt short-term unhealthy lifestyles during periods of celebration or festivities. It is, therefore, 
both surprising and concerning that such detrimental changes in vascular function and insulin 
sensitivity were observed in healthy adult males after only 7-days. The data presented in Chapter 6 
are, therefore, an important indication of the negative consequences such lifestyles have on 
cardiovascular health and furthermore, are suggestive of the early manifestation of changes 
throughout the vascular tree that may subsequently progress to overt CVD.  
 
Given that Chapter 6 observed impaired insulin signalling and altered glucose metabolism that are 
characteristic of insulin resistance, these findings demonstrate the development of insulin resistant 
mechanisms after only 7-days of an altered lifestyle. Under healthy conditions, NO production in the 
endothelial cells is stimulated by insulin activating NOS via the PI-3K pathway (Sena et al., 2013), but 
this process is impaired in an insulin resistant state, thereby diminishing NO production and 
subsequently impairing the ability of vessels to dilate (Kim et al., 2006). That changes in insulin 
sensitivity were detectable after only 7-days suggests that the inflammatory cascade leading to 
atherosclerosis manifests early following changes in lifestyle. However, it is unknown whether such 
rapid changes translate to long-term changes in the vasculature and metabolic pathways. 
Furthermore, the precise mechanisms responsible for tea-induced changes in glucose control and 
insulin sensitivity are uncertain. Animal models suggest several mechanisms, including a reduction in 
glucose production in the intestinal tract due to inhibition of carbohydrate digestive enzymes 
(Kobayashi et al., 2000; Oh et al., 2015). Enhanced insulin binding to adipocytes and improved glucose 
uptake by myocytes are also suggested to be responsible for improved insulin sensitivity following tea 
and catechin consumption (Wu et al., 2004a; Wu et al., 2004b; Ueda et al., 2010; Ueda-Wakagi et al., 
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2015). However, the metabolic pathways in humans have yet to be determined and Chapter 6 did not 
investigate the gut microbiota so the mechanisms underlying the improved glucose handling and 
enhanced insulin sensitivity remain uncertain. It is perhaps interesting to consider the possibility that 
improved vascular function (as outlined in Chapter 6) could have also contributed to the improved 
glucose control and insulin sensitivity through improved delivery/disposal for example (Wagenmakers 
et al., 2016).  
 
The observations of previous research suggesting a cardioprotective role of tea on the vasculature 
were both supported and further extended by the findings of Chapter 6, in that daily green tea 
consumption attenuated the negative consequences of the short-term lifestyle intervention in 
previously healthy male adults. Previous studies have generally assessed the acute impact of tea on 
conduit artery endothelium-dependent vasodilation (Hodgson et al., 2005; Schreuder et al., 2014), 
with no prior work examining the vascular effects of tea on lifestyle changes. The ability of green tea 
to not only attenuate, but improve vascular function throughout the vascular tree in the presence of 
an unhealthy lifestyle, suggests that tea exerts a potent effect at the level of the endothelium, likely 
related to activation/upregulation of endothelium-derived vasodilators, such as NO. The observed 
metabolic changes are also consistent with this theory, given that green tea enhanced insulin 
sensitivity which is partly responsible for stimulating NO production in endothelial cells via the 
catalytic conversion of L-arginine to L-citrulline. Whilst the precise mechanisms underlying the tea-
induced improvements in vascular and metabolic function remain unclear, the cumulative findings of 
Chapters 5 and 6 are consistent with a NO-mediated mechanism.  
 
Despite the beneficial effects of tea consumption observed in the peripheral vasculature in Chapters 
5 and 6, based on current work contained within this thesis, tea and the tea-derived catechin (-)-
epicatechin, do not appear to exert any effect upon cerebrovascular function in healthy adult males. 
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Such findings are largely consistent with the few studies previously undertaken concerning the 
cerebrovascular effects of tea consumption (Vidyasagar et al., 2013). Given that the brain is a large 
organ and requires a large stimulus to induce functional variations, it is feasible that the duration 
and/or dosage of tea/(-)-epicatechin were insufficient to influence the cerebrovasculature. Similarly, 
the lifestyle intervention may not have been severe enough to generate an impairment in 
cerebrovascular function, particularly since the control mechanisms of the cerebrovasculature are 
different to those in the peripheral vessels. Furthermore, it is acknowledged that the sample sizes for 
the cerebral data of Chapters 6 and 7 were small and unlikely to detect any subtle changes in function 
that may have been present. Likewise, current findings were observed in healthy adult males with 
optimal cerebral endothelial function. The impact in individuals with compromised endothelial 
function may exhibit different changes, particularly an ageing population. Further research is, 
therefore, required to determine the effects of tea in such populations who are at greater risk of 
cerebrovascular disease.  
 
The work contained within this thesis provides compelling evidence for a cardioprotective role of tea 
on peripheral vascular function. The experimental studies detailed herein have contributed to the 
collective understanding of the role of tea in mitigating CVD risk and being a useful therapeutic 
approach in improving overall cardiovascular health. Furthermore, the experimental work of this 
thesis has contributed to the understanding of underlying mechanisms likely responsible for the 
observed vascular improvements and this thesis highlights the value of performing simultaneous local 
thermal hyperaemic assessment to interrogate the microvasculature for mechanistic insight.  
 
8.4 Implications  
Cardiovascular disease remains the leading cause of global mortality (WHO, 2016) and an economic 
burden for public health. Management of modifiable CVD risk factors remains an important strategy 
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in combating the progression of CVD risk towards overt disease. The research work undertaken in this 
thesis provides important insight into the effects of tea consumption on peripheral vascular function 
and insulin sensitivity, particularly its beneficial effects on lifestyle-induced vascular impairments. 
Chapters 5 and 6 are the first studies to evidence improved cutaneous microvascular function 
following both black and green tea, respectively, suggesting that the benefits of tea may not be 
confined to one type and, therefore, its effects may be experienced by a greater percentage of the 
population. Moreover, the beneficial impact in the cutaneous microvasculature is encouraging given 
that it is an important vascular bed in the pathogenesis of diabetic microangiopathy (Jaap et al., 1994; 
Tooke, 1995). Together with the generalised improvements in peripheral vascular function and insulin 
sensitivity observed in response to a short-term lifestyle intervention in Chapter 6, regular tea 
consumption may present a viable means of mitigating the deleterious impact of an unhealthy 
lifestyle. However, importantly, regular tea consumption should not be seen as a “quick fix” to temper 
the detrimental effects of an unhealthy lifestyle, or reduce the importance of regular exercise and a 
balanced diet in maintaining a healthy lifestyle and overall cardiovascular health. Nevertheless, 
regular tea consumption may represent a suitable intervention during forced periods of inactivity 
and/or excess calorie intake, such as illness or holiday periods, respectively. Longitudinal randomised 
controlled trials are required to determine whether such tea-induced vasoprotective effects are 
apparent following more prolonged lifestyle behaviours/changes. As higher levels of NO provide anti-
atherogenic benefits and the data presented within this thesis support the role of tea in improving NO 
bioavailability, these findings provide potentially significant implications for the maintenance of 
cardiovascular health, in addition to the future prevention and management of CVD. Tea consumption 
presents a simple, inexpensive, non-pharmacological cardioprotective strategy to help combat the 
ever-increasing global burden of CVD.  
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8.5 Methodological Considerations and Limitations  
There are several strengths in the methodology of this thesis. Firstly, determining the reproducibility 
of local heating protocols used to assess microvascular function (Chapter 4) enabled appropriate 
protocols to be selected for use in intervention studies in subsequent chapters of this thesis (Chapters 
5 and 6). Furthermore, the simultaneous use of such local heating protocols within this thesis 
highlights that it is a simple, applicable and feasible approach to assess cutaneous microvascular 
function and may provide further insight into the skin vasodilatory mechanisms.  The studies 
contained within this thesis were some of the first to adopt use of multiple local heating protocols.  As 
the skin is a complicated organ, it is sensible to use a multiple protocol approach rather than focus on 
a single technique. It is, therefore, recommended that future microvascular studies should adopt a 
similar approach to the work contained within this thesis and simultaneously use multiple local 
heating protocols to interrogate the skin vasculature. As FMD assessment was undertaken according 
to the latest peer-reviewed consensus guidelines (Thijssen et al., 2011), together with the use of 
custom-designed edge-detection and wall-tracking analysis software (Chapter 6), the accuracy, 
validity and prognostic index of FMD measures was maximised. Further methodological rigor was 
adhered to throughout the experimental chapters, with strict inclusion and exclusion criteria, in 
addition to the control of dietary polyphenols prior to and during laboratory measures. Finally, 
compliance to the (in)activity levels and dietary intake was monitored during the lifestyle intervention 
(Chapter 6) .  
 
Despite the methodological strengths, there are apparent limitations within this thesis. The modest 
sample sizes of the intervention studies mean that the findings cannot be generalised towards the 
wider populace. Furthermore, the studies were undertaken in healthy individuals so the findings 
cannot simply be extrapolated to patient groups. The research contained within this thesis does not 
provide any biochemical or biomolecular insight into the mechanisms underlying the vascular and 
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metabolic improvements following tea consumption, although it is important to emphasise that this 
was beyond the aims of the thesis. A further limitation is the method used to assess insulin resistance 
in Chapter 6, whereby a mixed-meal tolerance test was used; a two-stage hyperinsulinaemic-
euglycaemic clamp with infusion of deuterated glucose (Shojaee-Moradie et al., 2007) would have 
provided a more comprehensive assessment of hepatic and peripheral insulin sensitivity. However, 
given that the participants arrived to the laboratory fasted and underwent a series of vascular 
assessments prior to the insulin and glucose measures, a mixed-meal was deemed more appropriate 
and ethical.  
 
8.6 Future Direction   
Several potential areas of future research have emerged following the studies detailed within this 
thesis. Firstly, whilst the effect of acute black tea consumption on microvascular function was 
established in Chapter 5, the long-term effects of tea on the microvasculature remain unknown which 
could potentially have wider implications for cardiovascular health in the general population. 
Furthermore, the tea-induced, likely NO-mediated, improvements in cutaneous vascular function 
were observed in healthy individuals and given that reduced NO bioavailability and endothelial 
dysfunction are early markers of atherosclerosis and type 2 diabetes (Sena et al., 2013), further 
research is warranted to determine whether such improvements are seen in a population with 
compromised endothelial function, or whether they are confined to healthy individuals. Likewise, the 
mitigating effect of tea on the peripheral vasculature and metabolic function demonstrated in 
combination with the lifestyle intervention in Chapter 6, requires longitudinal study to determine 
whether tea exhibits such a protective role following an unhealthy, or even a ‘normal’ or healthy, 
lifestyle of a much greater duration. Further longitudinal randomised controlled trials will provide 
greater insight into whether regular tea consumption may also benefit both healthy individuals and 
patient groups.  Given the increasing economic burden of CVD together with an ageing population, it 
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is important to establish whether the apparent cardioprotective properties of tea may be exploited 
for consideration as a potentially inexpensive, non-pharmacological alternative for improving 
cardiovascular health.  
 
An important area requiring further study relates to the sequence of physiological events by which 
tea improves both vascular and metabolic function, as observed in Chapters 5 and 6. Whilst it is likely 
that tea exerts its beneficial effects via a mechanism related to upregulation of chemical mediators 
such as NO, it is currently unclear whether the observed improvements occur firstly in the vasculature, 
or whether tea consumption exerts an insulin-sensitising effect and stimulation of the PI-3K pathway 
to enhance NO production from the vascular endothelium. Determining this sequence will further our 
collective understanding of the mechanistic processes underpinning the beneficial effects of tea and 
any additional signalling pathways that may be involved.  
 
It remains unclear whether tea and its isolated constituents such as (-)-epicatechin, influence 
cerebrovascular function based upon the work detailed within this thesis and the overall paucity of 
studies performed to date. Future research should, therefore, endeavour to further explore both the 
acute and chronic effects of tea and tea-derived catechins on the cerebrovasculature. The present 
findings were observed in healthy individuals whereby the brain may require a much greater stimulus 
than the studies herein to demonstrate any functional change. It would, therefore, be prudent to 
examine the effects of tea in a population at risk of cerebrovascular disease, particularly older 
individuals. Furthermore, it would be valuable to investigate the effects of tea and isolated tea-derived 
compounds on cognitive function, particularly since cerebral hypoperfusion is considered to be a 
potential trigger of cognitive decline and the development of neurodegenerative disorders, such as 
dementia (Farkas et al., 2002).  
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Given the tea-induced improvements on endothelial function, it would be worthwhile examining the 
impact of tea consumption upon athletic performance, particularly since blood flow and maximum 
cardiac output are critical determinants of overall cardiovascular performance (Somerville et al., 
2017). Polyphenols, such as quercetin, have demonstrated improved aerobic performance in double-
blind randomised controlled trials linked to mechanisms related to upregulation of mitochondrial 
biogenesis (MacRae & Mefferd, 2006; Nieman et al., 2010). However, tea and tea-derived catechins 
have demonstrated equivocal outcomes and warrant further investigation.  
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